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Cells of the early vertebrate embryo are distinct in their ability to commit into
any cell lineage. How the embryo acquires this remarkable plasticity from two
terminally differentiated gametes remains largely unknown. The plasticity in early
embryo relies on achieving a unique transcriptome, which is regulated at multiple
levels - including chromatin accessibility at developmental enhancers and genes.
To understand the global landscape of chromatin accessibility during early embryo-
genesis, we utilized zebrafish embryos and explored three aspects of chromatin
regulation.
We first focused on the ATPase subunits (Brg1 and Brm) of SWI/SNF com-
plexes, which are important regulators of chromatin accessibility and gene expres-
sion in all eukaryotes. To understand where they act in the genome, we profiled the
occupancy of Brg1 and Brm by ChIP-seq at three early embryonic stages around
major onset of zygotic genome activation. We observed the occupancy of Brg1 and
Brm during early embryogenesis is highly dynamic. The promoters of key pluripo-
tency factors and other developmental transcription factors are robustly occupied
by Brg1 and Brm. Interestingly, Brg1, but not Brm, is highly correlated with active
histone modifications. However, only Brm commonly occupies gene bodies, which
is dependent on transcription elongation. This work suggests SWI/SNF complexes
might play important roles during early embryogenesis, and also reveals distinct
roles of Brg1 and Brm in early zebrafish development.
We then profiled the global landscape of accessible chromatin by ATAC-seq
at three embryonic stages, as well as one differentiated tissue, adult liver. The
data suggest chromatin accessibility increases during early embryogenesis. Here,
∼60% of open chromatin regions reside at genic regions and are highly enriched
at promoters. Furthermore, many interesting candidate transcription factors are
revealed based on motif analyses. Finally, ATAC-seq fragments with length of
120-220bp, together with MNase-seq date are used to profile nucleosome posi-
tioning. Our data determines nucleosome positioning during early embryogenesis,
also discovered many interesting sequence characteristics involved in nucleosome
positioning at various gene features.
In summary, this work has extensively investigated the dynamics of chromatin
landscape and the role of chromatin remodelers during early zebrafish develop-
ment, which allow the comprehensive understanding of the regulation during early
embryogenesis.
iv
To my greatest parents and dearest husband.
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During early embryogenesis, the vertebrate embryo reprograms the terminally-
differentiated gametes and becomes totipotent, which allows the embryonic cells to
adopt any cell fate. The ability to differentiate into all cell types except extraembry-
onic lineage is known as pluripotency. Elucidating how pluripotency is established
and regulated is pivotal for our understanding of development, reprogramming,
regeneration and tumorigenesis.
This fascinating plasticity relies on highly regulated transcription circuits. Specif-
ically, genes required for pluripotency and early development are selectively ex-
pressed, while lineage-specification genes are poised in a repressed but compe-
tent state for later expression and development (Jaenisch & Young, 2008; MacArthur
et al., 2009). The pluripotent transcriptome is coordinately modulated at multiple
levels, including transcription factors binding, DNA methylation, histone modifi-
cation and chromatin accessibility (Lessard & Crabtree, 2010; Burton & Torres-
Padilla, 2014). Among these, chromatin accessibility is especially important due to
its direct impact on the ability of transcription factors and co-regulators to bind
within chromatin. This dissertation aims to provide insights into the regulation
of pluripotency from a chromatin perspective, using the zebrafish embryo as a
model. In principle, we hope to determine the genome-wide chromatin landscape
2in early zebrafish development, and how it is regulated by chromatin remodelers,
particularly SWI/SNF complexes. To answer these questions, it is important to
understand the basics of chromatin; how does chromatin state affect transcription;
how chromatin state, especially chromatin accessibility is regulated. I would also
introduce chromatin remodelers, the central regulators of chromatin accessibility,
with a focus on SWI/SNF complexes. Furthermore, what is known about chromatin
state in early embryos, and how it is regulated will also be introduced.
1.1 Chromatin and chromatin accessibility
Genomic DNA is packaged into chromatin, which allows a tight control of gene
expression and remarkable compaction of the genome. In most cell types, the
basic unit of chromatin is nucleosome, which is composed of ∼147bp DNA and
an octamer of four histones, H2A, H2B, H3, and H4 (Kornberg, 1974). Each
nucleosome is separated by linker DNA, which is occupied by the fifth histone, H1.
The linker DNA and H1 ensure the regularly spacing of nucleosome and enable
the condensation of nucleosomes into higher-order chromatin structure (Kornberg,
1977; Luger et al., 1997).
Besides the canonical histones, histone variants can also be incorporated into
nucleosomes. For example, H3.3 and CenH3 are variants to H3, and H2A.Z,
H2A.X and macroH2A are variants to H2A. The histone compositions greatly im-
pact the stability of nucleosomes. In addition, histone tails are subject to a variety of
posttranslational modifications including methylation (mono-, di-, tri-methylation),
acetylation, phosphorylation, ubiquitination, and recently discovered sumoylation
and crotonylation (Tan et al., 2011). These histone modifications are differentially
3distributed at euchromatin and heterochromatin, and are tightly related to gene
expression (Li et al., 2007).
Another important concept about chromatin is chromatin accessibility. When
DNA is wrapped around histones, it is inaccessible to many (but not all) DNA-
binding regulatory proteins due to the tight interaction with histones, which is known
as chromatin inaccessibility. However, during gene expression, DNA repair and
replication, the DNA must be made accessible to various factors mediating these
processes (Clapier & Cairns, 2009; Lessard & Crabtree, 2010) (Figure 1.1). Coop-
eratively, histone composition, histone modification, as well as chromatin accessi-
bility contribute to a highly dynamic and complex chromatin state that is pivotal in
essentially all genome-related processes.
1.2 Chromatin state and transcription regulation
Chromatin state has a profound impact on transcription regulation at multiple
levels. First, chromatin accessibility, as it is defined, determines whether the
promoters or enhancers are permissive for the binding of transcription factors and
co-regulators, which leads to gene activation or repression based on the nature of
the transcription factors.
Second, histone modifications, which act individually or cooperatively, are in-
volved in gene activation, repression and poising (Li et al., 2007). Transcriptionally
active genes often have H3K4me3 at the promoters, which can be directly bound
by TAF3 in TFIID of the transcription machinery (Vermeulen et al., 2007; Lauberth
et al., 2013). H3K4me3 is also capable of recruiting chromatin remodelers to
dissemble nucleosome and to open the chromatin (Wysocka et al., 2006). Fur-
4thermore, histone acetylation marks, such as H3K27ac, are also highly enriched
at active promoters. Acetylation disrupts the interaction between DNA and histone
and slightly increases the mobility of nucleosome (Ferreira et al., 2007). More-
over, acetylation can be recognized by bromodomains present in the subunits of
chromatin remodelers (e.g. Brg1, Brm, PRDM1) (Filippakopoulos & Knapp, 2012),
which then increase the chromatin accessibility. Of note, active promoters are
also DNA hypomethylated, which allows the binding of transcript factors and other
co-regulators (Tate & Bird, 1993). Besides promoters, transcribed genes also bear
H3K36me3 at gene bodies, which are reported to recruit histone deacetylases,
preventing RNA Pol II from initiating transcription within gene bodies (Carrozza
et al., 2005; Joshi & Struhl, 2005). It is interesting to note that H3K36me3 has
been found on promoters of silenced genes in zebrafish sperm, which suggests
distinct roles of H3K36me3 in different cellular contexts (Wu et al., 2011).
In contrast, promoters of transcriptionally silent genes carry high DNA methy-
lation, which prevents protein binding. Additionally, H3K27me3 and H3K9me3 are
prevalent in repressed genes, which either antagonize active marks or condense
the chromatin by recruiting specific chromatin remodelers (Li et al., 2007). Interest-
ingly, in ES cells, a combination of H3K4me3 and H3K27me3 has been discovered
specifically on development genes (Bernstein et al., 2006). The co-occurrence of
active and repressive marks is termed ”bivalent marks” and has been identified
later in multipotent stem cells (Cui et al., 2009), early embryos (Vastenhouw et al.,
2010; Lindeman et al., 2011), and germline (Hammoud et al., 2009; Wu et al.,
2011). Bivalent marks poise genes in a repressed but competent state for later
expression and development.
5The chromatin state at enhancers also plays a key role in regulating tran-
scription. Enhancers are predominately marked by H3K4me1, which has been
proposed to either prevents the de novo methylation at enhancers or promotes
incorporation of H2A.Z to create a permissive chromatin. This in turn facilitates TF
binding and leads to the expression of target genes (Ooi et al., 2007; Altaf et al.,
2010). H3K4me1 in combination of H3K27ac is enriched at active enhancers (Calo
& Wysocka, 2013), whereas co-localization of H3K4me1 and H3K27me3 is an
indicator of poised enhancers (Rada-Iglesias et al., 2011). To sum up, transcription
is tightly regulated at the chromatin level, which suggests chromatin regulation
may play a key role in the establishment and maintenance of pluripotency in early
embryo, as pluripotency relies on highly regulated transcription circuits.
1.3 Regulators of chromatin state and
SWI/SNF complexes
The diverse chromatin states are regulated by a variety of proteins and com-
plexes, which can be generally divided into two classes, histone modifiers and
chromatin remodelers. Histone modifiers include ”histone writers” and ”histone
erasers” (Eberharter & Becker, 2002). For instance, histone acetyltransferases
(p300 or CBP) establish H3K27ac, which can be removed by histone deacetylases
(HDACs). Chromatin remodelers are multisubunit protein complexes that use the
energy from ATP hydrolysis to alter nucleosome compositions or slide/eject nucle-
osomes. They can be divided into four major subfamilies − SWI/SNF, ISWI, INO80
and CHD − based on the domain structures of the ATPase subunits, subunits,
complex subunit composition, and their specialized functions (Clapier & Cairns,
2009). In general, chromatin remodelers that assemble chromatin by organizing
6nucleosome arrays are involved in gene repression, whereas chromatin remodel-
ers associated with chromatin/nucleosome disorganization and disassembly pro-
mote gene activation. Among these, SWI/SNF complexes are well-studied for their
involvement in gene activation via disorganizing chromatin, which is a focus of my
dissertation.
The complex was initially discovered in yeast (Winston & Carlson, 1992; Cairns
et al., 1996), and similar complexes were later identified in fly and vertebrates
(Mohrmann & Verrijzer, 2005). In yeast, there are two classes of SWI/SNF family
chromatin remodelers, one is RSC complexes, the other is SWI/SNF complexes.
The RSC complexes is about ten-fold more abundant than SWI/SNF complexes
and and is essential for yeast viability (Cairns et al., 1996). In vertebrates, two
major SWI/SNF complexes exist: BAF (Brg1-assoicated factor) and PBAF (poly-
bromo Brg1-assoicated factor). The two complexes are comprised of one of two
mutually exclusive ATPase subunits (Brg1 and Brm), several highly conserved core
subunits (SNF5, BAF155 and BAF170), and some subunits that are unique to
BAF or PBAF (Figure 1.2). Specifically, ARID1A and ARID1B are two mutually
exclusive subunits of BAF complex, whereas PBRM1 and ARID2 are specific to
PBAF complex (Wilson & Roberts, 2011). Other than the ubiquitously expressed
BAF and PBAF complexes, tissue-specific SWI/SNF complexes have been widely
identified, which consist of tissue-specific subunits. For instance, ES cell-specific
BAF complex (esBAF) is characterized by the replacement of BAF170 subunits
with a second copy of BAF155 subunit (Ho et al., 2009b). Additionally, nBAF,
another well-studied BAF complex, is specifically present in postmitotic neurons,
and is distinct in its incorporation of BAF53b, BAF45b and CREST which are
7exclusively expressed in neurons (Wu et al., 2007).
1.4 ATPase subunits of SWI/SNF complex
Brg1 and Brm are two mutually exclusive ATPase subunits of SWI/SNF com-
plexes, conserved in vertebrates. The two proteins are very similar in protein
sequence, where their protein sequences share 72% identities in zebrafish and
78% identities in human. Why do vertebrates need two ATPase subunits if they
are so similar in protein sequence? Is it because Brg1 and Brm have specialized
functions? Expression profiles reveal that Brg1 and Brm are co-expressed in
various cells and tissues (Reyes et al., 1998; Becker et al., 2009). However,
Brg1 is preferentially expressed in cells that undergo proliferation and self-renewal,
whereas Brm appears more abundant in cells that are not constantly proliferating
(Reisman et al., 2005). Moreover, Brg1 interacts with zinc finger proteins (KLF,
GATA, etc.) through a unique N’terminal domain which is absent in Brm. On the
other hand, only Brm binds ankyrin repeat proteins (ICD22 and CBF-1), which
are the components of Notch signaling pathways (Kadam & Emerson, 2003). In
contrast to the binding specificity, Brg1 and Brm has also been shown to interact
with retinoblastoma (Rb) protein, glucocorticoid receptor and C/EBP (Muchardt &
Yaniv, 1993; Kowenz-Leutz & Leutz, 1999).
In order to better elucidate the specialized functions of Brg1 and Brm, a few
studies directly compared the roles of Brg1 and Brm in different systems. In
osteoblast differentiation, Brm deletion accelerates differentiation, whereas Brg1
deletion inhibits differentiation, suggesting antagonistic roles of Brg1 and Brm (Flow-
ers et al., 2009). In skeletal myogenesis, both Brg1 and Brm are required for
8MyoD-mediated differentiation (de la Serna et al., 2001). However, Brg1 functions
on gene activation at early stages of differentiation, whereas Brm promotes Ccnd1
repression and cell cycle arrest prior to the activation of muscle genes (Albini et al.,
2015). In addition, my data suggest Brg1 and Brm might have shared functions, as
well as specialized roles. Collectively, these data suggest that Brg1 and Brm may
have similar, auxiliary and antagonistic roles depending on the cellular contexts.
Nevertheless, the most evident differences between Brg1 and Brm are from genet-
ics studies in mouse and cancer studies, which will be discussed in the following
two sections.
1.5 SWI/SNF complex and early embryo development
To become a totipotent zygote, the embryos need to reprogram two differen-
tiated gametes via extensive chromatin reorganization. Chromatin remodelers,
especially SWI/SNF complexes, regulate chromatin accessibility and are important
in the early development. In mice, zygotic knockdown of Brg1 renders embryonic
lethality at preimplantation stages, while maternal-zygotic Brg1 null mouse em-
bryo is arrested at as early as the two-cell stage (which is when ZGA happen
in mouse) (Bultman et al., 2000, 2006). In line with its role in gene activation,
30% of genes are downregulated in Brg1 maternal null mouse, and exhibit a
decrease of H3K4me2. In contrast, zygotic Brm null mouse is viable and fertile,
and only exhibits mild defects including increased body weight and deregulation
of cell growth control in embryonic fibroblasts (Reisman et al., 2005). However, it
has to be acknowledged that the Brm null mouse can circumvent the Brm deletion
by alternative splicing to create a short isoform containing all essential domains
9(Thompson et al., 2015). Therefore, complete knockout of Brm is needed to com-
pare the importance of Brg1 and Brm directly. Besides the ATPase subunits,
inactivations of other core subunits (ARID1A, ARID1B, BAF155 and SNF5) also
result in embryonic lethality. Furthermore, deletion of Brm, which is the only
ATPase subunit of SWI/SNF complex in fly, results in severe embryonic defects
and eventfully leads to lethality before adulthood (Brizuela et al., 1994).
Additional support came from studies in ES cells. It has been demonstrated
that the esBAF complex is required for maintaining the pluripotency of mouse ES
cells (Ho et al., 2009b). Moreover, SWI/SNF complexes bind pluripotent genes,
and displayed extensive genome-wide colocalization with Oct4, Nanog and Sox2
(Ho et al., 2009a; Kidder et al., 2009). Knockdown of Brg1 in mouse ES cell
downregulated pluripotency related genes, while upregulated the genes involved
in differentiation (Kidder et al., 2009). Furthermore, in human ES cell, Brg1 has
been found localized at a large number of enhancers (Rada-Iglesias et al., 2011).
These evidence, suggest SWI/SNF complexes, represented by Brg1, may increase
promoter and enhancer accessibility, and govern the proper transcription regulation
in ES cells.
1.6 SWI/SNF complexes and tumorigenesis
With the extensive high-throughput sequencing of cancer genomes, SWI/SNF
complexes have emerged as major tumor suppressors, as more than 20% of
human tumors contain mutations on subunits of SWI/SNF complexes (Kadoch
et al., 2013)(Figure 1.3). Around 400 mutations have been found in Brg1 among a
variety of tumors. Most of the mutations are high-impact missense substitutions or
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truncating mutations. In contrast, only around 100 mutations are identified in Brm,
which is still a high mutation rate (Hodges et al., 2016). SNF5 is another subunit
that is mutated in nearly all rhabdoid tumors. Conditional biallelic inactivation of
SNF5 in mouse renders cancer phenotype as early as 11 weeks, which is even
more aggressive compared to p53 deficiency where cancer onsets around 20
weeks (Roberts et al., 2002). In addition, ARID1A and PRDM1 are frequently
mutated in a number of cancers. ARID1A mutations were reported in ∼50% of
ovarian clear cell carcinomas, ∼34% of uterine endometrial carcinomas, ∼29% of
bladder tumors and ∼34% stomach tumors (Hodges et al., 2016). PRDM1 muta-
tions or losses are identified in 41% of renal clear cell carcinomas (Varela et al.,
2011). All these reported mutations make SWI/SNF complexes the most frequently
mutated chromatin regulatory complexes in cancer. However, the mechanism yet
remains obscure. Therefore, understanding the functions of SWI/SNF complexes
in both normal development and cancer contexts will provide valuable insights into
our understanding on tumorigenesis and therapeutic approaches.
1.7 Chromatin dynamics in mouse early development
Zygotic genome activation (ZGA) is one of the most important molecular events
in early embryogenesis, when the zygotic genome transits from transcriptional
silence to transcriptional activation (Figure 1.4). At ZGA, genes that are required
for early development are selectively expressed, while genes needed for lineage
specification and organogenesis are primed in a repressed state. This plasticity is
achieved in part through coordinate regulation of chromatin accessibility.
Histone modifications are highly dynamic in the early embryos and display
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parental asymmetries. Early studies in mouse embryos using immunofluorescence
and mass spectrometry revealed unique histone modifications profiles. Upon fer-
tilization, the maternal genome displays a histone modification profile largely re-
sembling somatic cells, where discernable levels of acetylated lysine, methylated
H3K4me, H3K9me2/3, H3K20me3 and H3K64me3 are detected. H3K20me3 and
H3K64me3 are then rapidly removed at 2-cell stage (Adenot et al., 1997; Kourmouli
et al., 2004; Santos et al., 2005). For paternal genome, exchange of protamines to
hyperacetylated histones supplied from the oocytes initiates immediately after fer-
tilization. Then the acetylated histones are substituted with primarily monomethy-
lated histones (i.e. H3K4me, H3K9me, H3K27me, and H3K20me) (Kimmins &
Sassone-Corsi, 2005; Lepikhov & Walter, 2004). In addition, H3.3 is incorporated
into the paternal genome, which is important for pericentric heterochromatin for-
mation (Santenard et al., 2010).
Very recently, three groups overcame technical challenges with early mouse
embryo, and performed ChIP-seq on H3K4me3, H3K27ac, and H3K27me in ga-
metes and pre-implantation embryos (Liu et al., 2016; Zhang et al., 2016; Dahl
et al., 2016). All three studies found that H3K4me3 displays a broad distribution
specifically in oocyte, which becomes confined to narrow distribution at two-cell
stage, as seen in ES cells and differentiated cells. Although they detected co-
occurrence of H3K4me3 and H3K27me3 at certain genes in early two-cell em-
bryos, it is infrequent and unstable (Liu et al., 2016).
Finally, the genome-wide chromatin accessibility in early embryos has begun
to be uncovered by liDNase or ATAC-seq experiments (Lu et al., 2016; Wu et al.,
2016). These data revealed that the chromatin is less accessible before the genome
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activation and becomes increasingly open after ZGA, which is in contrast to the re-
sult from electron-microscopy (EM) where the zygote chromatin is less condensed
compared to that of later-stage embryo (Ahmed et al., 2010). The authors argued
that the EM results reflect a less-established higher-order chromatin structure but
not a permissive local chromatin state. Regardless, the genome-wide profiling of
open chromatin revealed the accessible regions usually located at promoters and
especially at enhancers. Additionally, the accessible regions changes extensively
at different stage of embryogenesis. In summary, dynamic chromatin reprogram-
ming and establishment take place in early development, which is essential for
pluripotency and cell fate specification.
1.8 The advantage of zebrafish as a model organism
Zebrafish has been extensively used as an important model organism in the
studies on vertebrate development, regeneration, and diseases (Dooley & Zon,
2000). An adult zebrafish is around 3 to 4 centimeters long, and can be maintained
in large scale easily and economically. One pair of male and female zebrafish
can produce around 200 embryos per week. The embryos fertilize and develop
outside of the mother, which enables easy collection of thousands of embryos in
one day. In addition, the zebrafish embryos are nearly transparent, which allows a
clear visualization of reporter genes and the examination of phenotype. Moreover,
the zebrafish embryo develops rapidly: it establishes most cell types and tissues
by five days postfertilization, and reaches sexual maturity around 2 to 3 months
(Kimmel et al., 1995). These features make zebrafish suitable for large-scale
forward genetic screen and promote the development of various means for re-
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verse genetics such as MO knockdown, ZFNs, TALENS and CPISPR technology
(Lawson & Wolfe, 2011; Zu et al., 2013; Auer et al., 2014).
Furthermore, the zebrafish genome is well annotated and composed of around
26,000 protein-coding genes, most of which are highly conserved (Howe et al.,
2013). Notably, many key chromatin regulators and transcription factors regulating
early embryogenesis are conserved and function in comparable pathways (Mudb-
hary & Sadler, 2011). Importantly, zygotic genome activation in zebrafish happens
at 1000-cell stage around 3hpf (hour postfertilization), while ZGA happens at 2-cell
stage in mouse, and at 2-cell to 4-cell stage in humans (Figure 1.4). The abun-
dance of cells at ZGA and the feasible collection of a vast number of embryos
make zebrafish a great system for studying early embryogenesis.
1.9 Regulation of early zebrafish embryogenesis
In zebrafish, transcription factors, small RNAs and chromatin regulators are
central players in early embryogenesis. For the proper transition from maternal
to zygotic control of embryogenesis, maternal factors have to be destabilized in
a regulatory way. In zebrafish, miR-430 directly modulates the degradation of
several hundred maternal provided mRNA targets, which is in part via deadeny-
lation (Giraldez et al., 2006). Deficiency of miR-430 in dicer null fish (Dicer is the
enzyme required for microRNA biogenesis) leads to defects in gastrulation and
delayed development, suggesting a vital role of miRNA in the early embryogenesis
(Giraldez et al., 2005). Here, a key question is which factors help to promote the
early and robust transcription of miR-430, which is informed in this dissertation.
Besides transcription factors and small RNAs, DNA methylation is also im-
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portant in the early development. Inhibiting DNMTs (DNA methyltransferases)
by 5-Aza-2’-deoxycytidine arrested the embryos during gastrulation, and misregu-
lated transcription of about 3,000 genes (Martin et al., 1999; Potok et al., 2013).
Consistently, knockdown of DNMT1 causes intestinal and pancreatic differentiation
abnormalities, and knockdown of DNMT3 leads to neurogenic defects (Rai et al.,
2006; Anderson et al., 2009; Rai et al., 2010).
Dynamic histone modification profiles are also observed in zebrafish embryos.
Before ZGA, low levels of H3K4me3 is detected on around a thousand of the genes
that are required for early development, such as pou5f1. After ZGA, the levels
of histone modifications increase dramatically, where more than 80% of genes
acquire H3K4me3 at the promoters (Vastenhouw et al., 2010). Bivalent marks
are also established and poise the development genes (i.e. Hox genes) for later
expression (Lindeman et al., 2011; Wu et al., 2011). Furthermore, some zebrafish
HDAC (histone deacetylases) mutants display abnormalities in early development
and various tissue developments (Mudbhary & Sadler, 2011). Although mutants of
most histone modifiers have not been established in zebrafish, it is still likely that
histone modifiers play indispensable roles in zebrafish early development, con-
sidering the conservation of histone modifiers between zebrafish and mammals,
and the important roles of histone modifiers in mouse embryogenesis (Lessard &
Crabtree, 2010).
Pou5f1, Nanog, and Sox2 are core pluripotency factors of stem cell self-renewal.
Their conserved zebrafish homologs are also involved in the establishment of
pluripotency in early embryo. Based on genetic inactivation of Pou5f1 (annotated
as Pou5f3 in zebrafish genome build, zv10) and morpholino inhibition of Nanog
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and SoxB1 factor (Sox2, Sox2, Sox19a, and Sox19b), the Lee group found that
the treated embryo is completely arrested before gastrulation, accompanied by a
substantial gene downregulation at ZGA (Lee et al., 2013). Meanwhile, another
group demonstrated Pou5f1 preferentially binds around 40% of genes that are
activated at the ZGA, and probably enhances their gene expression. Of note,
the transcription at ZGA is downregulated but not abolished when simultaneously
inactivated Pou5f1, Nanog, and SoxB1 factors, suggesting other unknown factors
are also required for gene activation at ZGA (Leichsenring et al., 2013). One in-
triguing question is how did Pou5f1, Nanog, and SoxB1 factors manage to bind the
promoter of their target genes. Are SWI/SNF complexes involved in augmenting
the local chromatin accessibility, thus facilitating their binding? Our data suggest
so, and will be described in detail later in Chapter 2.
In conclusion, the studies on small RNAs, chromatin regulators and transcrip-
tion factors are valuable for our understanding of the regulation of embryogenesis.
However, two major aspects of embryogenesis regulation are still poorly charac-
terized in zebrafish: 1) the role of chromatin remodelers, and 2) the genome-wide
chromatin accessibility. Understanding the chromatin landscape and how it is
shaped by chromatin remodelers will provide invaluable insights to our knowledge
of early embryogenesis, cell plasticity and reprogramming, which is the focus of
my dissertation.
1.10 Dissertation overview
In this dissertation, works from three major projects are highlighted. These
projects include the first genome-wide profiling of Brg1 and Brm in the early ze-
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brafish embryo and the dynamic chromatin landscape in early embryos and adult
liver based on ATAC-seq and MNase-seq.
In Chapter 2, ChIP-seq data of Brg1 and Brm at embryonic stages are de-
scribed. We revealed the occupancy of Brg1 and Brm in early embryos is highly
dynamic. Brg1 and Brm co-occupy a large number of genes, but also bind specific
genes, respectively. In addition, Brg1 and Brm occupancy correlates with higher
gene expression, more accessible chromatin and active histone modifications.
One distinct feature of Brg1 is the correlation with active histone modifications
(H3K27ac, H3K4me1 and H3K4me3) but not with repressive histone modification,
H3K27me3. Uniquely for Brm, it occupies not only promoters but also gene bodies
of a large number of genes, which perfectly correlates with the occupancy of Pol
II. We further demonstrated the distribution of Brm at gene body is dependent on
transcription elongation, suggesting coordination of functions.
In Chapter 3, extensive bioinformatics analyses of ATAC-seq from three embry-
onic stages and adult liver are presented. We revealed the chromatin accessibility
at Pol II genes and enhancers increases substantially from pre-MTB to MBT. A
large set of open chromatin regions are present at genic regions, with a prefer-
ence at promoters. Genes that are associated with open chromatin are generally
expressed, except a group of genes that are marked by H3K4me1 and H3K27me3
at their promoters. My analyses also extend to Pol III genes, and show the number
of Pol III genes which are associated with open chromatin decreases as embryo
develops − a trend opposite to Pol II. In addition, motif analysis is performed to
identify transcription factors that are potentially involved in the regulation of early
embryogenesis. I confirmed the enrichment of known factors including Pou5f3
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and Sox-family factors, and also identified novel motifs, such as Nr3e2 and NFYB.
Finally, fragments with length of 120-220bp, which presumably represent mono-
nucleosomes, can be utilized to profile nucleosome positioning.
In Chapter 4, I focus on nucleosome positioning at embryonic stages and adult
liver, which is profiled by MNase-seq. Nucleosome positioning from crosslinked
and noncrosslinked samples are largely similar. However, crosslinked samples
have a better representation of ‘weak’ nucleosomes compared to noncrosslinked
samples. Comparisons of nucleosome positioning at different stages suggest
embryonic samples at pre-MBT are distinct from that of later stages, especially
at gene or promoter regions. Additionally, the establishment of nucleosome array
is not dependent on transcription, but may be related to the poised Pol II and
DNA sequences. Furthermore, nucleosomes are also enriched on exons, which
could be mediated by the high frequency of polyA(5) sequence at the 5’end of
exons and the alternation of A/T and G/C dinucleotides inside exons. Interestingly,
exons with strong AT-GC alternation often have weak polyA(5) sequence at their
5end, whereas exons with weak AT-GC alternation tend to have strong polyA(5)
sequence – a feature that is also observed in other organisms.
In Appendix A, I summarize all the commercial antibodies that have been tested
for various zebrafish transcription factors and chromatin remodelers. A couple of
the antibodies robustly detect their target proteins, and a few have been validated
for their application in ChIP-seq. However, a lot of the tested antibodies fail to
recognize their target proteins, which are also listed to help others avoid wasting
time on them.
In Appendix B, I summarize an additional 10 customized antibodies that have
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been generated but not used in previous projects. The detailed information regard-
ing antigen regions, cloning primers, and peptide purification are described. Four
antibodies displayed promising results based on Western blotting, including Oct1,
SNF2H, SNF2L and Sox3.
Lastly, in Appendix C, plasmids containing cDNA of two transcription factors and
four chromatin remodelers have been constructed. Dominant negative constructs
of Brg1, Brm, SNF2H have also been generated.
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Figure 1.1: Epigenetic regulation of transcription. Simplified inactive gene is on the
left and active gene is on the right. From the top to bottom, status of DNA methy-
lation, histone modifications and histone variants, chromatin accessibility, and
higher-order structures such as nuclear lamina-associated domains are depicted.
Genes that are inactive have methylated DNA and inaccessible chromatin. They
are also associated with repressive histone marks, H3K9me3 and H3K27me3,
as well as lamina. In contrast, active genes have DNA hypomethylation (or
absence), accessible chromatin. They are also associated with active histone
marks, H3K4me3 and H3K36me3. In addition, they reside in transcription factory
domain. Reprinted by permission from Macmillan Publishers Ltd: Nature Reviews
Genetics (Zhou et al., 2011)
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Figure 1.2: Homology of SWI/SNF complexes in different organisms. (A) BAF-
and PBAF- like complexes in yeast (SWI/SNF and RSC complexes), fly (Brahma-
associated proteins (BAPs) and Polybromo-associated BAP (PBAP) complexes),
mouse and human (BAF and PBAF complexes). (B) Summary of the alternative
names of subunits of SWI/SNF complexes. Reprinted by permission of Cold Spring
Harbor Laboratory Press (Hodges et al., 2016)
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Figure 1.3: Mutation frequency of SWI/SNF complexes subunits in cancer. Fre-
quency includes all nonsilent mutations, biallelic deletions, and gene fusions. MRT,
malignant rhabdoid tumor; PCNSL, Primary central nervous system lymphoma;
DLBCL, diffuse large B-cell lymphoma; AML, acute myeloid leukemia. Reprinted




Figure 1.4: Overview of maternal-zygotic transition in different organisms. Red
zone indicates the degradation of maternal provided factors; light blue zone
indicates the ‘minor’ wave of zygotic genome activation (ZGA); dark blue zone
indicates the ‘major’ wave of ZGA. Cell cycles and respective time for key embry-
onic stages are labelled under each organisms. Reprinted by permission of THE
COMPANY OF BIOLOGISTS LTD. (Tadros & Lipshitz, 2009)
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CHAPTER 2
DISTINCTIVE ROLES OF BRG1 AND BRM IN EARLY
ZEBRAFISH DEVELOPMENT
2.1 Abstract
Brg1 and Brm function as alternative core enzymatic ATPases of SWI/SNF
complex in vertebrates, with clear homologs in zebrafish. Brg1 (but not Brm) is
required for early cleavage-stage transcription in mice, but where and how Brg1
or Brm impact chromatin in early embryos remains unexplored. Here, we utilize
zebrafish embryos to provide the first simultaneous genome-wide profiling of Brg1
and Brm occupancy in any organism/cell type, alongside our profiling of open
chromatin and RNA polymerase II. We reveal shared and unique loci for Brg1
and Brm, their shared occupancy of open chromatin and particular developmen-
tal promoters, and higher transcription at co-occupied genes. Interestingly, only
Brg1 is strongly associated with active histone modifications. Strikingly, only Brm
commonly occupies gene bodies, overlapping precisely with Pol II. Functional ex-
periments involving Pol II elongation inhibition alongside bioinformatic analyses
suggest that Brm travels with Pol II into gene bodies, primarily at short, very
highly-transcribed genes with few introns. Taken together, our results support
roles for Brg1 primarily at promoters and enhancers, and for Brm in association




Early embryogenesis is a fascinating stage in development, where the embryo
– formed from two highly specialized terminally-differential gametes – gains the
ability to differentiate into any cell lineage. These pluripotent embryonic cells
have to selectively express genes required for pluripotency and early development,
while also poising lineage-specification genes in a repressed but competent state
for later expression and development (Jaenisch & Young, 2008; Zernicka-Goetz
et al., 2009; Lee et al., 2014). This tight control is established through precise
regulation of chromatin state at multiple levels, including chromatin accessibility –
which involves interplay between transcription factors and chromatin remodeling
complexes (Clapier & Cairns, 2009).
Here, we explore the roles of SWI/SNF subfamily chromatin remodelers in
very early development, using the advantages of the zebrafish model. SWI/SNF
complexes are known to play important roles in helping transcription factors bind
to chromatin. They are multi-subunit chromatin remodeling complexes that are
conserved in eukaryotes, and consist of a highly-conserved set of six core subunits
accompanied by an additional set of auxiliary subunits, which can vary between
organisms and/or cell types (Clapier & Cairns, 2009; Hota & Bruneau, 2016).
Among the core subunits is a central catalytic ATPase, which functions as an
ATP-dependent DNA translocase, which can pump DNA around nucleosomes.
SWI/SNF complexes promote accessibility of transcription factors to chromatin
through utilizing their DNA translocation activity to slide or eject nucleosomes,
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and can facilitate the binding of either activators or repressors; therefore, they can
facilitate either activation or repression – though activation appears more common
(Clapier & Cairns, 2009).
In vertebrates, SWI/SNF-subfamily complexes are built around one of two core
ATPase subunits: Brg1 or Brm, which are highly similar, and assemble in a mutually-
exclusive manner into the complex. Brg1 and Brm can interact with distinct classes
of transcription factors, and thus potentially localize to different genomic loci –
however, as no genome-wide study of Brm occupancy currently exists, its lo-
calization remains largely unknown (Kadam & Emerson, 2003). Brg1 knockout
confers embryonic lethality at preimplantation stages, whereas the Brm mutant
mouse appears viable and fertile, though 15% heavier than controls (Bultman
et al., 2000; Reyes et al., 1998). However, alternative splicing in certain cell
types may allow the current Brm insertion mouse to splice around the insertion
to create a slightly smaller functional isoform containing all essential domains –
requiring a full deletion/knockout to definitively determine the Brm null phenotype
and contribution to cancer (Thompson et al., 2015). In addition, human BRG1
and BRM are mutated in a number of malignancies, with BRG1 more frequently
disrupted than BRM (Hodges et al., 2016). Curiously, Brm but not Brg1 appears
involved in alternative splicing, with Brm occupancy demonstrated at three test
genes (Batsche´ et al., 2006).
A key question in very early development is how the genome transitions from
transcriptional quiescence (and reliance on maternally-derived proteins and mRNA)
to transcriptional activation, termed zygotic genome activation (ZGA). Here, a ma-
jor role for chromatin remodeling can be envisioned, to help sculpt the nucleosome
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landscape and open chromatin for transcription factors to define genes that will
be activated or repressed when transcription is enabled. However, assessing very
early roles in the embryo for factors is challenging due to the maternal inheritance
of protein and/or mRNA (requiring oocyte-specific mutant/depletion for genetic ex-
amination), and the limitations in cell numbers at ZGA, limiting genomics/molecular
approaches. In mice and humans, major ZGA occurs at/around the 2-cell or
4-cell stage, respectively. However, in zebrafish major ZGA occurs around the
tenth cell cycle (∼1000 cells), enabling genomics approaches (Tadros & Lipshitz,
2009). In zebrafish, the larger process commonly referred to as the midblastula
transition (termed MBT, cell cycles 10-12) is coincident with strongest phase of
ZGA, so we will hereafter use the term MBT. Notably, elegant prior work in mice
demonstrated that oocyte-specific loss of Brg1 conferred a 2-cell arrest, strongly
suggesting Brg1 involvement in ZGA (Bultman et al., 2006). However where Brg1
(or Brm) remodels chromatin and its relationship to RNA polymerases has not
been determined. Beyond ZGA, disruption of particular core subunits of SWI/SNF
complexes (e.g. Brg1, SNF5, or BAF155) in ES cells impairs pluripotency (Lessard
& Crabtree, 2010). Mechanistically, SWI/SNF complexes occupy the promoters of
core pluripotency factors (Oct4, Nanog, Sox2) and a subset of their target genes,
which promotes the activation of pluripotency circuitry in ES cells (Ho et al., 2009).
However, whether and how SWI/SNF complexes bind or regulate pluripotency
genes in early embryos – mouse, human or zebrafish – remains unknown, as
do the unique and redundant roles of Brg1 and Brm. In zebrafish, Brg1 and Brm
proteins are highly similar to their orthologs in mice and humans (Table 2.1), and
zebrafish genome contains orthologs of all core SWI/SNF subunits found in the
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mouse and human genomes, as well as many of the accessory subunits (Table
2.1). Although oocyte-specific deletions of zebrafish brg1 or brm have not been
created, loss of brg1 causes defects in early eye and heart development, and
lethality at 6 days postfertilization (Eroglu et al., 2006), whereas no study has
examined the roles of brm in zebrafish.
To understand how Brg1 and Brm regulate chromatin and transcription during
early embryogenesis, including whether Brg1 and Brm have specialized functions
at this stage, we mapped Brg1 and Brm genome occupancy in early zebrafish em-
bryos, defined open chromatin regions via ATAC-seq, identified RNA polymerase II
(Pol II)-occupied genes – and also performed functional experiments involving Pol II
transcription inhibitors. Here, we reveal the dynamic properties and specialization
of Brg1 and Brm during MBT stages, showing that Brg1 functions primarily at active
promoters and enhancers, whereas Brm uniquely functions with Pol II, residing
within the bodies of mainly short highly-transcribed genes during genome-wide
transcriptional activation.
2.3 Results
2.3.1 Specific antibodies for Brg1 and Brm
reveal embryonic expression
Rabbit polyclonal antibodies that specifically recognize zebrafish Brg1 or Brm
were produced by raising antibodies against unique regions of zebrafish Brg1 and
Brm proteins, and conducting affinity purification (Figure 2.S1A and 1B). Each
purified antibody specifically recognized Brg1 or Brm, and displayed low or neg-
ligible cross-reactivity, respectively (Figure 2.S2A). Immunoblotting identified Brg1
at ∼200kDa and Brm at ∼170kDa, slightly larger (or smaller, respectively) than
38
their predicted sizes of 182kDa or 178kDa (Figure 2.S1C). We detected low levels
of Brg1 and Brm proteins in oocytes and 1-cell embryos – suggesting maternal
inheritance – and higher levels as early development progressed, with Brg1 protein
levels moderately higher than Brm (Figure 2.S2B, C), consistent with mice (LeGouy
et al., 1998).
2.3.2 Genomic profiling reveals Brg1- and Brm-specific
regions during early development
To help understand the roles of Brg1 and Brm during early development, we
performed ChIP-seq of Brg1 and Brm at pre-MBT (2.5hpf), MBT (4hpf) and post-
MBT (5.3hpf) stages utilizing the two polyclonal antibodies (Figure 2.1A, Table 2.1).
As the replicates (typically two) were highly similar (pairwise r>0.95) the datasets
were combined and peaks were called by MACS2 (q-value FDR 0.01). For Brg1,
we identified 94 occupied regions at pre-MBT, which increased substantially to
5,469 regions at MBT, and to 11,778 regions at post-MBT (Figure 2.1B). A similar
trend was observed for Brm: 551 at pre-MBT, 11,482 regions at MBT, and 15,456
regions at post-MBT (Figure 2.1B).
To characterize these occupied regions, we examined their genomic distribution
on different genomic features, as annotated by Refseq. First, we found that Brg1
and Brm are highly enriched at promoters (Figure 2.1C). Interestingly, Brm dis-
played a much higher fractional occupancy in coding (exon/intron) and downstream
regions than did Brg1 (Figure 2.1C), attributes explored in more detail later. Exam-
ination of Brg1- and Brm-occupied genes at each stage reveals a moderate-high
degree of overlap, along with a substantial number of genes occupied specifically
by either Brg1 or Brm – a proportion which increases as development progresses
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(Figure 2.1D). Notably, Gene Ontology (GO) analysis of Brg1 and Brm occupied
genes at pre-MBT revealed ‘transcription’ and ‘development’ as the most enriched
terms. At MBT, enrichment additionally included metabolic processes such as
‘ribosome’ and ‘nucleotide binding’, whereas post-MBT enriched terms like ‘cell
migration’ and ‘embryonic organ development’ were prevalent (Figure 2.S3A).
To reveal how occupied regions change during development, we examined
regions that gain or lose occupancy by Brg1 and Brm. To display, we provide
Brg1 and Brm ChIP-seq signal at each stage aligned to the center of the occupied
regions (Figure 2.2A, B). Occupied regions were separated into three categories:
‘pre-MBT’ (regions occupied pre-MBT), ‘MBT gained’ and ‘post-MBT gained’ –
separately, for both Brg1 and Brm. Interestingly, the vast majority (∼80%) of
Brg1-occupied regions at pre-MBT were maintained at MBT (Figure 2.2A, B, Figure
2.S4A), and 81.5% of these Brg1-occupied regions at MBT were maintained post-
MBT (Figure 2.2A, B). We observed a similar pattern for Brm, though a slightly
lower portion of sites maintained occupancy during each developmental phase
(Figure 2.2C, D, Figure 2.S4B). Consistent with our analysis of occupied regions,
genes occupied by Brg1 and Brm at early stages were largely maintained at later
stages (Figure 2.S4C).
To display these different modes of occupancy dynamics, we provide a gallery
of genome snapshots (Figure 2D), which includes regions/genes consistently oc-
cupied (e.g. cxcl12a and etv4), those restricted to pre-MBT (Figure 2.2D klf1,
hoxb8b, zgc:66455), ‘MBT gained’ (Figure 2.2D bmp2b) or ‘post-MBT gained’
(Figure 2.2D tcf7 ). In addition, we also identified regions specifically bound by Brg1
or Brm, which also have diverse occupancy dynamics (Figure 2.S5). Curiously,
40
sites that exhibit a ‘switch’ in occupancy, either Brm-to-Brg1 or vice versa, were
very rare. Taken together, Brg1 and Brm genes increase in number from moderate
(<200) pre-MBT to numerous (>5200) by post-MBT, and although they largely
overlap, there are clear specific sites for Brm at all stages, and for Brg1 at all
stages after pre-MBT.
2.3.3 Motif analyses and ChIP-seq profiling reveal
candidate factors for SWI/SNF recruitment
To identify candidate transcription factors for SWI/SNF recruitment (Brg1- or
Brm-containing) we employed Regulatory Sequence Analysis Tools (RSAT) (Medina-
Rivera et al., 2015) to determine the over-represented motifs at Brg1- and Brm-
occupied regions at three stages (Figure 2.3A). At pre-MBT, we found Rfx1, Eomes
and Pou3f2 motifs enriched at both Brg1- and Brm-occupied regions, and Dmrt1
and HoxD motifs only at Brm-occupied. Later in development, motifs for Sox3,
HoxD, and Runx1 were enriched, accompanied by the loss of Rfx1 and Dmrt3
motifs at both Brg1- and Brm-occupied regions. In addition, three unknown motifs
(CAAAACA, CTGCAG and TACTGTA) were obtained. To determine whether the
candidate recruiting motifs/co-factors for SWI/SNF complex at enhancers and pro-
moter are different, we partitioned occupied regions into promoters and intergenic
areas, and performed the same motif analysis (Figure 2.S6). This additionally
revealed Sox and Dmrt motifs enriched at pre-MBT Brg1-occupied promoters, and
motifs for Tbx5, Pou3f2 and unknown motif GCTAAC in intergenic regions.
Among the enriched motifs, Eomes, Pou3f2, and Sox3 are of high interest in
very early development; Eomes promotes trophectoderm differentiation in mam-
mals, while Pou5f1 and Sox factors promote pluripotency and ES-cell self-renewal,
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and early zebrafish development (Russ et al., 2000; Niwa, 2007; Leichsenring
et al., 2013). Beyond motif analysis, to assess co-occupancy of these factors
with Brg1 or Brm, we processed the public ChIP-seq data of Eomesa (ortholog
of mammalian Eomes) (Nelson et al., 2014), Sox2, Pou5f3 (annotated as Pou5f3
in the zebrafish genome build zv10 and as Pou5f1 in zebrafish genome build zv9,
ortholog of mammalian Pou5f1) (Leichsenring et al., 2013) and Nanog (Xu et al.,
2012). Interestingly, all four factors were highly enriched at the centers of Brg1-
occupied regions at MBT, and moderately enriched at Brm-occupied regions (Fig-
ure 2.3B). Likewise, regions with high levels of Brg1 or Brm had high levels of these
transcription factors, displayed either as heat maps (Figure 2.3C, Figure 2.S7) or
quantiles based on q-value (Figure 2.S8) – and is observed at both promoters
and distal regulatory elements (Figure 2.4D, Figure 2.S9). Interestingly, SWI/SNF
complex and several TFs (e.g. Pou5f3, Sox2 and Nanog) bind themselves; each
is co-localized at the promoter and distal regulatory elements of Pou5f3, Sox3,
Nanog – whereas the Eomesa promoter/enhancer is not occupied. In sum, these
data unveil a potential regulatory network of SWI/SNF complex and TFs (Eomesa,
Pou5f3, Sox2 and Nanog) during early zebrafish development. Taken together, we
reveal enriched motifs for both known and unknown factors, providing candidates
of interest for future work. We note that genetic null mutants in these factors are
either not publicly available, or do not create healthy maternal zygotic null animals
appropriate for feasible functional studies in very early embryos, preventing a sim-
ple assessment of recruitment.
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2.3.4 Correlation of Brg1 and Brm occupancy with gene
expression, open chromatin and active histone marks
As SWI/SNF slides and ejects nucleosomes to facilitate the binding of tran-
scription machinery, we investigated whether Brg1- and Brm-occupied genes have
increased expression. To test, we ranked all annotated RefSeq genes by expres-
sion level (FPKM) at 5.3hpf, and compared to occupancy of Brg1, Brm and RNA
Polymerase II (Pol II), centered at the transcription start site (TSS). Notably, highly-
transcribed genes have higher occupancy of Brg1, Brm and Pol II at promoters. We
then focused on genes occupied by Brg1 or Brm at MBT or post-MBT. In keeping,
genes bound by Brg1 or Brm have higher expression compared to the genes not
bound by Brg1 or Brm, or to the genome average (Figure 2.4B, C).
To reveal whether Brg1 and Brm binding is correlated with increased chromatin
accessibility, we performed ATAC-seq in embryos at pre-MBT, MBT and post-MBT
stages. As expected, highly expressed genes displayed more accessible and
broad promoters (Figure 2.4A, blue heatmap). In keeping, we found Brg1- and
Brm-occupied regions have higher ATAC-seq signals (chromatin opening) com-
pared to the neighboring areas (Figure 2.4D). These maps also reveal clear phas-
ing of nucleosomes into the coding region of the genes, a feature revisited later.
SWI/SNF-bound regions are correlated with histone modifications in yeast, meta-
zoans and mammals. To examine zebrafish early embryos, we processed public
ChIP-seq data of H3K27ac, H3K4me1, H3K4me3 and H3K27me3, and profiled
their occupancy, centered at the TSS (Figure 2.4A, right panel) (Zhang et al., 2014;
Bogdanovic´ et al., 2012). We observed correlation of highly transcribed genes with
multiple active marks (H3K27ac, H3K4me1 and H3K4me3) but not a repressive
mark (H3K27me3) around their promoter regions. To examine all regions (not just
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promoters) we then profiled the occupancy of histone marks around all Brg1- and
Brm-occupied regions at all three stages. Intriguingly, we discovered that active
marks, especially H3K27ac, are highly enriched at Brg1-occupied regions, but
enrich to a much lesser extent at Brm-occupied regions (Figure 2.4E), explored
further below. Taken together, Brg1 and Brm occupancy correlates with higher
gene expression and increased promoters accessibility, and for Brg1-occupied loci
also with the presence of active histone marks.
2.3.5 Enrichment of positive histone marks
at Brg1-bound regions
To interrogate the difference between Brg1 and Brm and histone marks in more
depth, we partitioned Brg1- or Brm-occupied regions based on the presence or ab-
sence of H3K27ac and H3K4me1 (Figure 2.5A), marks associated with enhancers.
Notably, the large majority (71.2%) of Brg1-occupied regions bore both marks
and 87.3% bore at least one, whereas only 40.8% of Brm-occupied regions had
both marks and 44.2% had neither mark. We find Brm and Brg1 (in aggregate)
present at a minority (15.2%) of active enhancers (enriched for both H3K27ac
and H3K4me1) but virtually absent (< 2%) at poised enhancers (enriched only
for H3K4me1) (Figure 2.5B).
To further understand the differences between Brg1 and Brm, we separated
the occupied regions at MBT into intergenic and genic, and further classified them
into three types: ‘Common’, Brg1-specific and Brm-specific regions. Strikingly,
both ‘Common’ and Brg1-specific regions were highly enriched for active marks,
whether present in intergenic or genic areas (Figure 2.5C, D, E, Figure 2.S12). A
similar pattern was also observed in post-MBT regions (Figure 2.S10, 13). Al-
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though many Brm-specific regions reside in gene bodies, Brm-specific regions
in promoters still displayed considerably lower enrichment for active marks than
Brg1-specific regions (Figure 2.S11,12,13).
Regarding gene-function correlations, GO analysis showed that ‘Common’ genes
are enriched for housekeeping functions (e.g. ribosome and protein biosynthesis)
and Brm-specific genes were enriched for both housekeeping functions and devel-
opment regulation (Figure 2.5F). In contrast, Brg1-specific genes were specifically
enriched for transcription regulation and development regulation (Figure 2.5F).
Of particular interest, ‘Common’ genes displayed substantially higher expression
compared to Brg1- and Brm-specific genes, suggesting an additive/cooperative
effect of Brg1 with Brm on gene expression (Figure 2.5G).
2.3.6 Occupancy of Brg1 and Brm at key pluripotency factors
and miR-430, but not HOX loci
We now return to occupancy profiles at genes, and highlight notable occupied
and nonoccupied genes. First, Brg1 and Brm occupy many key development
regulators (Figure 2.6A), including the core factors linked to pluripotency (nanog,
pou5f3, several sox genes), several Fox-family transcription factors (e.g. foxh1,
foxd3), epigenetic regulators (anp32e, smarca4a/brg1) and signaling molecules
(wnt11, fgf3 and etc.). As elucidated in the GO analysis, Brg1 and Brm also occu-
pied housekeeping genes, such as actb1, actb2. Most surprisingly, we also found
Brg1 and Brm are highly enriched at the miR-430 locus in a stage-specific manner.
Notably, robust Pol II binding at miR-430 cluster is observed at pre-MBT, which
is consistent with previous work identifying miR-430 cluster as highly transcribed
before zygotic genome activation. Curiously, little or no enrichment was observed
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at the zebrafish hox loci at all three stages – reinforcing the observation that Brg1
and Brm are notably absent from almost all regions marked by H3K27me3 in the
early embryo (Figure 2.S14). Taken together, Brg1 and Brm occupied a wide
range of genes, suggesting involvement in cell homeostasis, pluripotency factors,
regulators of lineage specification, and the transcription of miR-430, to degrade
maternal RNA and promote the maternal-zygotic transition.
2.3.7 Precise co-occupancy of Brm and RNA Pol II
at gene bodies
Perhaps the most striking observation in our datasets is the distribution of Brm
over a high fraction of gene bodies, with nearly precise colocalization with RNA
Pol II, a feature distinctly different from Brg1 (Figure 2.6). The generality of this
observation can be observed in a meta-gene analysis, which displays high Brg1
enrichment specifically at promoter and very early coding region, whereas Brm
has enrichment not only at promoters but also throughout gene body and into the
downstream areas (3’UTRs and beyond; Figure 2.6B). We then classified genes
into promoter genes (genes with only the promoter occupied) and body genes
(genes with both promoter and body occupied). In keeping, the percentage of
Brm Body genes is much higher than Brg1 Body genes at all three stages (Figure
2.6B), and in those cases where Brg1 displays occupancy in the body of a gene, it
is typically restricted to ∼1kb in the promoter-proximal region.
As previewed above, we also observed a striking correlation between Pol II
and Brm at Body genes, where these two factors almost always start and end at
the same location (e.g. Figure 2.6A). This property is more generally displayed in
metagene heatmaps for all the Brm Body genes and Promoter genes, which reveal
46
a high correlation between Brm and Pol II (Figure 2.S15A), which together suggest
a role for Brm in transcription elongation. In support, Brm-occupied Body genes
show significantly higher expression than either Brm Promoter genes or all genes.
(assessed by FPKM at MBT and post-MBT, Figure 2.6D). In sum, these data reveal
striking co-incidence of Brm and Pol II over the bodies of highly-transcribed genes,
suggesting a role in transcription elongation.
2.3.8 Brm occupancy over gene bodies requires
transcription elongation
Next, we investigated how Brm is recruited to gene body. In principle, Brm
could travel with Pol II during transcription elongation, or alternatively, Brm could be
recruited to gene body by histone marks such as H3K36me3, which is established
co-transcriptionally by the KMT3a/Set2 complex, but remains after Pol II passage.
To determine which is the underlying mechanism, we performed ChIP-seq of Brm,
Pol II and H3K36me3 in flavopiridol-treated embryos (an inhibitor of transcription
elongation; initial pilot experiments established dose and time parameters). To
test, embryos were left untreated until 3.75hpf, which allowed both the ‘minor
wave’/pre-MBT transcription, as well as ‘major wave’/general transcription for 45
min, and enabled the establishment of H3K36me3 marks on transcribed genes
(Figure 2.7A). Embryos were then briefly treated with flavopiridol to inhibit the
transcription elongation, which arrested the embryo at MBT (4hpf). Embryos were
then processed for ChIP-seq of Brm, Pol II and H3K36me3. Here, if Brm travels
with the Pol II transcription machinery, Brm occupancy should be lost at gene
bodies only in drug-treated embryos. In contrast, if Brm is alternatively recruited by
H3K36me3 (or an alternative transcription-dependent mark) post-transcriptionally,
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Brm occupancy should be retained at gene bodies.
First, we observed clear effectiveness of our flavopuridol treatment, as Pol II
converted from promoter and body occupancy (at Body genes) to promoter-specific
occupancy only in drug-treated embryos. Here, our data clearly support the first
hypothesis; Brm is recruited to the gene body by Pol II itself. In untreated em-
bryos, Brm was highly correlated with Pol II and H3K36me3 (Figure 2.7B, left three
heatmaps). Once elongation was inhibited, although some reduction in H3K36me3
was evident, a considerable fraction of body genes still retained moderate-high
H3K36me3 marks in their gene bodies. However, neither Pol II or Brm displayed
appreciable occupancy within gene bodies. Instead, both Pol II and Brm were
largely restricted to the promoter, a feature clear in heatmaps of the entire dataset
(Figure 2.7B, right three heatmaps), and also at individual genes (Figure 2.7C).
Taken together, Brm appears to travel with RNA pol II during transcription elonga-
tion at ∼35% of all transcribed genes (Figure 2.S16), with a strong preference for
the most highly transcribed genes.
2.3.9 Brm-occupied body genes are short,
and have fewer exons
We then sought features that might explain why only a subset of genes are
bound by Brm along the gene body. Interestingly, we found that Body genes in
general are significantly shorter than promoter genes, and also have significantly
fewer exons than promoter genes (Figure 2.7D). We showed earlier that Brm-
occupied body genes have higher transcription, suggesting Brm might be required
to facilitate fast Pol II progression through gene bodies, perhaps to contend with
nucleosomes in front of Pol II. However, these Brm- and Pol II-occupied body
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genes are not nucleosome-free, as our ATAC-seq maps show clear phasing of
nucleosomes in the gene body, and lack general openness (Figure 2.4A). Taken
together, we speculate that a considerable fraction of genes in early development
have evolved to be short, contain fewer exons, and to utilize Brm remodeling to
slide nucleosomes to facilitate their high transcription during a unique period of
development that includes exceptionally short cell cycles and frequent competition
of RNA polymerase with the replisome.
2.4 Discussion
Vertebrate embryos pass through a phase after fertilization that lacks transcrip-
tion, during which their inherited parental/gametic genomes are reprogrammed at
the chromatin level, to prepare genes for the regulated ‘waves’ of gene expression
that occur at and after initial zygotic/embryonic transcriptional activation (Tadros
& Lipshitz, 2009). This period of transcriptional inactivity can be relatively short
(e.g. two cell cycles in humans) or relatively long, such as the 9-10 cell cycles
for many fish and frogs. A key question is how and where transcription factors,
chromatin modifiers and chromatin remodelers sculpt the landscape prior to and
during the onset of embryonic transcriptional activation to properly identify and
regulate enhancers and genes. Recently, multiple labs have begun to investigate
this process in several organisms, including zebrafish, where genomic profiles and
relationships have been examined between DNA methylation, nucleosomes and
transcription (Vastenhouw et al., 2010; Lindeman et al., 2011; Lee et al., 2013;
Leichsenring et al., 2013; Potok et al., 2013; Zhang et al., 2014). Here, we greatly
extended on those studies by examining chromatin accessibility (ATAC-seq), pre-
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MBT RNA Pol II – and for the first time in any cell type or embryo – the chromatin
remodelers Brg1 and Brm together. Together, our work has provided several new
insights into chromatin reprogramming and remodeling prior to and during tran-
scriptional onset, and revealed clear differences between Brg1 and Brm occupancy
in the early embryo genome – highlighted by the selective association of Brg1 with
active histone marks, and the co-incidence of (and reliance on) RNA Pol II for
Brm occupancy of coding regions and 3’UTRs of short highly-transcribed genes.
Here, we find that Brg1 and Brm occupy certain loci during the pre-MBT phase,
including nanog and miR-430; notably, virtually all genes with expression during
the pre-MBT stage are bound by Brg1, Brm, or both. In fact, the miR-430 locus is
the most highly transcribed locus in the early ‘minor’ wave of transcription during
pre-MBT (Heyn et al., 2014). Locations of Brg1 and Brm binding increase greatly
at MBT, and include particular developmental transcription/chromatin factors and
housekeeping genes. Regarding gene categories, bound genes include pluripo-
tency factors (nanog, pou5f3 (the zebrafish POU5F1/OCT4 ortholog)), several
Fox-family transcription factors (e.g. foxh1, foxd3), particular epigenetic regulators
(anp32e, smarca4a/brg1). Furthermore, Brg1 and Brm occupy a set of genes
encoding particular signaling molecules, as well as many housekeeping genes.
Again, virtually all occupied genes are active – either in the ‘minor’ wave or ‘major’
wave of transcription. Furthermore, genes co-occupied by Brg1 and Brm display
a significantly higher level of transcription than do nonoccupied active genes. In
contrast, Brg1 and Brm were generally absent from H3K27me3-marked regions
in the early embryo, including zebrafish Hox loci and the promoters of many Tbx-
and Gata-family transcription factors. Thus, Brg1 and Brm function (by localization)
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appears focused on short-term preparation and execution of activation, and not
long-term poising or repression of developmental genes. Interestingly, Brg1 and
Brm differ greatly in their correlations with active histone marks. Brg1-specific
regions, as well as regions co-occupied by both Brg1 and Brm, were highly en-
riched for active marks. We also observed that more than 80% of intergenic
Brg1-bound regions bear at least one of two histone marks associated with en-
hancers, H3K4me1 and H3K27ac. Thus, our observations are consistent with prior
work showing Brg1 occupancy at enhancers (Bultman et al., 2005; Rada-Iglesias
et al., 2011). In counter distinction, Brm-specific regions displayed considerably
lower enrichment of active marks than Brg1-specific regions. Our results are
consistent with Brg1 displaying more interactions and/or cooperativity with histone
modifiers that promote enhancer marking and/or transcription initiation than Brm.
The most striking result in our datasets is the localization of Brm over a high
fraction of gene bodies, with nearly precise co-localization with RNA Pol II, a
feature distinctly different from Brg1. Our functional experiments involving inhibition
of Pol II elongation strongly suggest that gene body occupancy of Brm is due to
association of Brm with RNA Pol II, or with Pol II-associated elongation factors,
on coding regions rather than post-transcriptional recruitment through H3K36me3
deposition. We provide two possible reasons why Brm might travel with Pol II over
gene bodies. First, Brm may play a role in splicing, as prior work in a human
cell line showed that overexpression of Brm increased the inclusion of variant
exons. Furthermore, Brm physically interacted with splicing machinery, and was
shown by ChIP-qPCR to bind the coding region of a gene, CD44 (Batsche´ et al.,
2006). Importantly, zebrafish Brm shares high homology with the small region
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at the C-terminus of human Brm, which promotes splicing (Batsche´ et al., 2006).
Second, Brm likely has roles other than regulating splicing, as a notable minority
(∼6%) of Brm-containing Body genes lack introns. Here, we speculate that Brm
may also be required in embryos to facilitate rapid transcription elongation through
chromatin. This interpretation is based partly on RNA polymerase transcription
rates; although direct measurements have not been made in zebrafish embryos,
those measured in other vertebrates generally range between 1-2kb/min (Sher-
moen & O’Farrell, 1991). Importantly, early embryos exhibit complete cell cycles of
only ∼15 min at pre-MBT, and ∼20-30 min at MBT, which puts a large fraction of
transcribed genes at risk for collision events between RNA and DNA polymerase
during replication. Although transcription complexes can survive DNA polymerase
passage, minimizing collisions by facilitating transcription and splicing efficiency
would provide a major fitness advantage. In support, Brm-occupied ‘Body’ genes
display a strong and significant bias for short, highly-transcribed genes with fewer
exons. Indeed, others have previously noted the correlation between short gene
size and transcription in zebrafish and Drosophila at these developmental phases
(De Renzis et al., 2007; Heyn et al., 2014), also citing the intuitive competition
between transcription and replication – and here we provide a candidate molecular
mechanism to help minimize this competition. Taken together, we suggest the
following model for specialized Brg1 and Brm function in early embryos. Brg1
occupancy is largely restricted to enhancers and promoter regions, and is almost
always co-localized with active histone modifications, perhaps due to its ability to
interact with histone modifiers, or its preferred interaction with transcription factors
that do so. Brm is likewise recruited to certain enhancers and promoters, but
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is only modestly correlated with active histone modifications compared to Brg1.
Instead, Brm is uniquely specialized to travel with RNA Pol II through to the TTS.
Here, Brm may facilitate fast Pol II progression through gene bodies, possibly by
helping Pol II to contend with nucleosomes and avoid pausing, but does not itself
create nucleosome-free regions within coding regions (Figure. 2.4A). Our work
raises several new areas of investigation regarding Brg1 and Brm specialization
and transcription – where the zebrafish offers unique advantages. First, it will
be of high interest to determine how Brm is specialized to interact with RNA Pol
II itself (or one of the many known Pol II-associated elongation factors) in early
embryos, and to further explore whether and how Brm ATPase activity might help
contend with nucleosomes in coding regions. Second, as interaction of the splicing
machinery and mammalian Brm has only been tested at a few select genes, the
zebrafish system provides the opportunity to explore this function genome-wide
and in early embryogenesis. Third, recent advances in epitope tagging genes
in the zebrafish genome may allow a direct examination of transcription factor
recruitment of Brg1 and Brm complexes, to better understand how focal recruitment
of chromatin remodelers might help sculpt the chromatin landscape during this
unique phase of development, prior to transcription, to prepare the genome for
transcription onset.
2.5 Methods
2.5.1 Zebrafish and sample collection
Tubingen zebrafish lines were maintained and raised under standard condi-
tions. Wildtype embryos were collected after 10 min of mating to ensure the
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synchrony of embryo development, raised in embryo water at 28◦C and staged
as previously described (Kimmel et al., 1995).
2.5.2 Generation of polyclonal antibodies to Brg1 and Brm
For Brg1, 35 amino acids from the N-terminal (S155-P189) and 40 amino acids
from the C-terminal (H1385-K1424) were chosen as the antigen. For Brm, 37
amino acids from the N-terminal (S255-P291) and 40 amino acids from the C-
terminal (Q1529-E1568) were chosen as the antigen. The corresponding DNA
sequence were synthesized, PCR amplified and cloned through BamHI and NotI
sites into pETDuet-1 vector (Novogen, #71146-3), containing a N-terminal tag of
10 histidines. The constructs were transformed into BL21-CodonPlus Competent
Cells, and recombinant proteins were expressed and purified via Ni/NTA affinity
under denaturing conditions. The purified recombinant proteins were sent to Open
Systems, Thermo Fisher Scientific using 2 rabbits on a 90-day protocol for poly-
clonal antibody generation.
Day90 serum was affinity purified using NHS-activated SepharoseTM 4 Fast
Flow (GE, 17-0906-01). Peptides used as antigen for antibody generation were
equilibrated in the coupling buffer (0.2M NaHCO3, 0.5M NaCl pH8.3) using PD-10
Desalting columns (GE, cat#17-0851-01). The peptides were then coupled to
the NHS-activated Sepharose beads according to the manufacturer’s procedure.
Day90 serum was diluted 1:1 in cold PBS, and incubated with the peptide-coupled
beads at 4◦C overnight. Next day, after extensive washing with cold PBS, the
antibodies were eluted by elution buffer (100mM Glycine, pH2.5), and were imme-
diately neutralized by 1M Tris [pH8.8], followed by dialysis against PBS. Purified
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antibodies were stored at -80◦C.
2.5.3 Antibodies and Western blotting
Antibodies used were histone H3 (Abcam ab1791), H3K36me3 (Abcam ab9050),
RNA pol II (8WG16/Covance MMS-126R), phosphoserine 5 version of RNA pol II
(H14/Abcam ab24759), phosphoserine 2 version of RNA pol II (H5/Abcam ab24758)
and a-tubulin (Abcam 4074).
Western blotting was performed according to standard procedures, and protein
sample preparation is described as below. In Figure 2.S1C, embryos around 6hpf
were collected, dechorinated, and deyolked as previously described (Link et al.,
2006). The cell pellet then was resuspended in lysis buffer (10 mM Tris-HCl pH
7.5, 150 mM NaCl, 1% Triton, 0.1% SDS) and lysed on ice for 10 min. In Figure
2.S2B, 30 embryos at each stage were dechorinated and directly boiled at 95circC
for 10 min in 2X sample buffer.
2.5.4 Chromatin immunoprecipitation
Embryos at pre-MBT (2.5hpf), MBT (4hpf) and post-MBT (5.3hpf) were carefully
staged, dechorinated by Pronase (Sigma-Aldrich 11459643001), and fixed in 1%
formaldehyde for 10 min at Room Temperature (RT). Formaldehyde was quenched
by adding glycine to a final concentration of 0.125M, followed by centrifugation
at 500g 5 min 4◦C. The embryo pellet was resuspended in ice-cold PBS, and
centrifuged again at 500g 5 min 4◦C. The washing was repeated twice, and the
embryos were snap frozen in liquid nitrogen, until enough embryos were collected.
For chromatin extraction, embryo pellets were resuspended in cell lysis buffer
(10mM Tris-HCl [pH 8.1], 10mM NaCl, 0.5% NP40) and lysed for 10 min, rotating
55
at 4◦C. Nuclei were collected by centrifugation at 1300g 5 min, 4◦C, and washed
twice by rotating at RT 5 min in nuclei wash buffer (50mM Tris-HCl [pH 8.0],
100mM NaCl, 10mM EDTA). The clean nulcei pellet were then resuspended in
nuclei lysis buffer (50mM Tris-HCl [pH 8.1], 10mM EDTA, 1%SDS) and lysed for 10
min on ice. Samples were diluted 10 times in IP dilution buffer (0.01% SDS, 1.1%
Triton X-100, 1.2mM EDTA, 16.7mMTris-HCl [pH 8.1], 167mM NaCl) and sonicated
with a Branson sonicator to obtain fragments around 300 bp. The fragmented
chromatin were precleared by incubation with Dynabeads 1hr at 4◦C (Dynabeads
Sheep Anti-Rabbit IgG (11204D) for Brg1, Brm and H3K36me3, Dynabeads Pan
Mouse IgG (11042) for Pan-PolII). Next, the chromatin was immunoprecipitated
using the desired antibody through overnight rotation at 4◦C, followed by pull-down
with dynabeads during a 4-6hr rotation at 4◦C.
Bound complexes were extensively washed six times with RIPA buffer (10mM
Tris-HCl [pH 7.5], 140mM NaCl, 1mM EDTA, 0.5mM EGTA, 1% (vol/vol) Triton
X-100, 0.1% (wt/vol) SDS, 0.1% (wt/vol) Na-deoxycholate), two times with WB
LiCl (10mM Tris-HCl [pH 8.0], 1mM EDTA, 250mM LiCl, 0.5%NP-40), and one
time with TE (10mM Tris-HCl [pH 8.0], 1mM EDTA). Then, the complexes were
eluted from the beads by elution buffer (10mM Tris-Cl [pH 8.0], 5mM EDTA, 300mM
NaCl, 0.1% SDS). The eluate was RNase treated (Ambion, AM2286) for 2hr at
thermomixer (37◦C 400rpm 2hr), followed by 2hr proteinase K treatment at 55◦C,




ATAC-seq was performed essentially as previously described (Buenrostro et al.,
2013). Briefly, embryos at pre-MBT (2.5hpf), MBT (4hpf) and post-MBT (5.3hpf)
were carefully staged, and dechorinated. The embryos were washed in cold PBS,
and then resuspended in lysis buffer (10mM Tris-HCl [pH 7.4], 10mM NaCl, 3mM
MgCl2, 0.1% IGEPAL CA-630) on ice for 10 min. During the lysis, a 20 Gauge
syringe was used three times to break the chorions and cells, followed by table top
spin for 10 seconds. The supernatant was then centrifuged at 1300g 5 min 4◦C
and nuclei was resuspend in 2X TD buffer, and incubated with Tn5 enzyme for 30
min at 55◦C (Nextera DNA Library Preparation Kit, FC-121-1031). The reaction
was terminated by adding SDS to a final concentration 1%. Then, the sample was
purified by Qiagen minElute column and PCR amplified by NEBNext High-Fidelity
2X PCR Master Mix (NEB, M0541L). qPCR was utilized to determine the optimal
PCR cycles to prevent over-amplification.
2.5.6 Transcription elongation inhibition
Embryos were dechorinated immediately after fertilization, and closely moni-
tored for the development stages. Flavopiridol (Sigma-Aldrich F3055) were added
to the embryo water to a final concentration of 10uM to inhibit transcription elonga-
tion at 3.75hpf, which allowed 45 min genome transcription.
2.5.7 Library preparation and sequencing
Libraries of ChIP-seq samples were prepared using the NEBNext ChIP-Seq
Library Prep Master Mix (NEB, E6240L). Eight ng of DNA was used and followed
the manufacturer’s procedure. Samples were then amplified by NEBNext High-
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Fidelity 2X PCR Master Mix (NEB, M0541L) and sequenced single-end 50nt on an
Illumina HiSeq 2000. For ATAC-seq samples, 101nt paired-end sequencing were
performed.
2.5.8 ChIP-seq data analysis
Fastq files from ChIP-Seq were uniquely aligned to zv10 zebrafish genome
assembly using Novoalign (Novocraft, Inc) with the following parameters: -r None
-Q 13 -k -o SAM, and converted to BAM files using Samtools. BAM files from
replicates were merged for downstream analysis. Peaking calling, relative to paired
input, was performed using MACS2 using the following parameters: -f BAM -g
1.4e9 -B --fix-bimodal --extsize 250 -q 0.01 (Zhang et al., 2008). Same
alignment and peak calling were performed to reanalyze the previously published
datasets, including Nanog ChIP-seq data (GSE34683), Eomesa ChIP-seq data
(GSE51894), Pou5f3 and Sox2 ChIP-seq data (GSE39780), H3K4me3, H3K27me3
and H3K36me3 ChIP-seq data (GSE44269), H3K4me1 and H3K27ac (GSE32483).
Peak distributions were defined using RefSeq annotation (downloaded from
http://www.genome.ucsc.edu on 15 September 2015). Customized R scripts were
used to associate peaks with the closest genes. Briefly, if a peak was within
−5kb/+5kb of a gene, it was grouped as a genic peak. If one peak could be
assigned to multiple genes, only the closest gene was used. Any peaks that were
not grouped as genic peaks were grouped as intergenic peaks. Distances within
−2kb/+1kb of a gene TSS were defined as promoter. Distances within 0/+2kb of a
gene TTS were defined as downstream.
For heatmap, data within −2kb/+2kb of a gene TSS, or of a peak center were
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collected every 50bp in 80 windows, using the program get relative data (http:
//search.cpan.org/dist/Bio-ToolBox/) and were visualized by Java TreeView
(Saldanha, 2004). Data in each window were averaged and graphed with Graph-
Pad Prism (GraphPad Software, Inc.) as scatterplot to represent the averaged data
distribution around genes TSS or peak centers.
For metagene model analysis, each occupied gene has been divided into 20
bins, and data within −3kb upstream TSS, and +3kb downstream TTS, and the
20bins of each gene were collected using the program get binned data (http:
//search.cpan.org/dist/Bio-ToolBox/).
Gene ontology analysis for all Brg1 and Brm at all stages were performed with
DAVID (Huang et al., 2009). Enrichment of known motifs was analyzed using RSAT
(Medina-Rivera et al., 2015).
Signal tracks representing −log(qvalue) were built using MACS bdgcmp with
parameter --m qpois, and were visualized using Integrated Genomics Viewer (IGV)
(Thorvaldsdo´ttir et al., 2013).
2.5.9 ATAC-seq data analysis
Paired-end fastq files were uniquely aligned to zv10 zebrafish genome assem-
bly using Novoalign (Novocraft, Inc) with the following parameters: -r None -Q
13 -k -o SAM -a CTGTCTCTTATACACATCT, and converted to BAM files using Sam-
tools. BAM files from replicates were merged for downstream analysis. Total
ATAC-seq data are divided into nucleosome-free reads and nucleosome signal
according to (Buenrostro et al., 2013). The coverage tracks of nucleosome-free
reads were generated using the program bam2wig (http://search.cpan.org/
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dist/Bio-ToolBox/) with the following parameters: --position span --pe --rpm
--bw.
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Table 2.1: Conservation of SWI/SNF complexes members between zebrafish and human
subunit NCBI Length Uniprot Length human homology
ID Length Identity similarity
Brg1 NP 853634.1 1,627 Q7ZSY3 1,627 NP 003063.2 1,647 86% 89%
Brm NP 001038240.1 1,568 Q6P9P2 1,568 NP 620614.2 1,590 82% 88%
Polybromo1 XP 693735.4 1,581 NA NA AAG48939.1 1,602 71% 81%
Arid1aa XP 009292406.1 2,261 A0A0R4IKJ3 2,286 AAG33967.1 2,285 62% 71%
Arid1ab XP 009292406.1 2,261 A0A0R4IR17 2,101 NP 065783.3 (1b) 2,249 56% 67%
Arid1b XP 009292820.1 2,121 Q5RGW7 2,121 NP 065783.3 (1b) 2,236 57% 69%
BAF155/smarcc1a AAH47827.1 839 Q7ZUU5 839 NP 003065.3 1,105 75% 85%
BAF155/smarcc1b NP 001082836.1 959 A0A0R4IDE0 969 NP 003065.3 1,105 65% 78%
BAF170 XP 695864.3 1,036 E7FFZ4 1,036 NP 003066.2 1,214 82% 90%
SNF5/BAF47a NP 001007297.1 373 Q5U379 373 NP 001007469.1 376 96% 98%
SNF5/BAF47b NP 571523.1 370 Q5XJR9 370 NP 001007469.1 376 93% 98%
BAF60a NP 938172.1 510 Q802C8 510 NP 003067.3 515 92% 94%
BAF60b XP 692749.2 501 E7EYW7 501 NP 001091896.1 531 78% 86%
BAF60ca XP 005163574.1 505 E7F1T4 505 NP 001003801.1 483 81% 88%
BAF60cb NP 001120778.1 476 B2KL77 476 NP 001003801.1 483 88% 92%
BAF53a NP 775347.1 429 Q8JGS6 429 NP 004292.1 429 88% 94%
BAF53b XP 005170633.1 426 F8W3Z2 426 NP 057272.1 426 86% 92%
BAF57 NP 958455.2 420 Q803S1 420 AAH07082.1 411 79% 85%
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mapped reads Mapp %
Pearson
Correlation
preMBT 22,619,187 16,178,109 71.52%
Brg1 MBT 22,164,263 16,003,970 72.21% 30,170,317 22,575,308 74.82% 0.94
postMBT 24,257,272 17,881,059 73.71% 38,612,645 28,936,176 74.94% 0.96
preMBT 27,682,342 19,081,720 68.93%
Brm MBT 30,559,682 21,418,799 70.09% 28,680,393 21,103,953 73.58% 0.96
postMBT 23,995,825 17,628,529 73.46% 39,188,263 29,255,118 74.65% 0.99
preMBT 31,857,139 22,004,993 69.07%
PolII MBT 42,684,043 31,376,888 73.51% 36,325,631 25,974,153 71.50% 0.98
postMBT 26,402,416 19,209,488 72.76% 29,459,020 21,791,312 73.97% 0.97
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Figure 2.1: Overview of the ChIP-seq datasets. (A) Schematic of ChIP-seq
approaches in embryos at pre-MBT, MBT and post-MBT stages. (B) Occupied
regions of Brg1 and Brm at each stage (defined by MACS2 peak calling). (C)
Distribution of Brg1 and Brm occupancy at each stage on RefSeq annotation
elements. Promoters represent the regions −2kb, +1kb around the TSS. (D) Venn
diagram analysis of the overlap between Brg1- and Brm-occupied genes at each
stage.
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Figure 2.2: Dynamic occupancy of Brg1 and Brm in early development. (A)
Heatmaps of Brg1 occupancy at three stages around Brg1-occupied regions at
pre-MBT, Brg1-occupied regions gained at MBT and post-MBT. Each row repre-
sents ±2kb around the center of occupied regions. Each heatmap corresponds to
one stage. (B) Pie charts of the percentage of maintained or lost of Brg1-occupied
regions at the subsequent stage. (C) Heatmaps of Brm occupancy at three stages
around Brm-occupied regions, as in (A). (D) Pie charts of the percentage of
maintained or lost of Brm-occupied regions at the subsequent stage. (E) Genome




Figure 2.3: Pluripotency factors are potential Brg1 or Brm interactors. (A)
Over-represented motifs identified at Brg1- and Brm-occupied regions during each
stage. The color represents the enrichment P-value, and the size the percentage of
occupied regions containing specific motif. (B) The mean profiles of Eomesa, Sox2,
Pou5f3, and Nanog signal (ChIP-seq data) around Brg1- and Brm-occupied re-
gions at MBT stage. (C) Heatmaps of ChIP-seq signal (from left to right Brg1, Brm,
Eomesa, Sox2, Pou5f3, and Nanog) around Brg1-occupied regions at MBT, ranked
by q-value. (D) Genome browser snapshots of representative co-localization of
Brg1 and Brm with transcription factors (Eomesa, Sox2, Pou5f3, and Nanog).
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Figure 2.4: Brg1 and Brm occupancy correlates with higher gene expression, open
chromatin, and active histone marks. (A) Heatmaps of PolII, Brg1, Brm, H3K27ac,
H3K4me1, H3K4me3, H3K27me3 and H3K36me3 signal (ChIP-seq) around ±2kb
of TSS, and ATAC-seq signal around ±1kb of TSS. Each row represents a RefSeq
gene TSS, ranked by RNA FPKM value at 5.3hpf (leftmost panel). (B) Boxplot of
expression level of Brg1 occupied genes, nonoccupied genes at MBT and post-
MBT stages, and all genes (t test: *** denotes p < 0.001). (C) Same as in (B)
but for Brm. (D) The mean profiles of ATAC-seq signal at pre-MBT, MBT and post-
MBT for Brg1- and Brm-occupied regions at each stage. (E) The mean profiles of
H3K27ac, H3K4me1, H3K4me3, H3K27me3 signal (ChIP-seq) at 4.3hpf for Brg1-
and Brm-occupied regions at each stage.
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Figure 2.5: Brg1-bound regions are enriched for active histone marks. (A)
Pie chart of the percentage of Brg1- and Brm-bound intergenic regions at MBT
having different combination of H3K4me1 and H3K27ac signal. (B) Pie chart of
percentage of active enhancers (marked by H3K4me1 and H3K27ac) and poised
enhancer (marked only by H3K4me1) having Brg1 and Brm signal. (C) Heatmaps
of Brg1, Brm, H3K27ac, H3K4me1, H3K4me3 and H3K27me3 signal (ChIP-seq)
around occupied intergenic regions at MBT. Common: regions co-occupied by
Brg1 and Brm; Brg1-specific: regions specifically occupied by Brg1; Brm-specific:
regions specifically occupied by Brm. Each row represents ±2kb around the
center of occupied regions. Among each category, occupied regions are ranked
by q-value. (D) The mean profiles of H3K27ac and H3K4me1 signal (ChIP-seq) for
common, Brg1-specific, Brm-specific and random regions. (E) Heatmaps of signal
around occupied genic regions at MBT, as in (C). (F) Boxplot of expression level
of Common (genes co-occupied by Brg1 and Brm), Brg1-specific genes (genes
specifically occupied by Brg1), Brm-specific genes (genes specifically occupied by
Brm), and genes at MBT and post-MBT stages (t test: *** denotes p < 0.001).
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Figure 2.6: Brm is highly enriched in gene bodies. (A) Genome browser snapshots
of representative Brg1 and Brm occupancy on pluripotency factors (nanog and
pou5f3), transcription factor (foxh1), epigenetic regulator (anp32b), microRNA
(miR-430) and housekeeping genes (actb2). (B) Meta-gene model of mean profiles
of Brg1 and Brm signal on their occupied genes at each stage. (C) Bar graph of
percentage of Body genes (genes have Brm occupancy at promoter and gene
body) and Promoter genes (genes only have Brm occupancy at promoter). (D)
Boxplot of expression level of Body and Promoter genes of Brm-occupied genes
at MBT and post-MBT stages (t test: *** denotes p < 0.001).
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Figure 2.7: Enrichment of Brm over gene body is dependent on transcription
elongation. (A) Schematic of elongation inhibition by flavopiridol. (B) Heatmaps
of Brm, PolII, and H3K36me3 ChIP-seq signal in untreated and flavopiridol treat
embryos around MBT Brm occupied Body genes and Promoter genes. Each row
represents one MBT Brm-occupied gene, which includes 20 bins for entire gene,
3 bins for upstream 3kb and 3 bins for downstream 3kb. H3K36me3 ChIP-seq
is performed with 4.3hpf embryos (public dataset), and all the other ChIP-seqs
are performed with 4hpf embryos (our original datasets). (C) Genome browser
snapshots of representative genes that have H3K36me3 but not Brm in the gene
body after flavopiridol treatment. (D) Boxplot of gene length and exon numbers of
Brm Body and Promoter genes at MBT and post-MBT stage.
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Figure 2.8: Model. (A) Brg1 and Brm overlap at most genes, but also
solely/specifically occupy certain genes. (B) Regions bound by Brg1, much more
so than Brm, correlate with active histone marks (H3K4me1/3 and H3K27ac), and
the absence of H3K27me3. (C) Brg1-containing SWI/SNF complex is enriched at
promoters, and Brm-containing SWI/SNF complex is enriched at both the promoter
and also at the gene body. Genes with the highest transcription tend to have both
Brg1 and Brm.
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Figure 2.S1: Antibody generation and validation. (A) Schematic of strategy for
polyclonal antibody generation. (B) Schematic of strategy for antibody affinity pu-
rification. (C) Immunoblotting using flow-through, unpurified antibody and purified
antibody against Brg1 in 6hpf whole embryo lysate. (D) Immunoblotting against
Brm, same as in (C).
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Figure 2.S2: Antibody specificity and protein level in zebrafish early embryo. (A)
Immunoblotting using purified Brg1 antibody against antigen peptide of Brg1 and
Brm. (B) Immunoblotting using purified Brm antibody against antigen peptide of
Brm and Brg1. (C) (D) Immunoblotting of Brg1 and Brm in early zebrafish embryos,
30 embryos per each stage.
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Figure 2.S3: Gene ontology analysis. Gene ontology analysis of Brg1- and Brm-
occupied genes at each stage, analyzed by DAVID.
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Figure 2.S4: Dynamic occupancy of Brg1 and Brm at each stage. (A) Zoom-
in view of Brg1-occupied regions at pre-MBT. Heatmaps of Brg1 signal at each
stage around peak centers (±2kb). (B) Zoom-in view of Brm-occupied regions
at pre-MBT. Heatmaps of Brn signal at each stage around peak centers (±2kb).
(C) Venn diagram analysis of the overlap between Brg1-occupied genes at three
stages (left) and the overlap between Brm-occupied genes at three stages (right).
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Figure 2.S5: Snapshots of dynamic occupancy of Brg1- and Brm-specific regions
in early development.
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Figure 2.S6: Motif analysis of Brg1- and Brm-occupied regions at intergenic re-
gions and promoters. Regions that reside at intergenic regions (A), and promoters
(B). The color of the circles represents the enrichment P-value. The size of the
circle represents the percentage of occupied regions containing specific motif.
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Figure 2.S7: Heatmaps of correlation between transcription factors and Brm.
ChIP-seq signal (from left to right Brg1, Brm, Eomesa, Sox2, Pou5f3 and Nanog)
around Brm-occupied regions at MBT, ranked by q-value.
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Figure 2.S8: Stronger Brg1- and Brm-occupied regions have higher enrichment of
TF binding signal. Brg1- and Brm-occupied regions at MBT are divided into four
groups based on the q-value at the summit of each peak. Then mean profiles of
Eomesa, Sox2, Pou5f3 and Nanog signal (ChIP-seq data) around different groups
of peaks are plotted.
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Figure 2.S9: Snapshots of co-localization between transcription factors and
Brg1/Brm. co-localization between Brg1, Brm and pluripotency at enhancers and
promoters of pluripotency factors, where only eomesa is not bound by Brg1 and
Brm.
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Figure 2.S10: Brg1-occupied regions at post-MBT are enriched for active his-
tone marks. (A) Heatmaps of Brg1, Brm, H3K27ac, H3K4me1, H3K4me3 and
H3K27me3 signal (ChIP-seq) around occupied intergenic regions at post-MBT.
Common: regions co-occupied by Brg1 and Brm; Brg1-specific: regions specifi-
cally occupied by Brg1; Brm-specific: regions specifically occupied by Brm. Each
row represents ±2kb around the center of occupied regions. Among each cate-
gory, occupied regions are ranked by q-value. (B) Heatmaps of signals around
occupied genic regions at post-MBT, as in (A).
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Figure 2.S11: Brg1-occupied regions at promoters are enriched for active his-
tone marks. (A) Heatmaps of Brg1, Brm, H3K27ac, H3K4me1, H3K4me3 and
H3K27me3 signal (ChIP-seq) around occupied promoter regions at MBT. (B)
Heatmaps of signals around occupied promoter regions at post-MBT, as in (A).
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Figure 2.S12: Class average of histone modifications on commonly and specif-
ically occupied regions at MBT stage. Occupied regions are classified into in-
tergenic, genic and promoter regions, which are further grouped into common,
Brg1-specific and Brm-specific regions. Next, the mean profiles of H3K27ac,
H3K4me1, H3K4me3, H3K27me3 signal (ChIP-seq) were plotted.
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Figure 2.S13: Class average of histone modifications on commonly and specif-
ically occupied regions at post-MBT stage. Occupied regions are classified into
intergenic, genic and promoter regions, which are further grouped into common,
Brg1-specific and Brm-specific regions. Next, the mean profiles of H3K27ac,
H3K4me1, H3K4me3, H3K27me3 signal (ChIP-seq) were plotted.
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Figure 2.S14: Genome browser view showing Brg1, Brm and Pol II are absent at
HOXA locus.
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Figure 2.S15: Correlation of Brm and Pol II. (A) Heatmaps of Brm and Pol II ChIP-
seq signal on Brm Body genes and Promoter genes at MBT (left) and, on those at
post-MBT (right). Each row represents one gene, which includes 20 bins covering
gene start to stop, 3 bins for upstream 3kb and 3 bins for downstream 3kb. (B)
Gene Ontology of Brm Body genes and Promoter genes at MBT and post-MBT,
analyzed by DAVID.
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Figure 2.S16: A subset of Pol II Body genes is bound by Brm. (A) Pie charts of
percentage of Pol II body genes bound by Brm at MBT and post-MBT. (B) Boxplot
of expression level of MBT and post-MBT Pol II Body genes bound or unbound
by Brm. (D) Boxplot of gene length and exon numbers of MBT and post-MBT Pol
II Body genes bound or unbound by Brm. The difference between two groups is
statistically significant by t test (*** denotes p < 0.001).
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CHAPTER 3
THE LANDSCAPE OF ACCESSIBLE CHROMATIN IN
EARLY ZEBRAFISH EMBRYO
3.1 Abstract
The early embryo undergoes extensive chromatin reprogramming to convert
two terminally-differentiated gametes into a totipotent zygote. Chromatin acces-
sibility is crucial for gene regulation and early embryo plasticity. However, the dy-
namics of accessibility and how it regulates early embryogenesis remain unknown.
Here, we provide the global landscapes of accessible chromatin at three embryonic
stages and adult liver determined by ATAC-seq. Chromatin becomes gradually
accessible during early embryogenesis, with a substantial increase from pre-MBT
to MBT. At MBT, more than half of open chromatin regions are distributed around
genes and are highly enriched at promoters. In general, transcription of genes
correlates with open chromatin, except a small percentage of genes. Interestingly,
the promoters of these genes are enriched for H3K4me1 and H3K27me3, which is
a new bivalent mark identified at promoters. In addition, intergenic open chromatin
regions displayed various patterns of H3K4me1 and H3K27ac. I further examined
Pol III genes, which behave opposite to Pol II: Pol III genes are generally open
pre-MBT, but become inaccessible as the embryo develops. Furthermore, both
active histone marks and Pol II are enriched around the TSS of most ‘open’ Pol
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III genes at MBT. Importantly, candidate transcription factors were identified at
open chromatin regions based on motif analysis, including pluripotency factors
Pou5f3, and Sox2, and novel factors Nr2e3, NFYB and others. Finally, nucleosome
positioning can be profiled utilizing ATAC-seq fragments with length of 120-220bp.
3.2 Introduction
Upon fertilization, the embryo undergoes extensive chromatin reorgranization in
order to acquire the ability to differentiate into any cell lineage. Specific transcrip-
tion circuits are the basis of pluripotency and subsequent cell fate specification,
which is orchestrated at multiple levels – including DNA methylation, histone mod-
ifications, chromatin remodeling, as well as higher-order chromatin structure (Bur-
ton & Torres-Padilla, 2014). How chromatin profiles are established and how chro-
matin profiles instruct gene expression during embryogenesis are pivotal questions
that remain to be answered.
A key aspect of the chromatin profile is chromatin accessibility. DNA is wrapped
around nucleosome which precludes binding from most nonhistone proteins, known
as inaccessible chromatin. For gene activation, chromatin at promoters and/or
enhancers has to become permissive. The accessible chromatin allows binding of
transcription factors (TFs) and other co-activators, leading to the following engage-
ment of polymerase and transcription (Levine & Tjian, 2003). Most TFs cannot
bind nucleosomal DNA, except pioneer transcription factors, such as FOXA and
GATA factors (Zaret & Carroll, 2011). These pioneer factors bind nucleosomal
DNA and recruit chromatin remodelers to open up the chromatin and make it
accessible to other transcription factors and co-activators. Profiling the global
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chromatin accessibility allows us to identify the candidate pioneer factors, as well
as key transcription factors that bind the opened chromatin and actively regulate
gene expression.
Extensive work have focused on Pol II genes to understand the interplay be-
tween chromatin accessibility and gene expression. However, evidence suggests
expression of Pol III genes is also modulated at the chromatin level (Hartley &
Madhani, 2009). RSC complex is a SWI/SNF-family chromatin remodeler in yeast.
Loss of the RSC function by mutating the catalytic subunit, Sth1, results in globally
reduced transcription of Pol I, II and III genes. Interestingly, Pol III genes consist of
a large class of RSC-occupied genes, and they have the lowest histone-occupancy
genome-wide (Parnell et al., 2008). Discovered in HeLa and other cell lines, many
active Pol III genes are in close proximity to Pol II genes who have permissive chro-
matin (Oler et al., 2010). Furthermore, Pol III occupancy is significantly correlated
with active histone modifications including H2AZ and H3K4me3. Collectively, these
data suggest Pol III gene activation also requires accessible chromatin and may
take advantage of the active chromatin environment established by the chromatin
remodeling occurring at Pol II genes (Oler et al., 2010).
In Chapter 2, we identified the regions bound by SWI/SNF complex, using Brg1
and Brm as a proxy. However, there are almost certainly other regions that either
rely on other chromatin remodelers and/or are accessible due to other mecha-
nisms, and will be missing if solely dependent on mapping the occupancy of Brg1
and Brm. Therefore, to gain a comprehensive understanding of chromatin land-
scape in early zebrafish development, we conducted ATAC-seq at three embryonic
stages, and also in differentiated liver (for comparisons). Fragments were grouped
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into ATAC-open and ATAC-mono based on length, which others have established
represent open chromatin (lacking nucleosomes) and mono-nucleosomes, respec-
tively. Notably, I found that focal chromatin accessibility increases as the embryo
develops. These open chromatin regions are highly enriched at promoters, and
correlated with gene expression level. Comparing open chromatin with histone
modifications also revealed many interesting features at promoters and intergenic
regions.
3.3 Results
3.3.1 ATAC-seq in early zebrafish embryos (and liver) reveals
accessible and nucleosome-occupied regions
To determine the accessible chromatin regions and how they regulate early em-
bryogenesis, we performed ATAC-seq experiments in three embryonic stages and
one differentiated tissue, adult liver. Two replicates for each stage are submitted
for paired-end sequencing, as well as Tn5 transposed naked DNA, which controls
for sequence bias of Tn5 enzyme (Figure 3.1). We obtained around 100M reads
for each replicate, which gave 10-fold genome coverage on average (Table 3.1).
The two replicates for each stage were highly correlated, with Pearson Correlation
score higher than 0.99 (Figure 3.2A-D). Notably, the samples from embryonic
stages are clustered together and the liver sample is divergent from the embryonic
samples (Figure 3.2E).
By plotting the fragment size distribution, I found there were three major groups
of reads: the first group of reads expands from 0-100bp; reads from the sec-
ond group mainly had length from 100 to 200bp; the third group had a much
shallower peak and expanded from 300bp to 400bp (Figure 3.3A). Group 2 and
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Group 3 reads displayed as bell curves, and their distributions were fitted by Gaus-
sian Distribution. The derived mean and standard deviation were used to group
reads with length from 120-220bp as ATAC-mono (group 2), and reads with length
from 270-410bp as ATAC-di. We further classified reads with length (0-100bp)
as ATAC-open. The three groups of reads likely represent mono-nucleosome,
di-nucleosome and open chromatin, respectively. Particularly, ATAC-mono reads
displayed periodical subpeaks corresponding to the helical pitch of DNA (Figure
3.3A, arrowhead). The percentage of ATAC-open reads in pre-MBT samples is the
highest among all stages, and it gradually decreased as the embryo developed.
In contrast, the percentage of ATAC-mono reads increased along development
(Figure 3.4A). One example is shown in Figure 3.4B, where the ATAC-open and
ATAC-mono clearly reflected two distinct populations, which were unresolved in
the ATAC-total.
3.3.2 Substantial increase of chromatin accessibility
from pre-MBT to MBT
Using MACS2 (FDR < 0.001) with subsequent filtration using stringent cutoff
(length ≥ 100bp and −log(q-value) ≥10), I identified 850, 24331, 32934 and
26799 strong open regions at pre-MBT, MBT, post-MBT and liver (Figure 3.5A).
The numbers of open chromatin regions increased dramatically from pre-MBT to
post-MBT, suggesting an increase in chromatin accessibility in early development.
Interestingly, open chromatin regions decreased from post-MBT to liver, indicating
that differentiated tissue has fewer open chromatins compared to embryonic cells.
Of note, very few open chromatin regions were identified at pre-MBT; this feature
could be caused by technical difficulties. The chromatin is largely condensed
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during mitosis in the fast cell cycle (15 min) at pre-MBT, and thus Tn5 enzyme
could inefficiently transposase in the open chromatin regions. Alternatively, this
might reflect a true chromatin landscape at pre-MBT that is the chromatin is re-
fractory globally, which is consistent with two recent studies investigating the open
chromatin in mouse embryo (Lu et al., 2016; Wu et al., 2016). More investigations
are needed to determine which is the case.
To characterize the open chromatin regions, I examined their distribution on dif-
ferent genome features. Although a majority of pre-MBT open regions localized at
the intergenic area, open regions at MBT, post-MBT and liver were highly enriched
at promoters and coding exons (Figure 3.5B). Next, I analyzed which regions at
one stage were lost or maintained in the next stage (Figure 3.5C). For instance,
∼70% of pre-MBT peaks were lost at MBT, while ∼30% were maintained at MBT.
Examining the genome distribution of the lost peaks revealed that open regions
at intergenic and coding area were preferentially lost compared to the regions at
promoters (compare Figure 3.5D to Figure 3.5B). In addition, substantial regions
were gained at MBT, post-MBT and liver, compared to their previous stages (Figure
3.5E). MBT-gained regions which were greatly enriched at promoter and coding re-
gions, whereas, liver-gained regions have a higher fraction in intron and intergenic
area (Figure 3.5F). This may suggest more enhancers become accessible in liver
compared to MBT.
To understand what the functions of genes associated with open chromatin are,
I performed Gene Ontology analysis. For gained regions at MBT, ‘transcription’
and ‘nucleotide binding’ were the most enriched terms. At post-MBT, enrichment
additionally included ‘pattern specification process’ and development terms like
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‘eye development’, and ‘determination of symmetry’. As expected, gained open
regions in liver were significantly enriched at various enzymatic processes that are
specific for liver (Figure 3.6), while transition from post-MBT embryo to liver was
accompanied by the loss of transcription and development related terms (Figure
3.6). The distinct GO terms at each stage reflect that open regions were associated
with different genes at each stage, and a few examples were provided in Figure
3.7. sp3a and actb2 are genes ubiquitously transcribed and have open chromatin
across MBT, post-MBT and liver, but not in control (DNA), whereas apoa and
serpina1 are key regulators in liver, and exhibited open chromatin specifically in
liver. Additionally, foxh1 and pou5f3 are genes required for early development and
were only open at MBT and post-MBT stages. In summary, our ATAC-seq data
reveal a highly dynamic chromatin in early development, and also demonstrate the
embryonic chromatin profiles are distinct from that of differentiated tissue.
3.3.3 Genes associated with open chromatin have
higher expression
Around 60% of open chromatin regions at MBT, post-MBT and liver resided in
the gene-related area (Figure 3.5B), which was associated with 23, 8356, 9846,
and 8936 genes at pre-MBT, MBT, post-MBT and liver (Figure 3.8A). Next, Meta-
gene analysis was performed to determine where open chromatin regions were
enriched related to genes. Open-chromatin signals were highly enriched at pro-
moters of occupied genes at MBT, post-MBT and liver, and enriched to a lesser
extent at pre-MBT. Moreover, open-chromatin signals of MBT and post-MBT were
moderately enriched at the downstream regions (Figure 3.8B). Open chromatin
at promoters allows transcription factors and Polymerase to bind, and usually in-
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dicates active transcription. Therefore, I asked whether genes associated with
open chromatin have elevated transcription. Indeed, genes associated with open
chromatin at MBT and post-MBT have higher expression compared to genes that
do not have open chromatin (Figure 3.8C).
To interrogate whether gene expression correlates with open chromatin acces-
sibility, I ranked all genes based on their expression at either MBT (Figure 3.9A)
or post-MBT (Figure 3.9C). As expected, highly transcribed genes (on top) have
stronger open chromatin signal. A similar conclusion can be drawn, when genes
were classified into 4 quantiles based on expression (1st quantile indicated the top
25% transcribed genes) (Figure 3.9B, D). These data indicate highly transcribed
genes are associated with strong open chromatin.
3.3.4 Potential new bivalent mark at promoters
Among all genes associated with open chromatin at MBT, the majority (78%,
6571 out of 8356 genes) of which have open chromatin at promoters, and are
actively transcribed (FPKM >1). However, ∼16% (1041 out of 6571) of genes
barely have any transcription (FPKM <1) even they are associated with open
chromatin regions. I then sought features that might explain why this subset of
genes have accessible promoters but are not transcribed. Firstly, I ranked all
ATAC-open peaks that resided at promoter based on the expression level of their
associated genes. Next, I profiled −log(q-value) of ATAC-open signals, ChIP-seq
signals of H3K27ac, H3K4me1, H3K4me3 and H3K27me3 around these peaks
(Figure 3.10A) (Zhang et al., 2014; Bogdanovic´ et al., 2012). Interestingly, re-
gardless of the expression level of associated genes, open chromatin regions
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exhibited similar strength (indicated by the intensity of color in the green heatmap
of Figure 3.10A). This ruled out the possibility that those genes have a weaker open
chromatin, which is insufficient to activate transcription. Next, I focused on histone
modifications. As expected, H3K27ac and H3K4me3 were highly correlated with
gene expression, while H3K27me3 are enriched for genes that are not transcribed.
Most interesting, genes down on the ranking list had high levels of H3K27me3 and
H3K4me1, and void of H3K4me3 and H3K27ac.
To investigate this further, I selected the top 10% peaks (associated gene are
highly transcribed) and the bottom 10% peaks (associated gene are not tran-
scribed). Notably, the top 10% peaks have high level of active histone marks
(H3K27ac, H3K4me1, and H3K4me3) but not repressive mark (H3K27me3) (Fig-
ure 3.10C). In striking contrast, the bottom 10% genes have a much lower H3K27ac
signal, and instead displayed high occupancy of H3K27me3 and H3K4me1 (Fig-
ure 3.10C). The active H3K4me1 and repressive H3K27me3 form a new bivalent
mark, which is different from the canonical bivalent mark defined by H3K4me3 and
H3K27me3 (Bernstein et al., 2006). I speculate the new bivalent mark might have
a similar function to the canonical one, which is to poise genes for expression at a
later stage. Whether this new bivalent mark is specific to zebrafish, or specific to
early embryo need to be further explored.
3.3.5 Intergenic open chromatin regions at MBT
A number of the ATAC-open peaks (∼40%) were distributed at intergenic re-
gions, which could be indicative of putative enhancers. Only ChIP-seq data of
histone modifications (H3K27ac, H3K4me1, H3K4me3 and H3K27me3) at 4.3hpf
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(close to 4hpf, MBT) are public available. Therefore, I focused on ATAC-open
intergenic regions at MBT, and profiled the signal of histone modifications around
the intergenic peaks. As expected, H3K27ac and H3K4me1, histone modifica-
tions that mark enhancers, were enriched at those intergenic regions. In contrast,
no significant occupancy of H3K4me3 and H3K27me3 was observed at those
loci (Figure 3.11A). To determine whether the intergenic regions have different
combination of histone marks, I performed k -mean clustering with the normalized
H3K27ac and H3K4me1 signal. Notably, a large percentage of the intergenic
regions were co-bound by H3K27ac and H3K4me1, while some regions were
preferentially bound by H3K27ac (Figure 3.11B, group 1 and group 2) or H3K4me1
(Figure 3.11B, group 3). Group 4 represented the regions that were only marked
by H3K4me1, and presumably were inactive enhancers. Interestingly, around 40%
of intergenic regions are nearly lacking H3K4me1 and H3K27ac (Figure 3.11B,
group 5). Whether other histone modifications mark these intergenic regions will
be interesting to know. In summary, the majority of the intergenic open chromatin
regions are associated with at least one active histone modifications, and could be
putative enhancers.
3.3.6 The number of Open Pol III genes decreases
as the embryo develops
Expressions of Pol III genes are regulated at the chromatin level as well. To
interrogate whether Pol III genes also associated with open chromatin in the early
embryo, I first identified all predicted Pol III genes based on zv10 genome anno-
tation (Table 2). tRNAs were identified from repeat masked tracks, and only those
longer than 72bp were kept as potential tRNAs. For all the Pol III genes, ATAC-open
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signal at each stage was collected around the TSS, and was subjected to k -mean
clustering. Interestingly, a lot more Pol III genes are relatively open at pre-MBT
compared to that at MBT, post-MBT and liver (Figure 3.12A). Across all stages,
a subset of Pol III genes has a very strong ATAC-open signal, and were referred
as ‘Open Pol III genes’. Notably, 1354 Pol III are potentially open at pre-MBT,
and this number decreases as the embryo develops (Figure 3.12B). Particularly,
nearly 1000 Pol III genes lost the open chromatin signal from MBT to post-MBT.
This suggests that Pol III genes are of greater need in early embryo (pre-MBT and
MBT), potentially to facilitate the translation of the vast amount of transcripts newly
generated at zygotic genome activation.
I then focused on the Open Pol III genes at MBT. The defined Open Pol III
genes indeed have more ATAC-open signal at MBT, which was reduced at post-
MBT (Figure 3.13A). Interestingly, these genes also have higher active histone
modifications, particularly H3K27ac, whereas repressive mark, H3K27me3, was
nearly absent (Figure 3.13B). Previous work from our lab suggested active Pol III
genes are close to Pol II genes that usually have an open chromatin (Oler et al.,
2010). In agree with this observation; around 16% of Open Pol III genes was
in close proximity within Pol II genes (Figure 3.13C). Moreover, Pol II was highly
enriched at the TSS of open Pol III genes, and moderately enriched at the regions
around TSS. In contrast, Pol II was nearly absent in the 2kb regions around TSS of
Pol III genes that are not open at MBT (Figure 3.13D). To sum, I have identified Pol
III genes associated with open chromatin at each stage. The number of Open Pol
III genes decreased dramatically from MBT to post-MBT. Additionally, promoters of
Open Pol III genes were enriched for active histone marks and Pol II occupancy.
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3.3.7 Motif analysis of open chromatin regions
at different stages
Transcription factors may serve as ‘pioneer factors’ to facilitate the establish-
ment of open chromatin, or can be targeted to the accessible chromatin for sub-
sequent gene regulation. Therefore, investigating the over-represented motifs at
open chromatin regions is informative for identification of candidate transcription
factors involved in both aspects. To this end, I employed Regulatory Sequence
Analysis Tools (RSAT) to determine the enriched motifs at open chromatin regions
of four stages (Figure 3.14) (Medina-Rivera et al., 2015). At pre-MBT peaks,
only three motifs were identified, which were all presented in nearly 80% of all
pre-MBT peaks. However, the enrichment was barely significant (E-value <0.05),
which was largely due to the small number of peaks identified at pre-MBT. Among
these, Nr2e3 is of particular interest, as its homolog, Nr5a2, was highly enriched
at open chromatin regions in mouse pre-implantation embryo (Figure 3.14A)(Wu
et al., 2016). Knockout of Nr5e2 leads to embryo lethality at E6.5, and reduced
the expression of pou5f1 and Nanog (Wu et al., 2016). Altogether, they suggest
Nr2e3 might play an important role in zebrafish early development that is previously
unknown. Another interesting motif is NFYB, which was highly enriched at MBT,
post-MBT and liver (Figure 3.14A). This motif was also enriched in early mouse
embryos, and knockdown of Nfya arrested mouse embryo at morula stage (Lu
et al., 2016). These data suggest the regulation of early embryogenesis between
zebrafish and mouse might be similar. Furthermore, POU5F1 and SOX motifs
were specifically enriched at MBT and post-MBT embryos, but not in liver (Figure
3.14A). This not only confirmed the identified open chromatin regions were cell-
type specific, but also support the known importance of zebrafish Pou5f1 (known
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as Pou5f3 in zv10) and SOX factors.
To determine whether the candidate transcription factors at enhancers and
promoter are different, I partitioned open chromatin peaks into promoter peaks
and intergenic peaks, and performed the same motif analysis (Figure 3.14B, C).
Additional motifs were discovered in intergenic area (i.e. RARG, GATA4) and
promoter area (i.e. MNT, HOXA13). Intriguingly, many motifs were co-enriched
at the promoter peaks of MBT, post-MBT and liver, which was in contrast to the
variability observed at intergenic area. This is in line with the notion that enhancers
are more dynamic compared to promoters. Of note, CTCF motif was only enriched
at the intergenic area but not at promoter, which is consistent with its role as insu-
lator. Finally, I also identified liver specific motifs including USF2, ELK4, NFIC, and
GATA4. Taken together, I reveal diverse enriched motifs at different stages. The
corresponding factors to some motifs (i.e. POU5F1, SOX2) are known to regulate
zebrafish early development, whereas, factors of other motifs (i.e. NFYB, Nr3e2,
YY, CREB1) have not been studied for their roles in zebrafish early development,
and will be candidates for future work.
3.3.8 Eomesa, Sox2, Pou5f3 and Nanog are enriched
at open chromatin regions
Among the enriched motifs at MBT and post-MBT, I am particular interested
in Eomes, Pou5F1, and Sox motifs; Eomes promotes trophectoderm differentia-
tion in mammals, while Pou5f1 and Sox factors promote pluripotency and ES-cell
self-renewal, and early zebrafish development (Russ et al., 2000; Niwa, 2007; Le-
ichsenring et al., 2013). To interrogate whether the corresponding proteins indeed
play roles in the regulation of chromatin accessibility, I profiled the public ChIP-seq
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data of Eomesa (4hpf), Sox2 (5hpf), Pou5f3 (5hpf) and Nanog (4.3hpf) around the
open chromatin regions (Figure 3.15A-F) (Nelson et al., 2014; Leichsenring et al.,
2013; Xu et al., 2012). Notably, all four factors were enriched at the centers of
open chromatin regions at MBT and post-MBT. In addition, Eomesa have higher
enrichment at intergenic peaks compared to promoter peaks, whereas Nanog,
Sox2 and Pou5f3 have similar intensity at intergenic and promoter peaks.
To understand whether Eomesa, Sox2, Nanog and Pou53 function individually
or cooperatively, ChIP-seq signals of Eomesa, Sox2, Nanog and Pou53 were
normalized, combined and subjected to k -mean clustering. I observed some in-
tergenic regions were bound by all four TFs (Figure 3.15G, group 1), while others
were preferentially bound by Nanog (Figure 3.15G, group 4). Interestingly, group 2
and group 3 peaks showed reciprocal binding pattern, where group 2 peaks were
bound by Eomesa and Nanog, and group 3 peaks were bound by Sox2 and Pou5f3
(Figure 3.15G, group 2 and 3). In addition, most of intergenic peaks (∼70%) were
not bound by the four TFs.
In contrast to the intergenic peaks, most promoter peaks were bound by in-
dividual or a combination of TFs (Figure 3.15H). A small percentage of promoter
peaks were bound by all four factors (Figure 3.15H, group 1), while other peaks
were predominantly associated with Pou5f3 (Figure 3.15H, group 5). Group 4
peaks seem associated with Sox2, Pou5f3 and Nanog. Intriguingly, peaks from
group 2 or group 4 are preferentially bound by Eomesa or Nanog, respectively.
Collectively, these data unveil Eomesa, Sox2, Nanog and Pou5f3 are enriched at
open chromatin regions, and form different regulatory networks at promoters and
intergenic area.
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3.3.9 Pou5f3 may serve as pioneer factor
for the establishment of open chromatin
Transcription factors in general are unable to bind DNA wrapped with histones,
except a special class of ‘pioneer factor’ including FoxA and GATA factors (Zaret &
Carroll, 2011). By recruiting chromatin remodeler, such pioneer factors can open
the local chromatin, which becomes accessible to other transcription factors. Since
Pou5f3, Sox2, Nanog are key regulators of zygotic genome activation in zebrafish,
it is intriguing to known whether they could also serve as pioneer factors. To test,
I collected ATAC-open signals at MBT around the ChIP-seq binding sites of Sox2,
Pou5f3 and Nanog, as well as Eomesa, followed by k -mean clustering. For all
factors, only 20-30% of peaks have strong open chromatin signals (Figure 3.16A,
B), which indicates that these four factors have the ability to bind closed chromatin.
In particular, nearly 80% of Pou5f3 binding sites barely exhibited low ATAC-open
signal, which argues strongly that Pou5f3 could be a pioneer factor.
If pioneer factors are able to open up the local protein, the nucleosome density
should be decreased. To investigate whether these factors (Eomesa, Pou5f3,
Sox2, Nanog) indeed serve as pioneer factors, I profiled our nucleosome sig-
nal (based on MNase-seq data described in more detail in Chapter 4) around
their binding sites, and only showing Nanog binding sites as an example. As
expected, at the center of strong open sites and open sites (indicated by dark
and light blue strip in 16A), nucleosome is depleted (Figure 3.16C, D). Strong
open sites also exhibited even lower nucleosome signal compared to open sites.
In contrast, closed sites were occupied by nucleosomes, confirming the k -mean
clustering results. Nanog binding sites were called based on ChIP-seq of Nanog
at 4.3hpf. If Nanog functions as pioneer factors on the closed sites, I should
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observe lower nucleosome signals at post-MBT (5.3hpf) compared to MBT (4hpf).
However, nucleosome signals at post-MBT were still high at the closed sites, which
is contradictory to our hypothesis. More investigations are needed to resolve this
contradiction.
3.3.10 ATAC-mono represents nucleosome positioning
around transcription start sites
As I initially defined, reads with length from 120 to 220bp were grouped as
ATAC-mono, which are close to a nucleosome size. To investigate whether ATAC-
mono can be used to profile nucleosomes, I ranked all genes based on their
expression at MBT, and then profiled ATAC-mono and my own MNase-seq data
around TSS. ATAC-mono at MBT, post-MBT and liver displayed a banding pattern
around TSS, which indicates nucleosome array. As expected, highly transcribed
genes formed a stronger array compared to genes expressed at a low level (Fig-
ure 3.17A). In agreement with ATAC-mono data, MNase-seq data also revealed
the presence of nucleosome array at TSS, and the strength of which correlates
with gene expression (Figure 3.17B). Nevertheless, there are evident differences
between these datasets. First, MNase-seq better represented nucleosomes dis-
tribution for gene transcribed at low level or nontranscribed genes (Figure 3.17B,
bottom part of the heatmap). Second, stronger +2 and downstream nucleosomes
were captured by MNase-seq data compared to ATAC-mono data. These differ-
ences were better illustrated in the class average maps, where ATAC-mono and
MNase-seq data were compared directly at each stage (Figure 3.18). These differ-
ences likely stem from the nature of the two enzymes. MNase is a small enzyme
(∼17KD), whereas Tn5 is relative large (∼55KD). In addition, MNase preferentially
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cut at AT-rich sequence, which has high frequency between nucleosomes (linker
regions). These attributes enable MNase to cut into heterochromatin regions, and
also to have higher efficiency at linker regions. In conclusion, ATAC-mono can
be used to reflect nucleosome positioning. However some information might be
missing if solely relies on ATAC-mono.
3.4 Discussion
Zygotic genome activation (ZGA) is a crucial stage in early embryogenesis,
where genes required for early development and transcription are selectively tran-
scribed while genes involved in cell fate specification are repressed. How to tightly
regulate this unique transcriptome and acquire the potential to differentiate into
any cell lineage are important questions that remain elusive. We want to provide
insights into these questions by profiling the genome-wide chromatin accessibility
in the early zebrafish embryo. Chromatin accessibility, modulated by chromatin
remodelers, controls transcription factors binding at promoters and enhancers, and
the subsequent gene expression. Profiling the chromatin accessibility will allow us
to understand how the unique transcriptome is regulated at the chromatin level and
what the crucial regulators in early development are.
In my results, the number of open chromatin regions at pre-MBT is significantly
lower compared to other stages. I argue it reflects a relative refractory chromatin
state, which could be explained in three ways. First, the genome is transcriptionally
quiescent. Thus, there is no need for the chromatin to be open. Second, there are
repressors to prevent the genome from becoming accessible. Third, the factors
responsible for opening up chromatin are not available or function at a low level.
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These mechanisms could be acting individually or coordinately. However, it is
also possible that the refractory chromatin state is a technical artifact, due to the
condensed chromatin at mitosis. At pre-MBT, the cell cycle is very short (∼15min),
and only has S and M phase. Therefore, Tn5 enzyme may be inhibited by the
compacted chromatin during M phase. However, there are no effective means to
synchronize embryos at S phase. Nevertheless, the relative inaccessible genome
is also observed in mouse preimplantation embryos by two different techniques,
ATAC-seq and DNA hyperactivity assay (Lu et al., 2016; Wu et al., 2016). This
makes the technical artifact hypothesis less likely, and supports that the less ac-
cessible chromatin in pre-MBT is biological.
A central question is how chromatin accessibility is established by the interplay
between transcription factors and chromatin remodelers, which can be informed
partly by the motif analysis on open chromatin regions. Many interesting motifs
are over-represented in our accessible chromatin regions at different stages. At
pre-MBT, motifs of Nr2e3, TBX and ZNF354C are present in almost 80% of open
chromatin regions. They could serve as pioneer factors and open up the local
chromatin at pre-MBT. Alternatively, they could bind these sites after the local
chromatin becomes accessible. It will be equally interesting no matter which is
the case. At MBT, post-MBT and liver, more candidates are suggested based on
the identified motifs. Some factors including Pou5f1 and Sox have been shown
to play important roles in ZGA. Others, including NFYB, CREB1, and YY1, have
not been studied for their functions in early embryogenesis. Interestingly, a close
homolog of NFYB, NFYA was recently identified in DHS (DNA hypersensitive sites)
of mouse 2-cell embryos (Lu et al., 2016). The authors suggest NFYA may function
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as a pioneer factor, as knockdown of NFYA reduces signals of ∼28% of DHSs (Lu
et al., 2016). Furthermore, NFYA KD embryos are arrested at the morula stage.
The evidence strongly suggests that zebrafish NFYB might have comparable roles
in early embryogenesis.
Pluripotent factors are key regulators of early embryogenesis. It is interesting
to determine whether they could serve as pioneer factors, in addtion to their roles
as transcription activators. I have focused on three pluripotent factors Pou5f3,
Sox2 and Nanog and one Tbx factor, Eomesa, which is homolog to Eomes in
mammals that promotes trophectoderm differentiation. By k -mean clustering, two
distinct groups of binding sites emerged for all these four factors. One group has
a higher signal of ATAC-open data, suggesting open chromatin. The other group
has much weaker ATAC-open signal, and the chromatin is probably inaccessible.
Take Nanog as an example; I indeed observed a strong nucleosome peak right at
the center of the closed sites, which are absent in the sites with open chromatin.
Unexpectedly, the binding event of Nanog did not promote a subsequent decrease
in nucleosome density. It is possible that the change of nucleosome density hap-
pens at later stages which are not covered in this dissertation work. Alternatively,
the binding events have purposes other than increasing chromatin accessibility.
In either case, further investigation is needed to determine whether these factors
are bona fide pioneer factors. One essential role of transcription factors binding
is to bring in co-activators such as histone acetyltransferases. By targeting those
histone modifiers, active histone modifications such H3K27ac, H3K4me1/3 can be
added, and further enhance the accessibility of these regions. Therefore, it will be
interesting to determine whether the binding of these transcription factors affects
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histone modifications.
In my results, I described a new bivalent mark at gene promoters, which is
composed of H3K27me3 and H3K4me1. This new bivalent mark is different from
the canonical one (H3K27me3 and H3K4me3). First, it will be interesting to know
what genes carry the new bivalent marks and what biological processes they are
enriched for. I would speculate genes such as Tbx, Fox or Hox genes, which are
required for cell fate specification and need to be repressed at MBT, could carry this
new bivalent histone modification. The repression would presumably be mediated
through H3K27me3, while H3K4me1 may facilitate the genes to transit from a
repressed to active state at proper cellular context. In ES cells, the active mark
is H3K4me3 on the poised genes. Why do zebrafish utilize H3K4me1 instead of
H3K4me3? This is not because H3K4me3 is limited, as actively transcribed genes
are highly enriched for H3K4me3. It is possible that zebrafish employed a different
strategy to distinguish the actively transcribed genes and poised genes. Therefore,
additional questions to pursue are: 1) if H3K4me1 is replaced by H3K4me3 at their
promoters once these bivalent genes are transcribed? 2) whether activation of
genes is due to the removal of H3K27me3 or owing to establishment of H3K4me3?
These questions can be answered by a combination of bioinformatics analysis,
manipulation of histone methyltransferase, and ChIP-seq experiments.
Previously, I have defined Open Pol III genes at each stage by their association
with open chromatin around the TSS. Open chromatin at promoter indicates their
potential for transcription but does not necessarily mean they are transcribed.
Here, Pol III ChIP-seq will help us validate whether these Pol III genes are tran-
scribed, which will be investigated by Candice Wike in the lab. Pol III ChIP data
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are also helpful to confirm the dynamics of Pol III during early embryogenesis. By
combining her data with my data I could address if my new bivalent modifications
also mark a subset of Pol III genes that are poised for transcription. In addition,
transcription of Pol I genes might also be regulated at chromatin level (Parnell et
al. 2008). Similar analysis for Pol III genes can be applied to Pol I to address
this question. However, due to the repetitiveness of the rRNA, reads need to be
mapped to rRNA locus using different alignment strategy.
In Chapter 3, I have described the ATAC-seq data generated from early em-
bryos and adult liver, with a focus on ATAC-open data (fragments with length from
0-100bp). Our data revealed the accessibility of chromatin increases dramatically
from pre-MBT to MBT, which suggests a permissive chromatin is underlining the
genome activation. This work also provides candidates transcription factors that
are seminal for the establishment of chromatin accessibility and in the regulation
of early embryogenesis. Furthermore, I have also observed various patterns of
histone modifications at promoters and intergenic regions. Particularly, a new
bivalent mark composed of H3K4me1 and H3K27me3 is identified at promoters
of certain genes. Future work should focus on studying the candidate transcription
factors that are potentially involved in early embryogenesis, and characterization
of the bivalent histone mark and further investigating its function.
3.5 Methods
3.5.1 Zebrafish and sample collection
Tubingen zebrafish lines were maintained and raised under standard condi-
tions. Wildtype embryos were collected after 10min of mating to ensure the syn-
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chrony of embryo development, raised in embryo water at 28◦C and staged as
previously described (Kimmel et al., 1995).
3.5.2 Isolation of adult liver
Adult fish were fasted for a week prior to dissection. Euthanasia of zebrafish
with ice water was conducted following the IACUC procedures. Dissection of
the adult zebrafish liver was performed under brightfield imaging on a dissection
microscope. Dissected livers were immediately transferred to Eppendorf tubes on
ice and rinsed with PBS. Nuclei extraction is similar to embryonic cells, and is
described in the following section.
3.5.3 ATAC-seq experiment
ATAC-seq was performed essentially as previously described (Buenrostro et al.,
2013). Briefly, embryos at pre-MBT (2.5hpf), MBT (4hpf) and post-MBT (5.3hpf)
were carefully staged, and dechorinated. The embryos were washed in cold PBS,
and then resuspended in lysis buffer (10mM Tris-HCl [pH 7.4], 10mM NaCl, 3mM
MgCl2, 0.1% IGEPAL CA-630) on ice for 10 min. During the lysis, a 20 Gauge
syringe was used three times to break the chorions and cells, followed by table top
spin for 10 seconds. The supernatant was then centrifuged at 1300g 5 min 4◦C
and nuclei was resuspended in 2X TD buffer, and incubated with Tn5 enzyme for
30 min at 55◦C (Nextera DNA Library Preparation Kit, FC-121-1031). The reaction
was terminated by adding SDS to a final concentration 1%. Then, the sample was
purified by Qiagen minElute column and PCR amplified by NEBNext High-Fidelity
2X PCR Master Mix (NEB, M0541L). qPCR was utilized to determine the optimal
PCR cycles to prevent over-amplification.
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3.5.4 Data analysis
Paired-end fastq files were uniquely aligned to zv10 zebrafish genome assem-
bly using Novoalign (Novocraft, Inc) with the following parameters: -r None -Q
13 -k -o SAM -a CTGTCTCTTATACACATCT, and converted to BAM files using Ssam-
tools. BAM files from replicates were merged for downstream analysis. Total
ATAC-seq data are divided into nucleosome-free reads and nucleosome signal
according to (Buenrostro et al., 2013). The coverage tracks of nucleosome-free
reads were generated using the program bam2wig (http://search.cpan.org/
dist/Bio-ToolBox/) with the following parameters: --position span --pe --rpm
--bw.
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Table 3.1: ATAC-seq sequencing summary
Pairs Pairs aligned % Aligned Corre-
lation
pre-MBT nCL rep1 127,360,630 108,799,541 85.4% 0.9997
pre-MBT nCL rep2 155,469,925 133,997,672 86.2%
MBT CL rep1 141,697,661 113,722,176 80.3% 0.9913
MBT CL rep2 88,064,503 70,400,750 79.9%
MBT nCL rep1 116,143,770 100,727,211 86.7% 0.9970
MBT nCL rep2 69,279,042 94,374,321 136.2%
post-MBT nCL rep1 144,010,745 126,396,904 87.8% 0.9989
post-MBT nCL rep2 104,215,950 90,975,359 87.3%
Liver nCL rep1 102,588,621 85,385,785 83.2% 0.9914
Liver nCL rep2 146,966,785 124,930,294 85.0%
Naked DNA 228,249,656 208,580,057 91.4%
Table 3.2: Pol III genes
Pol III genes 5s rRNA 7SK RNA vault RNA Y RNA U6 snRNA tRNA
Numbers 758 2 4 1 706 12465
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Figure 3.1: Overview of ATAC-seq experiment. (A) Schematic of experiment
design. Native chromatins are extracted from pre-MBT, MBT, post-MBT embryos,
and adult liver, and are subject to Tn5 transposition and paired-end sequencing.
Naked DNA is treated as chromatin samples and serves as a control. (B) TBE gels
of DNA fragments generated by transposition experiment of two replicates at each
stage.
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Figure 3.2: Replicates are significantly correlated. (A) Pairwise comparisons of
replicates at pre-MBT (A), MBT (B), post-MBT (C) and liver (D). For each replicate,
ATAC signals are collected at 100bp windows covering the entire genome. R value
represents Pearson Correlation score. (E) Pearson Correlations between any of
the 8 samples, clustered into heatmap.
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Figure 3.3: Fragment size distribution. (A) Fragment size distribution for merged
samples at pre-MBT, MBT, post-MBT and liver. Arrows indicate the three groups
of reads. (B) Fragment size distributions of all samples are fitted with Gaussian
distribution. (C-F) Fragment size distributions of each stage were fitted with
Gaussian distribution.
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Figure 3.4: ATAC-seq reads are separated into 3 groups based on size. (A) Per-
centage of each group at all stages. (B) Genome browser snapshots of ATAC-total,
ATAC-open and ATAC-mono.
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Figure 3.5: Dynamics of open chromatin regions. (A) Numbers of ATAC-open
peaks called by MACS2 and R filtration at each stage. (B) Distribution of ATAC-
open peaks at each stage on RefSeq annotation elements. (C) Percentage of lost
and maintained peaks at each stage comparing to the subsequent stage. (D) same
as in (B) for ATAC-open peaks that are lost in the subsequent stage. (E) Number of
ATAC-open peaks that are gained at each stage. (E) same as in (B) for ATAC-open
peaks that are gained comparing to its previous stage.
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Figure 3.6: Gene ontology of lost and gained ATAC-open peaks. Gene ontology
of peaks gained at MBT, post-MBT and liver, as well as post-MBT peaks that are
lost in liver. Analysis is performed with the online server, DAVID.
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Figure 3.7: Genome browser snapshots of representative loci. Sp3a and actb2
have ATAC-open signal at MBT, post-MBT and liver. apoa and serpina1 have ATAC-
open signal specifically in liver. foxh1 and pou5f3 have ATAC-open signal only at
MBT and post-MBT.
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Figure 3.8: Genes associated with open chromatin have higher expression. (A)
Numbers of genes associated with open chromatin at each stage. (B) Meta-gene
model of mean profiles of ATAC-open signals on their occupied genes at each
stage. (C) Boxplot of expression level of genes associated or not associated with
open chromatin (t test: *** denotes p<0.001).
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Figure 3.9: Highly transcribed genes have stronger open chromatin. (A) Heatmaps
of MBT ATAC-open signal around TSS ( 1kb). Each row represents a Refseq gene
TSS, ranked by RNA FPKM value at MBT (4hpf). (B) The mean profiles of MBT
ATAC-open signals at promoters of 4 groups of genes. Genes are grouped into
4 quantiles based on the expression level (FPKM) at MBT. 1st quantile: top 25%
expressed genes. 4th quantile: bottom 25% expressed genes. (C) similar as in
(A) for post-MBT ATAC-open signal on genes ranked by expression at post-MBT.
(D) similar as in (B), for post-MBT ATAC-open signals at promoters of 4 groups of
genes grouped by expression at post-MBT.
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Figure 3.10: Bivalent genes have open promoters but are not transcribed. (A)
Heatmaps of H3K27ac, H3K4me1, H3K4me3 and H3K27me3 (ChIP-seq signals)
around MBT ATAC-open peaks residing at promoters. Green heatmap represents
the mean −log(q-value) around the MBT ATAC-open peaks (±1kb). MBT ATAC-
open peaks are ranked by expression level of associated genes. (B) The mean
profiles of histone modifications signal around the top 10% of MBT ATAC-open
peaks. (C) Same as in (B), for the bottom 10% of MBT ATAC-open peaks. Signals
of H3K4me1, H3K4me3 and H3K27me3 are plotted on the left Y axis. Signal of
H3K27ac is plotted on the right Y axis.
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Figure 3.11: Intergenic ATAC-open peaks are enriched for H3K27ac and
H3K4me1. (A) Heatmaps of H3K27ac, H3K4me1, H3K4me3 and H3K27me3
(ChIP-seq signals) around intergenic MBT ATAC-open peak (±2kb around peak
center). (B) k -mean clustering of H3K27ac and H3K4me1 signals at intergenic
MBT ATAC-open peaks. For each peak, mean values of H3K27ac and H3K4m1
were collected and normalized.
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Figure 3.12: Pol III genes are relatively open at early stages. (A) k -mean clustering
of ATAC-open signal at pre-MBT, MBT post-MBT, and liver around the TSS of all
Pol III genes. The potential open Pol III genes are marked by color bar. (B) Number
of open Pol III genes at each stage.
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Figure 3.13: Correlation of Pol III genes with open chromatin, histone modifications
and Pol II distribution. (A) The mean profiles of ATAC-open signal at pre-MBT, MBT
and post-MBT around MBT open Pol III genes. (B) Same as in (A), for H3K27ac,
H3K4me1, H3K4me3 and H3K27me3 (ChIP-seq signals). (C) Pie chart of the
percentage of Pol III within 5kb of Pol II genes. (D) The mean profiles of Pol II
signals (ChIP-seq at MBT) around MBT open Pol III genes and MBT non-open Pol
III genes.
143
Figure 3.14: Over-represented motifs identified at ATAC-open peaks. (A) Top 10
enriched motifs reported by RSAT are summarized for all ATAC-open peaks at
pre-MBT, MBT, post-MBT and liver. (B) Same as in (A), for promoter peaks at
MBT, post-MBT and liver. (C) Same as in (A), for intergenic peaks at four stages
(C).
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Figure 3.15: Eomesa, Sox2, Pou5f3 and Nanog are enriched at open chromatin
regions. (A-C) The mean profiles of Eomesa, Sox2, Pou5f3, and Nanog signals
around MBT ATAC-open peaks (±2kb from the peak center). (A) all peaks, (B)
intergenic peaks, (C) promoter peaks. (D-E) same as (A-C), for post-MBT ATAC-
open peaks. Profiles of Eomesa, Sox2, Pou5f3 and Nanog are based on public
ChIP-seq data from 4hpf, 5hpf, 5hpf and 4.3hpf embryos, respectively. (G, H)
k -mean clustering of TFs signal at intergenic MBT ATAC-open peaks (G) and at
promoter MBT ATAC-open peaks (H).
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Figure 3.16: Eomesa, Sox2, Pou5f3 and Nanog bind both open and closed
chromatin. (A) k -mean clustering of MBT ATAC-open signals at binding sites of
Eomesa, Sox2, Pou5f3 and Nanog (from left to right). Potential open binding sites
were marked by color bar besides each heatmap. (B) Pie chart of the percentage
of potential open binding sites of each factors (Eomesa, Sox2, Pou5f3 and Nanog).
(C) The mean profiles of MBT nucleosome signals around different Nanog binding




Figure 3.17: ATAC-mono data can reflect nucleosome positioning around TSS.
(A) Heatmaps of ATAC-mono signals of pre-MBT, MBT, post-MBT and liver around
TSS (±1kb). TSS is ranked by gene expression at MBT (FPKM at 4hpf). (B) same
as in (A), for MNase-seq data.
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Figure 3.18: ATAC-mono cannot fully recapitulate nucleosome positioning com-
pared to MNase-seq. The mean profiles of ATAC-mono and MNase-seq at each
stage. pre-MBT (A), MBT (B), post-MBT (C), and Liver (D).
CHAPTER 4
NUCLEOSOME POSITIONING IN EARLY ZEBRAFISH
EMBRYO
4.1 Abstract
Proper regulation of transcription initiation, elongation and co-transcriptional
splicing involves dynamic changes in the presence and position of nucleosomes.
Nucleosomes are the basic subunit of chromatin, which is composed of ∼147bp
DNA and a histone octamer. Nucleosomes can inhibit transcription factor bind-
ing, while nucleosome-depleted DNA is highly accessible. ATAC-seq is useful for
mapping the accessible chromatin regions, but is inadequate for determining the
global nucleosome positioning. To better understand nucleosome occupancy and
dynamics around the midblastula transition (MBT) and embryonic transcriptional
onset, we employed MNase-seq during early stages of zebrafish embryogenesis.
First, comparisons of nucleosome positioning from crosslinked and noncrosslinked
samples at different stages generated similar nucleosome maps, with weak nu-
cleosomes better captured under crosslinking conditions. At the genome-wide
scale, nucleosome positioning from different stages was largely similar. However,
at genes and promoters, nucleosome positioning from pre-MBT embryos is distinct
from other stages. Interestingly, the formation of nucleosome arrays around TSS
is independent of transcription. Instead, Pol II occupancy and DNA sequences
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around the TSS appear to guide the establishment of a nucleosome array. Besides
the TSS, certain exons also displayed high nucleosome occupancy − those that
were correlated with polyA(5) sequences at their 5’ends followed by alternating
A/T, or G/C dinucleotides inside the exons. These exons can be partitioned into
two groups: 1) strong AT-GC alternation with infrequent polyA(5) sequences, or 2)
weak AT-GC alternation with frequent polyA(5) sequences. Interestingly, we find
these features and classifications of exons conserved in several other organisms,
which may support current speculation that nucleosome positioning may help to
coordinate RNA Pol II elongation and splicing.
4.2 Introduction
The nucleosome is the fundamental building block of a higher-order chromo-
some and is composed of 147bp DNA and a histone octamer (Kornberg, 1974).
This DNA-histone interaction affects transcriptional activity by occlusion of DNA
binding proteins, and leads to gene repression. Determining the nucleosome
positioning in early embryos will help us to understand the chromatin landscape
and how is it involved in gene regulation during embryogenesis. Additionally, the
genome-wide profiling of nucleosomes also allows us to investigate to what extent
DNA sequence instructs nucleosome positioning.
Nucleosome has been extensively studied for its role in gene regulation, which
can be mediated through histone positioning, histone tail modifications and histone
variants incorporation (Li et al., 2007). Nucleosome positioning describes where
nucleosomes are located on the genomic DNA. When associated with nucleo-
somes, promoters and enhancers are inaccessible for most transcription factors
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and co-regulators, usually leading to gene repression. Therefore, nucleosome po-
sitioning at regulatory elements are crucial for gene expression. The vast amount
of post-transcriptional modifications on histone tails adds another level of complex-
ity to transcription regulation. The modifications include methylation (mono-, di-,
tri-methylation), acetylation, phosphorylation, ubiquitination, and newly discovered
sumoylation and crotonylation (Tan et al., 2011). The diverse histone modifications
function individually or cooperatively to convey active or repressive signals for gene
expression. For instance, H3K4me1/3 and H3K27ac mark active promoters and
enhancers, whereas H3K27me3 and H3K9me3 are indicators of gene repression
and heterochromatin (Li et al., 2007). Furthermore, gene regulation is also in-
fluenced by the composition of histone octamer, where canonical histones (H2A,
H2B, H3, and H4) can be replaced by histone variants. The H3 variants (H3.3,
CenH3), and H2A variants (H2A.Z, H2A.X, macroH2A) are extensively studied and
considered to be the most important. H3.3 marks active chromatin and is incorpo-
rated into mouse paternal genome immediately after fertilization (Santenard et al.,
2010). H2A.Z is distributed at enhancers and upstream of transcription start site
(TSS), and is thought to decrease the stability of nucleosome and thus facilitates
chromatin accessibility (Jin et al., 2009).
Another essential question about nucleosome is how they are positioned through-
out the genome. In principle, nucleosome positioning is determined by a com-
bination of DNA-sequence, chromatin remodelers, transcription factors and RNA
polymerases (Struhl & Segal, 2013). However, the relative importance of each of
these determinants is under intense debate. One group argues DNA sequence
plays a central role in determining the nucleosome position. Nucleosome affin-
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ity to 147bp DNA varies based on the nucleotide compositions (Tha˚stro¨m et al.,
1999). In general, DNA sequence with 10 bp periodic placement of A/T and
G/C dinucleotides forms a nice curvature and makes stable contact with histones
(Satchwell et al., 1986; Segal et al., 2006). In contrast, DNA composed of a
strand of poly(dA:dT) is intrinsically stiff and is less feasible to wrap around the
histone octamer, and in turn, often disfavors nucleosomes (Struhl & Segal, 2013).
The sequence characteristics of nucleosome-favoring and -disfavoring sequence
can be modeled mathematically and used to predict the likelihood of nucleosome
formation at particular sequences (Segal et al., 2006). Surprisingly, the predicted
nucleosome positioning is correlated with observed in vivo nucleosome positioning
in yeast and c.elegans (Kaplan et al., 2009). Additionally, the in vitro reconstituted
nucleosome maps resemble the endogenous nucleosome maps (Kaplan et al.,
2009). These results strongly support the hypothesis that DNA plays a dominant
role in positioning nucleosome. However, another group which also reconstituted
nucleosome with yeast genomic DNA in vitro came to the opposite conclusion
(Zhang et al., 2009). They only found moderate similarity between the in vitro
and in vivo nucleosome map. Moreover, these two datasets differed significantly
around TSS. An array of nucleosomes formed downstream of TSS in the in vivo
data, which was absent in the in vitro data. Thus, they concluded DNA sequence
contributes a minor role in nucleosome positioning. The discrepancy between
the two studies probably stems from the preparation for in vitro reconstitution,
the sequencing depth, and the computational analysis. Nevertheless, with the
emergence of more nucleosome positioning data from other organisms, it is now
generally accepted that DNA sequence contributes to nucleosome positioning, but
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is not the dominant player (Valouev et al., 2008; Mavrich et al., 2008; Schones
et al., 2008; Stein et al., 2010).
A more prevalent model for nucleosome positioning is: nucleosome depletion
regions (NDR) are established at the poly (dA:dT) sequences, which are predom-
inantly distributed at promoter regions. NDR is recognized by ATP-dependent
chromatin remodelers (i.e. RSC, ISW2), which place -1 and +1 nucleosomes
flanking the NDR. Transcription factors and the preinitiation complex further shape
the unidirectional nucleosome array downstream of the +1 nucleosome. Finally,
chromatin remodelers that assemble nucleosomes (i.e. ISWI and CHD1) are re-
sponsible for the nucleosome positioning at coding regions and other nongene
regions (Struhl & Segal, 2013). In particular, the binding of preinitiation complex
at TSS is essential for the establishment of the +1 nucleosome and downstream
nucleosomes. On one hand, it can serve as a platform for the recruitment of
chromatin remodelers. On the other hand, it has been proposed that the large
complex can act as a barrier and permit the spacing of downstream nucleosomes,
which is known as ‘statistical positioning’ (Kornberg & Stryer, 1988).
In this chapter, I described the genome-wide nucleosome occupancy at em-
bryonic and differentiated stages of zebrafish. I found genome-wide nucleosome
positioning is overall similar between early embryos and adult liver. However, the
most variance is observed at gene and promoter regions between the pre-MBT
sample and the rest of the samples. In addition, nucleosomes displayed a higher
density at TSS and exons. The data suggest the formation of nucleosome ar-
ray downstream of TSS is not dependent on transcription, but instead may be
regulated by the Pol II occupancy and DNA sequence. I also revealed that exon
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sequences displayed a high frequency of polyA(5) sequences at the 5’end of exons
and A/T and G/C dinucleotides alternation inside exons, which might increase the
exons-nucleosome affinity.
4.3 Results
4.3.1 Nucleosome positioning in early zebrafish embryos
and adult liver
To understand how nucleosome positioning regulates gene activation in early
zebrafish embryo, and whether nucleosome map in early embryo is different from
that of differentiated tissue, I performed Micrococcal Nuclease (MNase) diges-
tion on chromatin extracted from three embryonic stages (pre-MBT (4.5hpf), MBT
(4hpf), post-MBT (5.3hpf), and adult liver (Figure 4.1). The digested mono-nucleo-
somes were then gel purified, and sent for paired-end Illumina sequencing (Table
4.1).
Although MNase digestion has been widely adopted for investigating nucleo-
some positioning, there is some variability and discrepancy across different ex-
periments. To ascertain that our nucleosome maps truly reflect the endogenous
nucleosome positioning, we have carefully controlled the experiments at three as-
pects. Firstly, over-digestion or under-digestion by MNase can impact the mapping
of nucleosomes (Flores et al., 2014). Under-digestion generates a larger propor-
tion of long fragments which will not be efficiently sequenced, thereby resulting
in more regions uncovered. On the other hand, over-digestion leads to partial
degradation of well-positioned nucleosomes, or even to dissociation of unstable
nucleosomes. To avoid over-digestion and under-digestion, and ensure our diges-
tions are comparable between stages, I have extensively optimized the procedures
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to acquire a digestion pattern containing 70-80% of mono-nucleosomes, 10-20%
of di-nucleosomes and some tri-nucleosomes (Figure 4.2). Secondly, the existing
MNase digestion studies have used either crosslinked chromatin or noncrosslinked
chromatin. Crosslinking covalently links the protein and DNA interaction and is less
affected by experiment conditions (i.e. temperature, salt concentration, and deter-
gents). However, crosslinking may introduce bias by linking unrelated protein-DNA
interactions. Surprisingly, no report has directly compared nucleosome positioning
maps generated from crosslinked (CL) and noncrosslinked (nCL) samples. There-
fore, I conducted our MNase digestion at both crosslinked and noncrosslinked
conditions, which allowed us to discover the endogenous nucleosome positioning
and resolve the ambiguity. Thirdly, MNase preferentially cuts AT-rich sequence. To
control for potential sequence bias introduced MNase, naked DNA was digested
by MNase.
With these controls, our two replicates at each stage under two conditions (CL
vs. nCL) are highly correlated (Pearson correlation around 0.8-0.94, Table 4.1). In
line with the significant correlation, fragment size distributions between replicates
are highly similar, except the ones for pre-MBT nCL (Figure 4.3). Nevertheless, the
two pre-MBT nCL samples are highly correlated genome-wide (Figure 4.4A). Thus,
I combined the two replicates at each stage at crosslinked and noncrosslinked
conditions, respectively, for further analysis.
4.3.2 Comparison of crosslinked and noncrosslinked samples
Examining the fragment size distribution, I found crosslinked samples displayed
a broader distribution compared to noncrosslinked samples, which could be be-
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cause MNase is less efficient in cutting between crosslinked chromatin (Figure 4.3
A and B). The fragment size difference between CL and nCL samples was even
more evident when comparing them side by side at each stage (Figure 4.3 C-F).
To investigate whether the difference in size distribution represents the difference
occupancy genome-wide, I collected the mean nucleosome signal every 100bp
spanning the entire genome, and performed pairwise Pearson Correlation. Notably,
CL and nCL samples were highly correlated (Figure 4.4 B-E). Also, I generated a
predicted nucleosome map utilizing the computational model built by the Segal Lab
with default parameters (c 0.1, t 1) (Kaplan et al., 2009). I argue that if CL and nCL
are correlated, they should have a similar correlation to the predicted nucleosome
positioning. Indeed, genome-wide correlation analysis indicated nucleosome maps
from both crosslinked and noncrosslinked samples correlate with the predicted
nucleosome map in a similar range (Table 4.2). In particular, digested fragments
from chromatin, either CL or nCL, were significantly different from that of naked
DNA (Table 4.2).
In addition to the genome-wide comparison, I also compared CL and nCL
samples specifically at promoters. For post-MBT and liver, CL and nCL samples
both formed nice nucleosome array around TSS, and are distinctly different from
digested DNA (Figure 4.5C, D). In contrast, pre-MBT CL and nCL samples only
exhibited moderate enrichments at TSS, yet no nucleosome array formed at the
naked DNA sample (Figure 4.5A). Unexpected, MBT CL and nCL samples dis-
played different distribution around TSS (Figure 4.5B). MBT CL sample clearly
captured the -1 nucleosome upstream of TSS, which was missing in nCL samples.
Since -1 nucleosomes are less stable, this observation suggests CL samples may
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better retain the less stable nucleosomes. In summary, CL and nCL were similar
in general, but CL samples may capture weak nucleosomes better.
4.3.3 Dynamic nucleosome positioning at different stages
Nucleosome is the basic subunit of higher-order chromatin structure, which also
protects the DNA from transposon insertion and inadvertent transcription. Since
only around 2% of the genome codes for genes, nucleosome positioning should
be largely unchanged globally in different cells or at development times, whereas
gene related regions should display higher dynamics as a result of the cell-specific
transcriptome. Indeed, when nucleosome positioning from two samples genome-
wide were compared, the difference was mild under either CL or nCL condition
(Figure 4.6A-F). Notably, at nCL condition, post-MBT and liver displayed higher
variance compared to other samples, reflecting the larger difference of transcrip-
tome between embryonic and differentiated tissue (Figure 4.6C, F). Hierarchical
clustering is then applied to all correlations from any of two samples. nCL samples
from embryonic stages were clustered as a group, and the rest of the samples were
clustered into another group (Figure 4.6G). This suggests nucleosome signal from
nCL embryonic samples are closely related. However, it has to be recognized the
genome-wide difference is mild, as most the pairwise comparisons have Pearson
Correlation score higher than 0.85.
To determine whether gene related areas have higher variation among samples
at different stages, similar correlation heatmaps for gene regions and promoter
regions were generated. Gene regions expand from upstream 5kb of gene start
to downstream 5kb of gene end, while promoter regions represent 2kb around
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TSS. Intriguingly, correlation at gene and promoter regions separated pre-MBT
(CL and nCL) and MBT nCL samples from MBT CL, post-MBT and liver samples
(Figure 4.7A, B). This indicates nucleosome positioning at gene related areas is
different between early embryonic stage and later embryonic stage or differentiated
samples.
4.3.4 Nucleosome array around transcription start site
Besides correlation, I also profiled the average nucleosome distribution around
TSS. Nucleosome arrays (defined by +1 nucleosome after TSS, followed by down-
stream nucleosomes) were observed in MBT, post-MBT and liver samples, but
not in the pre-MBT samples (Figure 4.5). Surprisingly, the predicted nucleosome
signal also exhibited an array around TSS (Figure 4.8A). Because the predicted
nucleosome signal is solely based on DNA sequence, I speculate DNA around
TSS may have some sequence characteristics favoring nucleosome. Of note, the
array in predicted nucleosome positioning shifted towards the upstream of TSS,
and no -1 nucleosome was observed in predicted nucleosome positioning. These
data suggest nucleosome formation around TSS is regulated by a combinatorial
effect of DNA sequence and proteins, likely transcription machinery.
To determine whether the formation of nucleosome array indeed relates to gene
transcription, genes were ranked based on the expression level (FPKM value from
RNA-seq) at MBT (4hpf). Interestingly, highly transcribed genes displayed a better
nucleosome array at MBT, which was more prominent at post-MBT (Figure 4.8B).
The same trend was observed when genes were grouped into four quantiles based
on their expression at MBT (Figure 4.9). For MBT, post-MBT and liver, the 1st quan-
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tile genes (top 25% transcribed) have distinct nucleosome depleted regions (NDR),
strong -1 nucleosomes, and nucleosome array downstream TSS. However, these
features are missing in the 4th quantile genes (bottom 25% transcribed). Curiously,
nucleosomes in liver also formed better nucleosome array at genes that are highly
transcribed at MBT (Figure 4.8B, Figure 4.9D). This can be interpreted in two ways.
First, the genes that are highly transcribed at MBT are also expressed at a high
level in liver. Thus nucleosome array formation is dependent on transcription. Sec-
ond, the highly transcribed genes at MBT have nucleosome favoring sequences
around the TSS, thereby nucleosome array consistently formed regardless the cell
types.
RNA-seq at MBT detects mRNA abundance regardless whether it is maternally
deposited or newly transcribed, and therefore is not perfect to use as an indicator
for transcription level. To faithfully reflect gene transcription status, I resorted to
RNA Pol II occupancy determined by ChIP-seq. Genes were grouped into Pol II
bound (indicating poised and transcribed genes) and non-Pol II bound (implicated
nontranscribed genes). One hundred sixty genes are bound by Pol II at pre-MBT,
which increased substantially to 5218 genes at MBT and 6746 genes at post-MBT.
Interestingly, the genes bound by Pol II at pre-MBT have better nucleosome array
compared to the unbound genes, which is consistently observed at MBT and post-
MBT (Figure 4.10). In contrast, Pol II binding failed to differentiate the predicted
nucleosome distribution, supporting the hypothesis that transcription (indicated by
Pol II binding) is required for the nucleosome positioning around promoter.
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4.3.5 Nucleosome array formation at promoter
is not dependent on transcription
To prove transcription regulates nucleosome array formation, I inhibited tran-
scription initiation by injecting a-amanitin in 1-cell embryo or inhibited transcription
elongation by soaking embryo in embryo water containing flavopiridol. The a-
amanitin and flavopiridol treatments were highly efficient, as nearly all treated (both
a-amaintin and flavopiridol) embryos were arrested at MBT. Then, MNase-seq
were employed on the chromatins of drug-treated embryos and their controls.
Unexpectedly, nucleosome array still formed on Pol II-bound genes even when
transcription initiation or elongation was inhibited (Figure 4.11A-D). These data
suggest the transcription activities are not the determinant of nucleosome array
formation; rather it is Pol II binding that instructs the nucleosome positioning. It has
long been speculated that Pol II binding serves as a barrier allowing ‘statistical
positioning’. This theory suggests that once a boundary is established, other
nucleosomes will naturally form around that boundary following thermodynamic
equilibrium. Here, our data support this model.
In yeast, DNA around TSS often harbors polyA sequences which create nu-
cleosome depletion regions that are crucial for +1 and -1 nucleosome placement.
Therefore, it is possible that Pol II-bound genes have a higher frequency of polyA
track than that of unbound genes, which allows better nucleosome formation around
TSS. The possibility might also be applied to highly transcribed genes. To test,
I profiled the frequency of AAAAA sequence (A5mer) around TSS. Surprisingly,
there is no difference in A5mer sequence between Pol II bound and unbound
genes, or between highly transcribed and poorly transcribed genes (Figure 4.12A).
I then turn to nucleosome favoring sequence, which often displayed ∼10bp
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periodicity of AT and GC dinucleotides. The AT-GC alternation renders the DNA
form a nice curvature, which can make stable contact with histones. Similar to
A5mer sequence, the frequency of AT and GC dinucleotide around TSS were
calculated. Interestingly, genes that are highly transcribed or bound by Pol II
at MBT have a higher GC content at the promoter and exhibit a better AT and
GC dinucleotide alternation compared to genes poorly transcribed or not bound
by Pol II at MBT (Figure 4.12 B-E). Notably, a AT dinucleotide peak is located
around -30bp upstream of TSS, which is coincident with TATA box. This suggests
TATA box in zebrafish gene could serve as a poly(dA:dT) sequence and play a
role in nucleosome positioning. Taken together, genes that are highly transcribed
or bound by Pol II at MBT have moderately higher intrinsic nucleosome affinity
around the TSS, and Pol II binding further enhances the formation of downstream
nucleosomes.
4.3.6 Nucleosome enrichment over exons
Nucleosome has been reported enriched on exons (Tilgner et al., 2009). To test
whether this is true in zebrafish, I profiled nucleosome signal over exons grouped
by their lengths. The majority of the zebrafish exons are about 100-300bp long,
which is close to a nucleosome size, ∼147bp (Figure 4.13A). The nucleosomal
DNA wraps around histone and contacts histones every 11bp as the minor groove
faces the protein. As shown in Figure 4.13B, I defined nucleosome-size exons
with a length of 125bp to 169bp. To match the 44bp length difference in this exon
group, I set the lower cutoff for small exons as 81bp and the upper cutoff for large
exons as 213bp. Then, the average nucleosome signals around the center of
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exons of all three groups were profiled. Consistent with the observations in other
organisms, nucleosomes of all examined stages were enriched at exons, as well
as the predicted nucleosomes. The high enrichment of predicted nucleosome over
exons suggests exons might have nucleosome favoring sequences. Indeed, the
5’end, but not the 3’end, of all 3 groups of exons have a high frequency of polyA
sequence (Figure 4.14). Interestingly, nice alternation of AT, GC dinucleotides
is observed over exons, which is absent from the neighboring sequence (Figure
4.15). In sum, the data suggest polyA tracks present at the 5’end of exons may
establish a boundary for nucleosome positioning, and inside the exons, AT and
GC alternation further promote the stable interactions between DNA and histones.
Therefore, together they contribute to stabilize nucleosome over exons.
4.3.7 Sequence characteristics of exons
To determine whether some exons have a better AT and GC alternation than
others, k -mean clustering was performed on each exon group. Interestingly, exons
were clustered into subgroups based on AT and GC alternation for nucleosome-
size exons (125-169bp) and large exons (169-213bp), but not for small exons (81-
125bp) (Figure 4.16). Then, I profiled the AT, GC dinucleotides and A5mer signals
for each subgroup of nucleosome-size exons. Strikingly, the top three subgroups
showed a very nice AT-GC alternation. In contrast, the bottom three subgroups had
poor AT-GC alternation but had slightly higher frequency of A5mer present on the
5’end (Figure 4.17). Similar results were observed for subgroups of large exons
(data not shown).
To understand whether the nucleosome positioning sequence on exons is con-
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served, A5mer, AT and GC distributions were analyzed on exons of human, mouse,
fly, medaka, fugu, and pufferfish. Intriguingly, this phenomenon is conserved in
other species: small exons have poor AT-GC alternation, nucleosome-size exons
and large exons have better AT-GC alternation, which can be divided into sub-
groups using k -mean clustering. As examples, human and mouse subgroups
of nucleosome-size exons (125-169bp) were shown in Figure 4.18. Both human
and mouse subgroup 1 have very nice AT-GC alternation, and they have a weak
A5mer sequence at the 5’end of exons. In contrast, subgroup 6 exons of human
and mouse have poor AT, GC alternation, but have a strong A5mer sequence
at the 5’end of exons. This suggests different exons employ different strategies
to position nucleosome. Some exons, such as the one in subgroup 1, position
nucleosome predominantly through the AT-GC alternation sequence. Other exons,
such as the ones in subgroup 6, position nucleosome preferentially through the
polyA sequence.
4.4 Discussion
The nucleosome is the basic subunit of chromatin, which is composed of∼147bp
DNA and eight histone proteins (two copies of H2A, H2B, H3, and H4). Each
nucleosome is separated by linker DNA (20-80bp), which is occupied by the fifth hi-
stone, H1, which facilitate the condensation of nucleosomes into higher-order chro-
matin structure (Kornberg, 1977; Luger et al., 1997). Besides its role in genome
compaction, the role of nucleosome in gene regulation has also been intensively
studied, which involves histone variants, histone modifications and nucleosome
positioning. In this chapter, I have described the profiles of nucleosome positioning
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in early embryos and adult liver cells, and provided insights on how nucleosomes
are positioned at promoters and exons.
At promoters, nucleosome arrays are observed in MBT, post-MBT, liver but
not pre-MBT samples. The nucleosome arrangement was also found in predicted
nucleosome but was distinct from the ones in observed nucleosome maps. Predi-
cated nucleosomes had no -1 nucleosome and NDR, and the center of +1 nucleo-
some was shifted upwards and resides right at TSS. In observed nucleosome pro-
files, the center of +1 nucleosome was downstream of TSS. This suggests nucleo-
some array does not solely rely on DNA sequence, and other factors are involved.
However, nucleosome array around TSS was not dependent on transcription, as
no difference is observed between untreated embryos and embryos treated with a-
amanitin and flavopiridol (transcription inhibitors). Interestingly, genes bound by Pol
II formed a stronger nucleosome array compared to genes that are not bound by
Pol II. This was true in pre-MBT, MBT and post-MBT embryos. However, predicted
nucleosome showed no difference in the two gene sets, indicating their promoter
DNA sequence were largely the same. Therefore, I speculate Pol II occupancy may
result in different nucleosome distributions at promoters. This speculation can be
supported by the ”statistical positioning” model which hypothesizes that boundary
(specific DNA sequence and/or protein binding) leads to an array of evenly spaced
nucleosome (Kornberg, 1981; Kornberg & Stryer, 1988).
The next question is how Pol II selectively binds those genes,; could the un-
derlying DNA sequence play an instructive role? To test, I focused on two types
of sequences, A5mer and AT-GC alternation. A 5nt long DNA has 1024 potential
sequence combinations. Among these, A5mer sequence has the lowest nucle-
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osomes density in yeast. The related poly(dA:dT) sequences, which are highly
enriched at the promoters of yeast genes, are proposed to create a boundary for
nucleosome array formation. Surprisingly, I do not observe a high frequency of
A5mer around TSS. It is possible that by counting the Amer using a fixed windows
(5bp) starting always at TSS, I might miss the A5mers that expand across two
windows. I can test this by generating different frequency tracks which start at TSS,
TSS+1bp, TSS+2bp, TSS+3bp, and TSS+4bp. In this way, all potential A5mers
can be captured by combining all these five tracks. An alternative explanation is
that other poly(dA:dT) sequences rather than A5mer are used in fish to create
nucleosome depleted regions. Besides A5mer, the distribution of A/T and G/C
dinucleotides was profiled. A peak of A/T dinucleotides around -30bp of TSS is
observed for all genes, which is coincident with where TATA boxes reside, and may
serve as a boundary. Moreover, I observed AT-GC alternation is better around TSS
of Pol II bound genes comparing to genes that are not bound by Pol II. Based on
the known higher affinity of AT-GC alternating sequences, I speculate the AT-GC
alternation sequence might play a role in nucleosome formation. Together with Pol
II occupancy, they promote the nucleosome array establishment.
Another interesting finding is that exons have sequence characteristics that
enhance their affinity for nucleosomes. Specifically, high frequency of A5mer se-
quence is observed right at the 5’end but not 3’end boundary of exons, while
inside exons, higher GC content, and AT-GC alternation are evident. Based on
the sequence features, exons can be further separated into two groups. One
contains better AT-GC alternation inside exons, while the other displays higher
frequency of A5mer at the 5’end of exons. The grouping of exons can be applied
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to other vertebrates, including human, mouse, medaka, pufferfish and fugu, but
is not so applicable to fly. This suggests a conserved strategy in vertebrates for
positioning nucleosome on exons. Furthermore, among all the organism that have
been examined, the difference of GC content between exons and adjacent area is
greater in fish (zebrafish, medaka, pufferfish, fugu) compared to mammals (human
and mouse).
Exons may utilize a high level of nucleosome to prevent internal transcription
and mutations introduced by transposons insertions. Alternately, high enrichment
of nucleosome over exons may facilitate splicing (Tilgner et al., 2009). Pol II
slows down when confronting exons with a high density of nucleosomes (Lowary
& Widom, 1998; Bondarenko et al., 2006). It is also known that splicing can
take place co-transcriptionally. Thus, the temporarily decelerated Pol II could gain
time for the spliceosome to conduct splicing. Surprisingly, splicing can also affect
nucleosome density. Over-expression of U1 snRNA or strengthening the 5’splice
site increases the nucleosome density over exons while inhibiting splicing with
meayamycin also alters nucleosome density (Keren-Shaul et al., 2013). Taken
together, the enrichment of nucleosome on exons is driven by specific sequence
characteristics and may protect exon from mutation and undesired transcription,
as well as contribute to splicing regulation.
In conclusion, my work in profiling chromatin landscape by MNase-seq provides
valuable information on nucleosome positioning at different stages, and also is a
complementary to ATAC-seq data that focused mainly on open chromatin. The nu-
cleosome positioning data allow us to discover interesting sequence characteristics
at promoters and exons.
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4.5 Methods
4.5.1 Zebrafish and sample collection
Tubingen zebrafish lines were maintained and raised under standard condi-
tions. Wildtype embryos were collected after 10 min of mating to ensure the
synchrony of embryo development, raised in embryo water at 28◦C and staged
as previously described (Kimmel et al., 1995).
4.5.2 Nuclei extraction from crosslinked embryonic samples
Embryos at pre-MBT (2.5hpf), MBT (4hpf) and post-MBT (5.3hpf) were carefully
staged, dechorinated by Pronase (Sigma-Aldrich 11459643001), and fixed in 1%
formaldehyde for 10 min at Room Temperature (RT). Formaldehyde was quenched
by adding glycine to a final concentration of 0.125M, followed by centrifugation
at 500g 5 min 4◦C. The embryo pellet was resuspended in ice-cold PBS, and
centrifuged again at 500g 5 min 4◦C. The washing was repeated twice, and the
embryos were snap frozen in liquid nitrogen, until enough embryos were collected.
For chromatin extraction, embryo pellets were resuspended in cell lysis buffer
(10mM Tris-HCl [pH 8.1], 10mM NaCl, 0.5% NP40) and lysed for 10 min, rotating
at 4◦C. Nuclei were collected by centrifugation at 1300g 5 min, 4◦C, and washed
twice by rotating at RT 5 min in nuclei wash buffer (50mM Tris-HCl [pH 8.0], 100mM
NaCl, 10mM EDTA).
4.5.3 Nuclei extraction from noncrosslinked
embryonic samples
Embryos at pre-MBT (2.5hpf), MBT (4hpf) and post-MBT (5.3hpf) were carefully
staged, and rinse with ice-cold PBS. Cell lysis buffer (10mM Tris-HCl [pH 8.1],
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10mM NaCl, 0.5% NP40) is add, and lysed for 10 min on ice. During the 10
min lysis, a 20 Gauge syringe was used three times to break the chorions and
embryonic cells, followed by table top spin for 10 seconds. The supernatant was
then centrifuged at 1300g 5 min 4◦C and the nuclei pellet was ready.
4.5.4 Nuclei extraction from crosslinked and
noncrosslinked liver cells
Adult fish were fasted for a week prior to dissection. Euthanasia of zebrafish
with ice water was conducted following the IACUC procedures. Dissection of
the adult zebrafish liver was performed under brightfield imaging on a dissection
microscope. Dissected livers were immediately transferred to Eppendorf tubes on
ice and rinsed with PBS.
For crosslinking liver cell, liver tissue was homogenized and fixed in 1% formalde-
hyde for 10 min at RT. Formaldehyde was quenched by adding glycine to a final
concentration of 0.125 M, followed by centrifugation at 500g 5 min 4◦C. The liver
cell pellet was resuspended in ice-cold PBS, and centrifuged again at 500g 5 min
4◦C. The washing was repeated twice. Liver cell pellet was resuspended in cell
lysis buffer (10mM Tris-HCl [pH 8.1], 10mM NaCl, 0.5% NP40) and lysed for 10
min, rotating at 4◦C. During the 10 min lysis, a 20 Gauge syringe was used 10
times, and the cell suspension was frequently pipetted. Nuclei were collected by
centrifugation at 1300g 5 min, 4◦C.
Noncrosslinking liver cells were treated essentially the same as the crosslinked
sample, but were not crosslinked.
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4.5.5 Drug treatment
For inhibition of transcription initiation, 1nl of a-amanitin (Millipore 129741-1MG)
with concentration of 1ug/ml was injected into 1-cell embryos. Embryos without
injection were used as control. For inhibition of transcription elongation, embryos
were dechorinated immediately after fertilization, then flavopridol (Sigma F3055-
1mg) was added to a final concentration of 1.5uM. Embryo incubated with 0.1%
DMSO were used as control. The drug treated embryos were arrested around
4hpf. Control and drug treated embryos were then collected and the procedures in
4.5.2 for nuclei extraction were followed.
4.5.6 MNase digestion
Nuclei were resuspended in MNase digestion buffer (50mM NaCl, 50mM Tris
[pH 7.4], 5mM MgCl2, 1mM CaCl2, 0.1% triton), followed by centrifugation at
1300g 5 min, 4◦C. The nuclei were then resuspended in 500ul MNase digestion
buffer, and equilibrated at RT for 5 min. The nuclei were then incubated with MNase
(Affymetrix, 70196Y) at 37◦C for 15 min. The MNase digestion was quenched by
adding 56ul 10X stop buffer (50mM Tris [pH 7.5], 500mM NaCl, 100mM EDTA,
20mM EGTA, 10% Triton X-100). The digested chromatins then were RNase
treated (Ambion, AM2286) for 2hr at thermomixer (37◦C 400rpm 2hr), followed by
2hr proteinase K treatment at 55◦C, reverse crosslinked overnight at 65◦C (skipped
for noncrosslinked samples). The DNA was purified with Phenol:chloroform pH8
(Invitrogen, No 15593-031), and was ethanol precipitated. DNA corresponding to
mono-nucleosome size was then gel purified.
172
4.5.7 Library preparation and sequencing
Libraries of ChIP-seq samples were prepared using the NEBNext ChIP-Seq
Library Prep Master Mix (NEB, E6240L). Eight ng of DNA was used and followed
the manufacturer’s procedure. Samples were then amplified by NEBNext High-
Fidelity 2X PCR Master Mix (NEB, M0541L) and sequenced paired-end 101nt on
an Illumina HiSeq 2000. For mono-nucleosomes from drug treated and control
samples, 50nt single-end sequencing were performed.
4.5.8 Data analysis
Paired-end fastq files were uniquely aligned to zv10 zebrafish genome assem-
bly using Novoalign (Novocraft, Inc) with the following parameters: -r None -Q 13
-k -o SAM -a CTGTCTCTTATACACATCT, and converted to BAM files using Samtools.
BAM files from replicates were merged and bigwig files were generated using the
program bam2wig (http://search.cpan.org/dist/Bio-ToolBox/) with the follow-
ing parameters: --position span --pe --rpm --bw.
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Table 4.1: MNase sequencing summary
Pairs Pairs aligned % Aligned Corre-
lation
pre-MBT CL rep1 37,490,039 33,735,777 89.99% 0.9369
pre-MBT CL rep2 32,977,143 29,604,460 89.77%
pre-MBT nCL rep1 35,331,450 32,105,355 90.87% 0.9460
pre-MBT nCL rep2 36,130,316 31,084,058 86.03%
MBT CL rep1 30,258,189 27,556,610 91.07% 0.9355
MBT CL rep2 28,785,987 26,107,065 90.69%
MBT nCL rep1 45,215,194 31,646,875 69.99% 0.8027
MBT nCL rep2 24,379,781 22,281,361 91.39%
post-MBT CL rep1 37,363,896 33,990,207 90.97% 0.93004
post-MBT CL rep2 34,434,974 31,407,138 91.21%
post-MBT nCL rep1 33,673,614 30,779,492 91.41% 0.9754
post-MBT nCL rep2 31,924,539 29,087,609 91.11%
Liver CL rep1 27,887,876 25,516,455 91.50% 0.9392
Liver CL rep2 28,589,271 26,095,727 91.28%
Liver nCL rep1 25,380,483 23,199,032 91.41% 0.8683
Liver nCL rep2 27,573,002 25,127,951 91.13%
Naked DNA(single-end) 84,740,186 62,303,818 73.50%
Table 4.2: Correlation between observed and predicted nucleosome map
Predicted Digested
nucleosome map Naked DNA
pre-MBT CL 0.3096891 0.2783015
pre-MBT nCL 0.4936699 0.2035423
MBT CL 0.3413961 0.2097353
MBT nCL 0.4957017 0.2931172
post-MBT CL 0.5262779 0.2297756
post-MBT nCL 0.4719718 0.1989889
Liver CL 0.3713786 0.2544334
Liver nCL 0.3541750 0.2181286
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Figure 4.1: Schematic of MNase-seq data in zebrafish embryos at pre-MBT,
MBT and post-MBT stages, and adult liver. At each stage, crosslinked and
noncrosslinked chromatin are extracted in parallel, and are subject to MNase-
digestion. Mono-nucleosomes are gel extracted, and the associated DNA is
purified and sequenced. Naked DNA is also MNase-digested and sequenced and
serves as a control.
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Figure 4.2: Agarose gel of MNase digestion. (A) MNase digestion of crosslinked
samples. Two replicates from each stage are digested and separated by elec-
trophoresis on aragarose gels. (B) Similar to (A) but for noncrosslinked samples.
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Figure 4.3: Fragment size distribution. (A-F) Fragment size distribution for all
crosslinked (CL) samples (A), all noncrosslinked (nCL) samples (B), CL and
nCL replicates at pre-MBT (C), CL and nCL replicates at MBT (D), CL and nCL
replicates at post-MBT (E), and CL and nCL replicates at Liver (F). The sizes of
sequenced fragments are acquired from pair-end sequencing.
180
181
Figure 4.4: Genome-wide correlation between crosslinked and noncrosslinked
samples at each stage. (A-D) Pairwise comparisons of normalized nucleosome
signal per 100bp in CL and nCL samples at pre-MBT (A), MBT (B), post-MBT (C)
and Liver (D). R value represents Pearson Correlation score.
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Figure 4.5: Nucleosome distribution of crosslinked and noncrosslinked samples at
promoters at each stage. (A-D) The mean profiles of nucleosome signal in CL and
nCL samples around TSS of all annotated RefSeq genes at pre-MBT (A), MBT (B),
post-MBT (C) and Liver (D).
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Figure 4.6: Genome-wide correlation between samples at different stages. (A-C)
Pairwise comparisons of normalized nucleosome signal per 100bp in CL samples
between pre-MBT and MBT (A), MBT and post-MBT (B), post-MBT and liver (C).
(D-F) Pairwise comparisons of normalized nucleosome signal per 100bp in nCL
samples between pre-MBT and MBT (D), MBT and post-MBT (E), post-MBT and
liver (F). R value represents Pearson Correleation score. (G) Pearson Correlation
between any of the 8 samples, clustered into heatmap.
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Figure 4.7: Correlation heatmaps of all samples at genes and promoters. (A)
Pearson Correlation between any of the 8 samples at gene regions, clustered into
heatmap. Gene region is defined as areas expanding from upstream 5kb of gene
start to downstream 5kb of gene end. Normalized nucleosome signals of all 8
samples are collected at each gene region. (B) Pearson Correlation between any
of the 8 samples at gene regions, clustered into heatmap. Promoter region is
defined as ±2kb of transcription start site (TSS). Normalized nucleosome signals
of all 8 samples are collected at each promoter region.
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Figure 4.8: Nucleosome array is observed around TSS. (A) Observed nucleosome
signals in all CL samples around TSS are averaged and plotted on the left Y
axis. Mean value of predicted nucleosome signals are plotted on the right Y axis.
(B) Heatmaps of predicted nucleosome signals, observed nucleosome signals at
pre-MBT, MBT, post-MBT, liver and naked DNA around TSS. Each row represents
±1kb around TSS, ranked by RNA FPKM value at MBT (4hpf) (leftmost panel).
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Figure 4.9: Nucleosome array around TSS correlates with expression level. Genes
are grouped evenly into 4 quantiles based on the expression level (FPKM) at MBT.
First quantile represents the top 25% expressed genes. Fourth quantile represents
the bottom 25% expressed genes. (A-F) The mean profiles of nucleosome signal
around TSS of four groups genes; nucleosome signals at pre-MBT (A), MBT (B),
post-MBT (C), liver (D), predicted nucleosome (E), and naked DNA (F).
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Figure 4.10: Pol II bound genes have strong nucleosome array around TSS.
Genes are partitioned into Pol II bound and unbound based on ChIP-seq of Pol
II at pre-MBT, MBT and post-MBT. (A) The mean profiles of nucleosome signals
at pre-MBT around Pol II bound and unbound genes at pre-MBT. (B) The mean
profiles of nucleosome signals at MBT around Pol II bound and unbound genes
at MBT. (C) The mean profiles of nucleosome signals at post-MBT around Pol II
bound and unbound genes at post-MBT. (D) Predicted nucleosome signals at Pol
II bound genes at pre-MBT, MBT and post-MBT, as well as Pol II unbound genes
at pre-MBT, MBT, and post-MBT.
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Figure 4.11: Nucleosome array formation is not dependent on transcription.
Genes are partitioned into Pol II bound and unbound based on ChIP-seq of
Pol II at MBT. The mean profiles of nucleosome signals from uninjected control
embryos (A), a-amanitin injected embryos (B), DMSO-treated control embryos (C),
flavopiridol-treated embryo (D) around TSS of the two groups of genes.
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Figure 4.12: Characteristics of DNA sequence around TSS. First quantile: top
25% expressed genes at MBT; Fourth-quantile: bottom 25% expressed genes at
MBT. MBT Pol II and non-MBT Pol II: genes bound or unbound by Pol II at MBT.
(A) A5mer (AAAAA) sequence frequency around TSS of 4 groups of genes. (B-E)
A/T dinucleotide and G/C dinucleotide frequency around TSS of 1st-quantile genes




Figure 4.13: Nucleosomes are also enriched on exons. (A) Histogram of exons
length of all RefSeq genes. (B) Schematic of separation of exons into 3 groups
based on exon length. (C-E) The mean profiles of observed nucleosome signal
of all stages and predicted nucleosome signals around the center of 81-125bp
exons (C), 125-169bp exons (D), 169-213bp exons (E). Observed nucleosome
signal from pre-MBT CL, MBT CL, post-MBT CL, liver CL and naked DNA are
plotted on the left Y axis. Predicted nucleosome signal is plotted on the right Y
axis.
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Figure 4.14: Strong A5mer presents specifically at the 5’end of exons. The mean
profiles of A5mer frequency around the 5’end (black) or 3’end of exons (pink).
Frequency is collected using 5bp windows expanding ±200bp around either end
of 81-125bp exons (A), 125-169bp exons (B); and using 5bp windows expanding
±250bp around either end of 169-213bp exons (C).
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Figure 4.15: AT and GC alternation is observed on exons. The mean profiles
of A/T(blue) and G/C (orange) dinucleotide frequency around the 5’end of exons.
Frequency is collected using 2bp windows expanding ±200bp around the 5’end
of 81-125bp exons (A), 125-169bp exons (B); and using 2bp windows expanding
±250bp around the 5’end of 169-213bp exons (C).
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Figure 4.16: Clustering of exons based on AT and GC alternation. For each exon,
A/T and G/C frequency are counted using 2bp windows around the 5’end of exons.
A/T and G/C frequency of each exon are then combined and subject to k -mean







Figure 4.17: A5mer and AT- GC alternation of each subgroup of 125-169bp
exons. The mean profiles of A/T(blue) and G/C (orange) dinucleotide frequency,
and A5mer (black) frequency around the 5’end of 125-169bp exons, grouped by
k -mean clustering. Subgroup 1 (A, B), Subgroup 2 (C, D), Subgroup 3 (E, F),
Subgroup 4 (G, H), Subgroup 5 (I, J), Subgroup 6 (K, L).
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Figure 4.18: AT- GC alternation on exons is conserved in human and mouse.
The mean profiles of A/T(blue) and G/C (orange) dinucleotide frequency, and
A5mer(black) frequency around the 5’end of 125-169bp exons, grouped by k -mean
clustering. Subgroup 1 of human exons (A, B), Subgroup 6 of human exons (C, D),
Subgroup 1 of mouse exons (E, F), Subgroup 6 of mouse exons (G, H).
CHAPTER 5
SUMMARY AND FUTURE DIRECTION
5.1 Summary of the roles of SWI/SNF complexes
in early zebrafish embryo
In Chapter 2, I have described the first survey of genome-wide Brg1 and Brm
occupancy in early zebrafish embryos, which allows us to understand how SWI/SNF
complexes are involved in early embryogenesis. In addition, our work enables the
direct comparison of Brg1 and Brm based on genome-wide occupancy, as there is
no genome-wide study of Brm occupancy available to date.
Brg1 and Brm occupancy increased substantially from pre-MBT to MBT. MBT
is around when zygotic genome activation (ZGA) happens, where hundreds of
genes are activated simultaneously and steeply. The dramatic increase of Brg1
and Brm occupancy implies they may play important roles in ZGA. Indeed, pluripo-
tency genes, pou5f1, nanog, sox factors are strongly bound by Brg1 and Brm.
Other transcription factors (e.g. foxh1 and ddx5) and epigenetic regulators (e.g.
anp32e and brg1) are also bound by Brg1 and Brm. However, genes required
later in development, such as hox genes and many tbx genes, are not bound
by Brg1 and Brm. In addition, Brg1 and Brm may also regulate homeostasis, as
many housekeeping genes (e.g. actb1 and actb2) are occupied by Brg1 and Brm.
Surprisingly, Brg1 and Brm are highly enriched at miR-430 locus in a stage-specific
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manner. The potential roles in activating miR-430 transcription suggest Brg1 and
Brm are also involved in degradation of maternally provided factors and promoting
the maternal-zygotic transition. Collectively, based on occupancy, Brg1 and Brm
function in diverse pathways, and may play important roles in regulating early
zebrafish embryogenesis.
To determine whether certain transcription factors are involved in recruiting
Brg1 and Brm to specific loci, I performed motif analysis and identified known and
unknown motifs at Brg1- and Brm-occupied regions, among which Eomesa, Sox2,
Pou5f3 and Nanog are of particular interests. Using published ChIP-seq datasets
of these factors, I confirmed they are enriched at Brg1 and Brm binding sites.
Moreover, Eomesa, Sox2, pou5f3 and Nanog co-localize with Brg1 and Brm at
many key development genes, including vent, vox, her5, and themselves (pou5f1,
sox2 and nanog).
Comparing their occupancy, we discovered shared and specific roles of Brg1
and Brm in early zebrafish development. First, Brg1 and Brm co-occupy a large
number of genes (57 at pre-MBT, 1836 at MBT, and 2854 at post-MBT), but also
bound specific genes, respectively. Common genes (co-bound by Brg1 and Brm)
are highly transcribed and are enriched for housekeeping functions based on Gene
Ontology analysis. In contrast, Brg1-bound specific genes are highly enriched
for transcription and development regulation. Brm-bound specific genes were
enriched for both housekeeping and development functions. These results suggest
Brg1 and Brm co-regulate housekeeping genes, and also have specific functions
in regulating development genes.
One feature unique to Brg1 but not to Brm is the high correlation with active
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histone marks. Common (co-bound by Brg1 and Brm) and Brg1-specific regions
are enriched for active histone marks (H3K27ac, H3K4me1, and H3K4me3), but
not repressive mark, H3K27me3, while Brm-specific regions have a considerably
lower enrichment for active histone modifications. Another striking observation is
the distribution of Brm over gene bodies of around 1000 genes. Although a few
studies have reported Brm binding at coding regions of a handful genes (by ChIP-
qPCR), it has not been investigated in a genome-wide scale. Our study provides
a comprehensive view and reveals Brm occupancy at gene body is prevalent and
is in distinct difference with Brg1, which specifically resides in promoter-proximal
regions. Importantly, Brm and Pol II occupancy overlap precisely at the gene body,
where they almost always start and stop at the same loci. Furthermore, Brm occu-
pancy at the gene body is lost significantly when Pol II elongation is inhibited, which
suggests Brm traveling to the gene body is dependent on transcription elongation.
Taken together, we demonstrate that Brg1 and Brm may play important roles in
early zebrafish development. We also reveal specific roles of Brg1 and Brm, and
especially the unknown role of Brm in elongation regulation.
5.2 Summary of the accessible chromatin
in early zebrafish embryo
To gain a comprehensive view of the dynamic chromatin profiles during early
embryogenesis, ATAC-seq was performed in early zebrafish embryos and adult
liver. Total reads were partitioned into ATAC-open and ATAC-mono based on
length. ATAC-open data are fragments with a length of 0-100bp and represent open
chromatin, whereas ATAC-mono data are fragments with a length of 120-220bp
and represent mono-nucleosome. By MACS2 peaks calling and subsequent filtra-
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tion with stringent cutoff, I identified 850, 24331, 32934, and 26799 open chromatin
regions at pre-MBT, MBT, post-MBT and liver, based on ATAC-open data. The
increase of chromatin accessibility is substantial from pre-MBT to MBT, which
suggests a generally permissive chromatin is underlying the genome activation.
The open chromatin regions at MBT, post-MBT and liver were highly enriched at
promoters, and were associated with genes enriched at different biological pro-
cesses. At MBT, open chromatin regions are enriched for both transcriptional
and metabolic processes. At post-MBT, newly gained open chromatin regions are
related to development processes including pattern specification and embryonic
morphogenesis. As expected, open chromatin regions in liver are enriched for
enzymatic pathways. These data suggest our ATAC-seq at each stage is indeed
stage specific, and allow us to understand the specific regulatory network at each
stage.
At MBT, post-MBT and liver, more than 8000 genes are associated with open
chromatin regions, and these genes are expressed at a higher level compared to
genes that are not associated with open chromatin regions. In addition, highly tran-
scribed genes have stronger open chromatin, suggesting open chromatin play an
important role in gene expression. However, ∼16% of genes have open chromatin
but are not transcribed. Interestingly, the open chromatin regions of these genes
are enriched for H3K4me1 and H3K27me3. This bivalent mark is different from
the canonical bivalent marks that are composed of H3K4me3 and H3K27me3.
However, I speculate their functions are analogous, which is to poise genes for
transcription.
Here, I also explored the open chromatin of Pol III genes. Contrary to the
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genome-wide increase of chromatin accessibility from pre-MBT to MBT, Pol III
genes gradually lose chromatin accessibility around the TSS from pre-MBT to MBT.
Interestingly, active histone modifications are enriched at the promoters of open Pol
III genes. In addition, ∼16% of Pol III genes reside within 5kb of Pol II genes, and
Pol II is enriched at the Open Pol III genes. These observations suggest Open Pol
III genes are also associated with active histone modifications and Pol III genes
may take advantage of the accessible chromatin established by Pol II genes.
A number of over-represented motifs are discovered in open chromatin regions
at different stages, providing candidate transcription factors for future work. Some
factors with known roles in early embryogenesis including Pou5f3, SOX factors,
are identified at MBT and post-MBT, but not in liver. Other novel factors including
Nr2e3 and NFYB have not been implicated in early zebrafish development, and
will be interesting candidates for future studies. In line with the motif analysis,
Pou5f3 and Sox2, as well as two other factors Eomesa and Nanog, are enriched
in the open chromatin regions. They also display a different occupancy pattern
at intergenic and promoter regions. In addition, these factors bind both open
and closed chromatin and could function as pioneer factors to open up the local
chromatin.
Finally, ATAC-mono data can be used to map nucleosome positioning, but can-
not fully recapitulate the nucleosome occupancy map generated by MNase-seq.
5.3 Summary of the nucleosome positioning
in early zebrafish embryo
Genomic DNA is wrapped with histones, which form nucleosomes. Nucleo-
somes are the building blocks for higher-order chromatin, and are also essential
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for gene regulation. At regions with active transcription, DNA is accessible and
can be detected by ATAC-seq. While most of the genome are assembled into
nucleosomes, which can be better assessed by MNase-seq. In short, ATAC-seq
and MNase-seq are complementary in profiling chromatin landscape, but have
their respective advantages.
Therefore, as a complementary to ATAC-seq data, and to gain a comprehensive
view of dynamic nucleosome positioning, MNase-seq was carried out in early
zebrafish embryos and adult liver. To truly reflect the endogenous nucleosome
positioning, MNase-seq experiments were performed at both crosslinked and non-
crosslinked conditions. Globally, nucleosome positioning under the two conditions
were largely similar, while at genes and promoters, the variation emerged at the
weak nucleosome (-1 nucleosome, upstream of TSS). At MBT, crosslinked sample
clearly captured the -1 nucleosome, which was missing in the noncrosslinked sam-
ples. This is the first illustration of how crosslinking affects nucleosome mapping,
and is informative to the establishment of a standard procedure for MNase-seq.
To determine the dynamics of nucleosome positioning during early embryo-
genesis, nucleosome density across different stages was compared at different
levels. At genome-wide scale, nucleosome positioning at various stages was
largely similar (Pearson correlation > 0.8), which is not surprising since only less
than 2% of the genome are protein coding genes. At the levels of genes and
promoters, nucleosome positioning at pre-MBT displayed a significant difference
from that of other stages, which might be owing to the absence of transcription at
pre-MBT.
Nucleosome array is defined by the co-occurrence of -1 nucleosome upstream
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of TSS, nucleosome depletion regions, +1 nucleosome downstream TSS, and the
subsequent downstream nucleosomes after +1 nucleosome. I observed highly
transcribed or Pol-II bound genes formed nucleosome array around the TSS. Sur-
prisingly, the predicted nucleosome signal also displayed nucleosome array around
TSS, but the +1 nucleosome resided right at the center of TSS. The difference be-
tween the observed and predicted nucleosome positioning suggests factors other
than DNA sequence also influence the establishment of nucleosome. However,
the factor was not the actual transcription activities, as nucleosome positioning
was almost the same between untreated embryos and embryos treated with a-
amanitin and flavopiridol (transcription inhibitors). Instead, our data suggest Pol II
occupancy could serve as a barrier and mediate the nucleosome array formation.
In addition, Pol II bound genes or highly transcribed genes have a better periodicity
of A/T and G/C dinucleotides compared to genes not bound by Pol II or genes with
low-level transcription. Furthermore, promoters of zebrafish genes do not have
enrichment of polyA sequence, though it is prevalent at the promoters of yeast
genes.
In addition, observed nucleosome at all stages and predicted nucleosome were
enriched at exons. This enrichment is probably mediated by higher polyA (A5mer)
sequence at the 5’end of exons, higher GC content and periodicity of A/T and G/C
dinucleotides inside the exons. By k -mean clustering, exons of length 125-213bp
can be divided into two groups (exons with length larger than 213bp have not been
investigated). One group has weak A5mer frequency at the 5’end of exons and
strong A/T and G/C dinucleotides alternation inside exons. The other group has
strong A5mer frequency at the 5’end of exons and weak A/T and G/C dinucleotides
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alternation inside exons. Two groups of exons with different sequence attributes
can also be found in other organisms, suggesting these sequence characteristics
of exons are conserved.
5.4 Future direction for understanding the roles
of SWI/SNF complexes
My work on the genome-wide profiling of Brg1 and Brm in early zebrafish
embryos supports the importance of Brg1 and Brm in early embryogenesis, as
reported in mouse and fly. Furthermore, distinct roles of Brg1 and Brm are revealed
based on our results. However, there are some aspects of zebrafish SWI/SNF
complexes that need to be further explored.
SWI/SNF complexes are highly conserved and have been identified in many
organisms including yeast, fly, mouse, human (Winston & Carlson, 1992; Cairns
et al., 1994; Peterson & Tamkun, 1995). It is unlikely that zebrafish does not
have these complexes, especially all conserved subunits of SWI/SNF complexes
are present in fish. Moreover, the protein sequences of zebrafish SWI/SNF com-
plexes subunits are highly similar to their human homologs (Table 2.1). Therefore,
I believe Brg1 and Brm, the core enzymatic subunits of SWI/SNF complexes,
can be used to represent zebrafish SWI/SNF complex. Nevertheless, it would
be interesting to know the subunit composition of zebrafish SWI/SNF complexes,
and whether there is an embryo specific complex in zebrafish. Purifying the ho-
mogenate SWI/SNF complex and verifying each subunit by Mass Spectrometry
will address these questions.
Our current work in this study did not have the functional analysis to ascertain
the importance of Brg1 and Brm in early zebrafish development. Given an accurate
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assessment of their roles in early development, Brg1 and Brm maternal-zygotic null
fish are required since both proteins are maternally provided. With the advances of
CRISPR technology, it has become feasible to knockout Brg1 and Brm zygotically
and maternally. However, this work is still challenging and requires at least 18
months. To date, yng is the only brg1 mutant fish line available, whereas no brm
null fish has been established (Link et al., 2000). The zygotic brg1 null embryo
is lethal around 6-day postfertilization due to neural defects (Eroglu et al., 2006).
To eliminate the maternal provided Brg1 protein, a conditional null in oocytes is
required. This involves the establishment of a transgenic line with endogenous
brg1 flanked by loxP sites, and subsequent cross with Zp3-cre fish line (drive
the recombination specifically in oocytes). Of note, the success of the above
experiment relies on the presumption that Brg1 is not required for oogenesis. As
for Brm, we decided to generate the Brm null fish using CRISPR. Four guide RNAs
have been designed to target two loci in the ATPase domain of Brm. Cloning
and in vitro transcription of these guide RNAs were completed. Currently, the
purified guide RNAs are ready for injection to validate whether they are capable of
disrupting the targeted sequences.
Alternatively, other approaches can be applied to disrupt the functions of the
maternal deposited Brg1 and Brm proteins, including morpholino (MO) knock-
down, expressing dominant negative constructs and antibody depletion. I have
extensively tested MOs to block the translation of Brg1 and Brm, respectively. Un-
fortunately, Brm MO had minimal impact on the injected embryos, where only mild
ventralization defects were discernable even at a very high dose of MO injection.
Brg1 MO caused embryo lethality around 5dpf, which is similar to the Brg1 null
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fish. However, residual Brg1 is still detectable in the MO injected embryos. In
summary, previous attempts using translational blocking MOs fail to deplete the
maternally inherited Brg1 and Brm. I also tried to express the dominant negative
Brg1 (point mutation K757R inactivates the enzymatic activities of Brg1). However,
the dominant negative Brg1 was translated at a low level, which might be ineffi-
cient to compete with the wildtype Brg1. Nevertheless, optimizing the polyA tail
length, or trying different protein tag (currently tagged with V5) might increase the
translational efficiency. As an alternative, a short dominant negative Brg1 that only
covers the ATPase domain might be better translated and still be able to antagonize
the wildtype Brg1. Finally, injecting Brg1 and Brm antibody may sequester the
Brg1 and Brm proteins, which is theoretically possible but has not been tested.
Taken together, disrupting the functions of maternally provided Brg1 and Brm is
challenging, and previous attempts failed to do so. Alternative approaches are
suggested and need to be further explored.
Using Brg1 and Brm as a proxy for SWI/SNF complexes, I observed their
occupancy at Pol II genes is robust and prevalent. Could Pol I and Pol III genes also
be regulated by SWI/SNF complexes? To test, I intersected the SWI/SNF binding
sites with annotated Pol III genes. I identified 221 Pol III genes, most of which are
tRNAs, that are highly enriched for Brg1 and Brm. I also observed active histone
modifications around the TSS of these Pol III genes. This interesting observation
suggests that SWI/SNF complexes could also regulate Pol III gene expression. A
followed up analysis on Pol I genes would provide further insights on the gene
regulation roles of SWI/SNF complexes.
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5.5 Future direction for understanding chromatin
accessibility in early zebrafish embryo
The work in Chapter 3 included in-depth bioinformatics analysis for the acquired
ATAC-seq data at various stages. There are a few interesting questions that have
not been fully investigated by the current analyses or experiments and are dis-
cussed as below.
Our ATAC-seq data demonstrated a substantial increase in chromatin acces-
sibility from pre-MBT to MBT, which is around ZGA. The accessible genome is
probably required for the ‘burst’ of genome-wide transcription activation. This
observation is consistent with the recent chromatin accessibility profiles in mouse
embryos, where the number of accessible regions at early 2-cell stage (before
ZGA) is around ∼20,000, which increases to ∼50,000 at 2-cell stage (ZGA) (Wu
et al., 2016). The increase of chromatin accessibility could be required preced-
ing ZGA or might be established due to the transcription at ZGA. Here, it will
be interesting to determine how transcription activity shapes the accessibility in
early embryos, which can be investigated by combining a-amanitin injection (which
inhibits transcription initiation) and ATAC-seq. Interestingly, in mouse embryo, the
open chromatin regions before zygotic genome activation (early 2-cell stage in
mouse, pre-MBT in zebrafish) are highly enriched at repetitive elements (Wu et al.,
2016). Among them, MERVLs are most enriched, which are highly transcribed
at ZGA and may activate over 300 genes (Peaston et al., 2004). Since most of
my open chromatin regions at pre-MBT are localized at intergenic regions, and
a lot of them are close to repetitive elements (by manually scanning through the
genome browser), it would be interesting to investigate whether repetitive elements
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in zebrafish are also relatively open before ZGA. Notably, only unique reads are
aligned for all the ATAC-seq paried-end data. This procedure will naturally filter out
the reads generated from repetitive regions. Hence, alternative alignment method
and downstream analysis can be performed to test whether repetitive elements are
also relatively open in early zebrafish embryo.
Comparing ChIP-seq data of Brg1 and Brm to ATAC-seq data, a large percent-
age of open chromatin regions are not occupied by Brg1 and Brm. It is known that
other chromatin remodelers are involved in the regulation of early development as
well. Knockout Mbd3 (subunits of the NuRD complexes) in mice lead to embryonic
lethality around implantation (Kaji et al., 2006, 2007). Deletions of ISWI complexes
subunits, Batf and Snf2H, are also embryonic lethal (Landry et al., 2008; Stopka &
Skoultchi, 2003). In ES cells, members of INO80 (Ep400) and CHD (Chd1, Chd4,
Ch6, Chd8) chromatin remodeler family are highly enriched at promoters of active
genes (de Dieuleveult et al., 2016). Together, they suggest other factors are also
involved in the establishment of accessible chromatin in the early embryo.
In the past, I have generated custom polyclonal antibodies against members
of all four families of chromatin remodelers, which are listed in Appendix B. Brg1
and Brm are two of them, which belong to SWI/SNF complexes. I also have Chd1,
belongs to CHD complexes; Ino80, belongs to INO80 complexes; Snf2h and Snf2l
which belongs to ISWI complexes. Antibodies for Snf2l, and especially Snf2h, are
quite promising. However, Chd1 and Ino80 did not recognize their corresponding
proteins based on Western blotting use unpurified serum. It is likely that affinity
purification will enrich the respective antibodies, and result in specific immunoblot-
ting results. Nevertheless, Snf2h antibodies have been purified, and ChIP-seqs
216
have been performed at MBT and post-MBT stages, with two replicates for each
stage. A close examination of these available data and further investigation of
other chromatin remodelers should be followed.
Recent ATAC-seq in mouse embryo suggests open chromatin is evident at pro-
moter with low CG density (Wu et al., 2016). However, others suggest CpG islands
in mammals are largely depleted of nucleosome (Wang et al., 2012). It will be
intriguing to determine the relationship between CpG density and chromatin acces-
sibility in early zebrafish embryos. A related question is how does DNA methylation
affect chromatin state? Moreover, whether different promoter (TATA box containing
and TATA-less) types maintain a different chromatin state. In conclusion, it would
be interesting to determine whether genes employed different strategies to gain
accessibility at promoters and enhancers by examining the characteristics of the
cis elements (GC density, TATA box, CTCF), histone codes (ChIP-seq of various
histone modifications) and DNA methylation status.
5.6 Future direction for understanding nucleosome
positioning in early zebrafish embryo
My nucleosome positioning data revealed very interesting sequence attributes
at promoters and exons. Some attributes are probably unique to teleost fish, while
some are conserved among vertebrates. There are a couple of questions that are
not fully addressed in the current study and are intriguing for future investigations.
Besides transcription start sites, transcription stop site (TTS) is another impor-
tant regulator of gene expression. In yeast, higher frequency of AA/TT sequences
has been observed, which leads to array formation upstream of the TTS (Mavrich
et al., 2008a). In addition, nucleosome is depleted at the TTS in both yeast and fly
217
(Kaplan et al., 2009; Zhang et al., 2009; Mavrich et al., 2008b). Furthermore, cleav-
age and polyadenylation sites, AATAAA, could serve as a poly(dA:dT) sequence
that defers nucleosomes. All this evidence suggests TTS might have a lower
nucleosome density which is probably regulated partly through DNA sequences.
In yeast, another poly(dA:dT) sequence, ATATA, has very low nucleosome den-
sity, at a similar level to AAAAA (A5mer) (Kaplan et al., 2009). Both ATATA and
AATAAA (cleavage and polyadenylation sites) are different from the A5mer se-
quence that I have profiled for TSS and exons. Notably, there are 1024 possible
sequence combinations for a 5nt long DNA. It is possible that zebrafish employed
poly(dA:dT) sequences other than A5mer. To evaluate which poly(dA:dT) se-
quence is preferably used in zebrafish, averaged nucleosome density on all 1024
possible combinations of a 5nt sequence (5mer) can be collected and compared.
It is also likely that at TSS or TTS, different poly(dA:dT) sequences are enriched,
which can be tested by plotting the frequency of these 1024 5mers as the A5mer
sequence.
In the first paper proposing the statistical positioning model, the author specu-
lated that sites bound by proteins might serve as barriers. Based on this assump-
tion, both enhancers (usually bound by p300) and transcription factors binding
sites could act as boundaries, and will be interesting to test. Enhancers can be
defined by ChIP-seq data of H3K4me1 and H3K27ac. Nanog, Pou5f3, Sox2, and
Eomesa are important regulator of early embryogenesis and have been proposed
in Chapter 2 to serve as pioneer factors. In addition, they are enriched in Brg1- and
Brm-bound regions, as well as open chromatin regions determined by ATAC-seq.
It would be interesting to know whether their binding could be informative to place
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nucleosomes and shape the chromatin landscape.
In the past, I consistently observed a unique type of nucleosome maps which is
characterized by low nucleosome density genome-wide and extremely high nu-
cleosome density over exons. This type of nucleosome positioning has been
observed in many cell types, including cells from early embryo (2.5hpf, 4hpf and
5.3hpf), cells from 5dpf embryo, liver cells, and ZF4 cells (zebrafish fibroblast
cell lines (Driever & Rangini, 1993)). As I already demonstrated in the Results
of Chapter 4, exons harboring specific sequences enhance the affinity between
exons and nucleosomes. It is possible that nucleosomes are most stable on exons
and are preferentially retained, whereas weak nucleosomes are lost under certain
experiment conditions. This result, if it is true, suggests endogenous DNA is
a key determinant of nucleosomes in zebrafish. However, in other experiment
conditions, as what I did in Chapter 4, both strong and weak nucleosomes are
equally represented. Therefore, under normal experiment conditions, the dominant
role of DNA sequence in positioning nucleosome is impossible to perceive.
To confirm the high enrichment of nucleosome on exons truly reflect a group
of most stable nucleosome, I have to be able to replicate this unique nucleosome
map, and understand what experiment conditions lead to this result. However, I
cannot fully replicate these maps even with exhaustive attempts testing many differ-
ent aspects of MNase-digestion. Recently, two nucleosome maps were compared;
one is from Aug 2014, and the other is from April 2016. They both used the same
mono-nucleosome DNA but were generated with different reagents during the
steps of library preparation and Illumina sequencing. The two nucleosome maps
are largely similar, which rules out the possibility that exonic sequences are over-
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represented during the PCR amplification step of library preparation and Illumina
sequencing. In addition, preliminary data suggest composition of the nucleosome
digestion buffer may influence the chromatin digestion and the corresponding nu-
cleosome map. A closer examination of this issue will help us to ascertain whether
DNA sequence plays a dominant role in determining the strongest nucleosomes
formation on exons.
5.7 Concluding remarks
During early embryogenesis, the maternally provided factors are gradually de-
graded while the zygotic genome undergoes ‘minor’ and ‘major’ wave of gene
activation and reaches a pluripotent state. These embryonic cells are pluripotent
because they have the potential to differentiate into any cell lineages. Elucidating
how pluripotency is regulated is essential for our understanding of development,
reprogramming, regeneration and tumorigenesis.
The remarkable plasticity of pluripotent cells relies on a unique transcriptome.
Specifically, genes that are required for early development and basic homeostasis
are selectively activated, whereas genes functioning during lineage commitment
are poised in a repressed but competent state. This transcription circuit is tightly or-
chestrated at multiple levels, including chromatin accessibility. Chromatin accessi-
bility controls the binding of transcription factors and coregulators to promoters and
enhancers, and thus influences gene expression. In this dissertation, I focused on
understanding what is the chromatin accessibility landscape in the early zebrafish
embryo, and how that is regulated by SWI/SNF complexes. To answer these
questions, I have employed a variety of techniques including biochemistry (for
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antibody generation), molecular biology, genomics (ChIP, ATAC-seq and MNase-
seq) and bioinformatics. I observed the genome is largely refractory at pre-MBT
(before zygotic genome activation) which becomes increasingly accessible at MBT
and post-MBT (after zygotic genome activation). Contrary to the genome-wide
increased accessibility, chromatin around Pol III genes becomes gradually inac-
cessible along the early development. Motif analysis of the accessible chromatin
regions allows me to identify candidate transcription factors (Nr3e2, Nfyb, Pou5f3,
Sox factors, Nanog and Eomesa), which may be involved in the establishment
of open chromatin regions and/or the regulation of the unique transcriptome in
the early embryo. Chromatin accessibility is modulated by chromatin remodelers,
one major class of which are SWI/SNF complexes. My work revealed the im-
portant roles of SWI/SNF complexes (represented by the ATPase subunits Brg1
and Brm) in early zebrafish development, as well as specific roles of Brg1 and
Brm. Specifically, Brg1- but not Brm-bound regions are highly enriched for active
histone modifications, whereas Brm but not Brg1 displayed prevalent distribution
over gene bodies. In addition, Brm precisely co-localize with Pol II at the gene
body, which is due to the association with Pol II during transcription elongation,
suggesting Brm may function in transcription elongation. Additionally, nucleosome
positioning data allow me to discover many interesting sequence characteristics
on promoters and exons, which provide novel insights on how nucleosomes are
placed in the genome.
Many interesting observations have been made in the dissertation, some of
which need to be further validated or explored for their biological impact. In par-
ticular: whether the identified candidate transcription factors indeed play roles in
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early embryogenesis; whether the important roles of SWI/SNF complexes can be
validated by functional studies; what is the interplay between transcription factor,
histone modification and SWI/SNF complex in shaping the chromatin accessibility;
what are the functions of Brm enrichment over gene bodies, and what are the
underlying mechanisms for the specialized function of Brg1 and Brm?
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Zebrafish is a valuable model system that has been used in many different
fields. However, one disadvantage is the limited commerically available antibodies.
Here, I summarized all the commercial antibodies that have been tested (Table
A.1. and Table A.2.). Most antibodies are against transcription factors, and some
are against chromatin remodelers. Antibodies against Pou5f3 and Foxh1 work
well for both Western blotting and ChIP. The Western blotting results of promising
antibodies are presented in following figures.
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Table A.1: Antibodies which recognize the corresponding proteins
Antibody Source Company Cat# Lot# WB ChIP-WB
Pou5f1 pRb Anaspec 55832 CT JK3013 1:1000 YES
55832 CT JK3014 1:1000 YES
55833 IN JK3002 1:1000 NA
Foxh1 pRb Anaspec 55671 IN JK3004 1:1000 YES
JK3003 1:1000 NA
NF-kb2 pRb Anaspec 55484 IN JL2804 1:1000 NA
b-catenin pRb Sigma C2206 NA 1:2000 YES
TBP mMs millpore MAB3658 NG1837795 1:1000 YES
Sox2 Goat R&D AF2018 KOY0110041 1:1000 NA
PolII mMs Covance MMS-126R 8WG16 1:1000 YES
mMs Active Motif 102660 NA 1:1000 YES
Lamin B2 mMs Abcam Ab8983 NA 1:1000 NA
Brg1* mMs Santa Cruz sc-17796 D2012 1:2000 NA
* Brg1 antibodies from different lot# have varies results
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Table A.2: Antibodies which do not recognize the corresponding proteins
Antibody Clonal Company Cat# Lot#
Foxh1 pRb Anaspec 55670 CT JK3007
JK3008
Snail1a pRb Anaspec 55648 IN JG3005
Snail1b pRb Anaspec 55649 IN JI0904
Sox11a pRb Anaspec 55854 NT JF2107
Pea3 pRb Anaspec 55589 CT JG0107
JG0108
TP53 pRb Anaspec 55915 IN JK0403
beta-catenin 1/2 pRb Anaspec 55365 CT JH1211
Hmga1 pRb Abcam Ab4078 GR7262-1
Lef1 pRb Abcam Ab52017 906861
Smad3 mMs Cell Signaling C67h9 7#5
p-smad3-Ser423/425 mMs Cell Signaling C25A9 #10
Brg1 pRb Abcam Ab4801 NA
Brg1 pRb Cell Signaling 3508S A52, #1
Brm pRb Abcam Ab15597 NA
Brm pRb Fisher PA5-34597 NA
BAF155 pRb Santa Cruz SC-10756 X Lot # A0813
BAF170 pRb Santa Cruz SC-10757 X Lot # G1603
CHD7 pRb Abcam Ab31824 NA
PolII pRb Abcam 817-100 NA
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Figure A.1: Western blotting and ChIP-qPCR of Pou5f3. (A-C) Western blotting
against Pou5f3 using different antibodies. Whole embryo lysate from different
stages are used. (D) ChIP-qPCR of Pou5f3 using antibody recognizing the internal
protein sequence (IN) and antibody recognizing the C-terminus protein sequence
(CT).
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Figure A.2: Validated commercial antibodies. (A-E) Immunoblotting against differ-
ent protein with their specific antibodies.
APPENDIX B
ADDITIONAL CUSTOMIZED POLYCLONAL ANTIBODIES
Chromatin remodelers can be classified into four major families, including SWI/
SNF, ISWI, CHD and INO 80 families. In general, SWI/SNF complexes eject
and slide nucleosome to promote transcription activation, while most ISWI family
complexes (ACF, CHRAC) assemble nucleosome in a regularly spaced manner
to compact nucleosomes and repress transcription. CHD family complexes are
involved in both transcription activation (CHD1) and repression (NuRD). INO80
family complexes not only regulate transcription, but also play a role in DNA repair
and DNA replication. To gain a comprehensive understanding on the different
roles of chromatin complexes in the regulation of early zebrafish development,
I have customized polyclonal antibodies against additional chromatin remodeler
complexes besides Brg1 and Brm, including BAF180, SNF2H, SNF2L, CHD1 and
INO80 (Table B.1.).
Additionally, I am very interested in the roles of transcription factors in the
regulation of zygotic genome activation. I first tested many commercial antibodies,
and found Pou5f3 and Foxh1 antibodies are very promising. However, to com-
prehensively investigate the roles of transcription factors, I would like to include
some general transcription factors, and a few development regulators. To this
end, I have generated polyclonal antibodies against different transcription factors,
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including Oct1, Sp1, Sox2, Eomesa and Zeb2b (Table B.1.).
B.1 Peptide expression
The principle for designing antigen is similar to that for Brg1 and Brm, where
around 40AA at N-terminal and C-terminal are chose. However, for SNF2H and
SNF2L, because C-terminal regions are identical between the two proteins, only
the different N-terminal regions are used (Figure B.1). The cloning strategy for the
10 proteins is also similar to that for Brg1 and Brm, except for SNF2L and Sox3.
For SNf2L and Sox3, two long oligos coding the entire peptide were synthesized,
annealed, and directly ligated to the pET-duet1 vector backbone cut by BamHI and
NotI. The long oilgos and primers are listed in Table B.2.
B.2 Antibodies result
As indicated in Table B.1., out of 10 antibodies, only SNF2H, SNF2L, Oct1 and
Sox3 have shown promising results determined by Western blotting. However,
we cannot completely rule out the possibility that the other antibodies might still
recognize the target proteins unless we 1) affinity purify the antibody and 2) test
the antibodies in lysate from different zebrafish embryonic stages.
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Table B.1: Protein and antigen information
Name family Antigen Full length Cloning sites D90 serum
Baf180 SWI/SNF XP 693735.4 1581 AA N-term: R146-V185 Not promising
C-term: A1525-L1564
SNF2H ISWI NP 001075098.2 1035 AA N-term: M8-G62 Great
SNF2L ISWI NP 001093467.1 1036 AA N-term: M1-E42 OK
CHD1 CHD XP 009303375 1778 AA N-term: M1-S40 Not promising
C-term: P1649-D1689
INO80 INO80 NP 001038584.1 1552 AA N-term: K281-K320 Not promising
C-term: E1281-G1320
Oct1 NP 571513.1 596 AA N-term: M1-P44 Great
C-term: G412-A451
Sp1 NP 997827.2 594 AA N-term: E8-S47 Not promising
C-term: R521-V560
Sox3 NP 001001811.2 300 AA N-term: K10-N30 OK
C-term: G263-T289
Eomesa NP 571754.3 661 AA N-term: N30-T69 Not promising
C-term: S610-H649
Zeb2b NP 001232895.1 1219 AA N-term: L64-E103 Not promising
C-term: N1270-V1219
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Figure B.1: Strategy for antigen peptide cloning and expression
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Figure B.3: Western blotting of Oct1 and SNF2L. (A) Western blotting against
Oct1 in protein lysate from 24hpf embryo or ZF4 fibroblast cell lines. PCA (peptide
competition assay) is to confirm the antibody specificity. (B) Oct1 expression levels
in early development. (C) Western blotting against SNF2L in protein lysate from
24hpf embryo or ZF4 fibroblast cell lines, and PCA.
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Figure B.4: Western blotting of SNF2H. (A) Western blotting against SNF2H using
D0 serum (control) and D90 serum in protein lysate from 24hpf. (B) Western blot-
ting using flow-through, unpurified antibody and purified antibody against SNF2H




Figure B.5: Western blotting of Sox3. (A) Western blotting against Sox3 in
protein lysate from 24hpf embryo or ZF4 fibroblast cell lines, and PCA. (B) Sox3
expression levels in early development.
APPENDIX C
CDNA CONSTRUCTS OF CHROMATIN REMODELERS
AND TWO TRANSCRIPTION FACTORS
C.1 Wildtype cDNA construct
I have extensively tested commercial antibodies and customized polyclonal
antibodies, in the hope of finding antibodies that are applicable for ChIP-seq. Some
candidates can be robustly recognized by their specific antibodies, while others
are still lacking specific antibodies. To circumvent the constraint from antibody, I
decided to overexpress cDNA tagged by V5. This enables us to investigate the
genome-wide occupancy of candidate proteins by performing ChIP-seq with V5
antibody. In summary, we have cloned cDNA for four chromatin remodeler sub-
units (SNF2H, SNF2L, CHD1 and INO80), and three transcription factors (Pou5f3,
Nanog, and Sox19b) (Table C.1.). The cDNAs have been engineered into pCS2+
vector containing 2XV5 tags at the downstream of multicloning sites. Translational
efficiency of in vitro transcribed RNA has not been investigated.
C.2 Dominant negative construct
Since protein levels of Brg1, Brm and SNF2H are largely unaffected by mor-
pholino injection, I speculate maternally inherited SNF2H protein may be sufficient
to support the embryo through the early development. To disrupt the maternal pro-
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tein, I cloned catalytic dead constructs for Brg1, Brm and SNF2H. Point mutations
for zebrafish Brg1 is K797R, for zebrafish Brm is K757R, and for zebrafish SNF2H
is K187R. In principle, the catalytic dead proteins can still form complexes with
other subunits. However, they lose the ability to slide or eject nucleosome due to
the impaired ATPase function, and thus serve as dominant negative mutant.
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SNF2H K187R (dominant negative)
K187R-F CTTGCTGATGAAATGGGTCTTGGTAGGACCCTCCAGAC
CATCTCTCTGCTG
K187R-R CAGCAGAGAGATGGTCTGGAGGGTCCTACCAAGACCCA
TTTCATCAGCAAG
SNF2L
SNF2L-F ATGTCGGACGAAGAGCTACCGTCTAC
SNF2L-R GGTACGAGCTTTCTTCTCCTTTTTCTCAGATGAC
EcoRI-Snf2L-F CGGAATTCCgccaccATGTCGGAC
snf2L-SpeI-R ggactagtccGGTACGAGCTTTCTTCTCC
CHD1
CHD1-F ATGGATGGACGCAGCGAGGATG
CHD1-R TGTCTTGCGGCCGCTCC
BamHI-CHD1-F cgGGATCCCgccaccATGGATGG
CHD1-SpeI-R ggactagtccTGTCTTGCGGCCGC
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Table C.1: Continued
INO80
INO80-F ATGGCCTCAGGGCAGGATGG
INO80-R CCGTCCACTGTGGTTGCTGG
EcoRI-INO80-F cgGAATTCCgccaccATGGCCTCAG
INO80-SpeI-R ggactagtccCCGTCCACTGTGGTTG
Oct4
SNF2L-F ATGACGGAGAGAGCGCAGAGC
SNF2L-R GCTGGTGAGATGACCCACCAAACC
EcoRI-Snf2L-F cgGAATTCcgccaccATGACGGAGAGAG
snf2L-SpeI-R ggactagtccGCTGGTGAGATGACCCACC
Nanog
Nanog-F ATGGCGGACTGGAAGATGCCAG
Nanog-R CAGCAAAGTTATTCCTTTAGTTGCCCACAGG
EcoRI-Nanog-F cgGAATTCcgccaccATGGCGGAC
Nanog-SpeI-R ggactagtccCAGCAAAGTTATTCCTTTAGTTGCCCAC
Sox19b
Sox19b-F ATGATGTACAGCATGATGGAGCACGAG
Sox19b-R GATGTGAGTGAGGGGAACAGTTCC
EcoRI-Sox19b-F cgGAATTCcgccaccATGATGTACAGCATGATGG
Sox19b-SpeI-R ggactagtccGATGTGAGTGAGGGGAACAGTTCC
